<?xml version="1.0" encoding="us-ascii"?>
<!-- Prepared by Clarity FSR  v6.5.1.1179 using Fujitsu Interstage XWand -->
<xbrli:xbrl xmlns:ci="http://www.ci.com/20101231" xmlns:negated="http://xbrl.us/us-gaap/negated/2008-03-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-roles="http://xbrl.us/us-roles/2009-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:invest="http://xbrl.us/invest/2009-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.us/dei/2009-01-31" xmlns:us-gaap="http://xbrl.us/us-gaap/2009-01-31" xmlns:ref="http://www.xbrl.org/2006/ref">
  <link:schemaRef xlink:type="simple" xlink:href="ci-20101231.xsd"/>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2007">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2007-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2007-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2007-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2007-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2007-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2007-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2007-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_ShareholderComprehensiveIncomeLossAndShareholdersEquityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:ShareholderComprehensiveIncomeLossAndShareholdersEquityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_ShareholderComprehensiveIncomeLossAndShareholdersEquityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:ShareholderComprehensiveIncomeLossAndShareholdersEquityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_ShareholderComprehensiveIncomeLossAndShareholdersEquityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:ShareholderComprehensiveIncomeLossAndShareholdersEquityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jun30_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jan31_2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_BusinessDispositionAxis_AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionRunOffWorkersCompensationAndPersonalAccidentBusinessMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:BusinessDispositionAxis">ci:AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionRunOffWorkersCompensationAndPersonalAccidentBusinessMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_BusinessDispositionAxis_SaleOfWorkersCompensationAndCaseManagementBusinessMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:BusinessDispositionAxis">ci:SaleOfWorkersCompensationAndCaseManagementBusinessMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_BusinessAcquisitionAxis_VanbredaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:VanbredaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:GreatWestHealthcareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:GreatWestHealthcareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_DisabilityAndLifeSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:DisabilityAndLifeSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_DisabilityAndLifeSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:DisabilityAndLifeSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_GoodwillBySegmentAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Dec31_2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_MoreThanThreeAndWithinFourYearsFromBalanceSheetDateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FiveYearsAndThereafterAxis">us-gaap:MoreThanThreeAndWithinFourYearsFromBalanceSheetDateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_MoreThanFiveYearsFromBalanceSheetDateAndThereafterMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FiveYearsAndThereafterAxis">us-gaap:MoreThanFiveYearsFromBalanceSheetDateAndThereafterMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_OneYearFromBalanceSheetDateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FiveYearsAndThereafterAxis">us-gaap:OneYearFromBalanceSheetDateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_MoreThanTwoAndWithinThreeYearsFromBalanceSheetDateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FiveYearsAndThereafterAxis">us-gaap:MoreThanTwoAndWithinThreeYearsFromBalanceSheetDateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_MoreThanFourAndWithinFiveYearsFromBalanceSheetDateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FiveYearsAndThereafterAxis">us-gaap:MoreThanFourAndWithinFiveYearsFromBalanceSheetDateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue201985InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2018635InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20204375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20204375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20204375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20204375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20205125InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20205125InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20205125InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20205125InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue201985InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Mar31_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Apr01_2010_TO_Jun30_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-04-01</xbrli:startDate>
      <xbrli:endDate>2010-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jul01_2010_TO_Sep30_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-01</xbrli:startDate>
      <xbrli:endDate>2010-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct01_2010_TO_Dec31_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-10-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Mar31_2009">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Apr01_2009_TO_Jun30_2009">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-04-01</xbrli:startDate>
      <xbrli:endDate>2009-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jul01_2009_TO_Sep30_2009">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-07-01</xbrli:startDate>
      <xbrli:endDate>2009-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct01_2009_TO_Dec31_2009">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-10-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_BusinessDispositionAxis_SaleOfWorkersCompensationAndCaseManagementBusinessMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:BusinessDispositionAxis">ci:SaleOfWorkersCompensationAndCaseManagementBusinessMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Sep30_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Sep30_2010_us-gaap_BusinessAcquisitionAxis_VanbredaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:VanbredaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareBasicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareDilutedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareDilutedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareDilutedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">ci:EffectOfDilutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">ci:EffectOfDilutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">ci:EffectOfDilutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareBasicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareBasicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2007_TO_Dec31_2007">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2007-01-01</xbrli:startDate>
      <xbrli:endDate>2007-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jul01_2009_TO_Sep30_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-07-01</xbrli:startDate>
      <xbrli:endDate>2009-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jul01_2009_TO_Sep30_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-07-01</xbrli:startDate>
      <xbrli:endDate>2009-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-10-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-10-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Mar31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Apr01_2010_TO_Jun30_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-04-01</xbrli:startDate>
      <xbrli:endDate>2010-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jul01_2010_TO_Sep30_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-01</xbrli:startDate>
      <xbrli:endDate>2010-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct01_2010_TO_Dec31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:CostReductionRollforwardBySeveranceAndRealEstateAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-10-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_HighestAnniversaryAnnuityValueMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis">ci:HighestAnniversaryAnnuityValueMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_AnniversaryValueResetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis">ci:AnniversaryValueResetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_OtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis">us-gaap:OtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_TotalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis">ci:TotalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_HighestAnniversaryAnnuityValueMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis">ci:HighestAnniversaryAnnuityValueMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_AnniversaryValueResetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis">ci:AnniversaryValueResetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_OtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis">us-gaap:OtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_TotalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis">ci:TotalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_OtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_TotalIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ci:TotalIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_OtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_TotalReportedInOtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ci:TotalReportedInOtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_TotalReportedInOtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ci:TotalReportedInOtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_SoftwareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_SoftwareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_TotalIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ci:TotalIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_PropertyPlantAndEquipmentByTypeAxis_OtherCapitalizedPropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_PropertyPlantAndEquipmentByTypeAxis_OtherCapitalizedPropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_PropertyPlantAndEquipmentByTypeAxis_TotalPropertyAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ci:TotalPropertyAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_PropertyPlantAndEquipmentByTypeAxis_TotalPropertyAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ci:TotalPropertyAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DepreciationAndAmortizationByTypeAxis_SoftwareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">us-gaap:SoftwareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DepreciationAndAmortizationByTypeAxis_SoftwareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">us-gaap:SoftwareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_DepreciationAndAmortizationByTypeAxis_SoftwareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">us-gaap:SoftwareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DepreciationAndAmortizationByTypeAxis_OtherCapitalizedPropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DepreciationAndAmortizationByTypeAxis_OtherCapitalizedPropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DepreciationAndAmortizationByTypeAxis_TotalPropertyAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">ci:TotalPropertyAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DepreciationAndAmortizationByTypeAxis_OtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">us-gaap:OtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DepreciationAndAmortizationByTypeAxis_OtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">us-gaap:OtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_DepreciationAndAmortizationByTypeAxis_OtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">us-gaap:OtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_DepreciationAndAmortizationByTypeAxis_TotalPropertyAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">ci:TotalPropertyAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DepreciationAndAmortizationByTypeAxis_TotalPropertyAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DepreciationAndAmortizationByTypeAxis">ci:TotalPropertyAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_DefinedBenefitPensionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:DefinedBenefitPensionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_OtherPostretirementBenefitPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_DefinedBenefitPensionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:DefinedBenefitPensionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_OtherPostretirementBenefitPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_DefinedBenefitPensionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:DefinedBenefitPensionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_DefinedBenefitPensionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:DefinedBenefitPensionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_DefinedBenefitPensionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:DefinedBenefitPensionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_OtherPostretirementBenefitPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_OtherPostretirementBenefitPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_OtherPostretirementBenefitPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_DefinedBenefitPensionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:DefinedBenefitPensionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_OtherPostretirementBenefitPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel3Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel3Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_FixedMaturitiesAndEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:FixedMaturitiesAndEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct22_2010_TO_Oct23_2010_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-10-22</xbrli:startDate>
      <xbrli:endDate>2010-10-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_FixedMaturitiesAndEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:FixedMaturitiesAndEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_FixedMaturitiesAndEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:FixedMaturitiesAndEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct14_2010_TO_Oct15_2010_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetTypeAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-10-14</xbrli:startDate>
      <xbrli:endDate>2010-10-15</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis_PortionAtAmortizedCostDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis">ci:PortionAtAmortizedCostDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis_UnrealizedGainMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis">ci:UnrealizedGainMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis_UnrealizedLossOrWriteDownMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis">ci:UnrealizedLossOrWriteDownMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis_PortionAtFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis_PortionAtAmortizedCostDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis">ci:PortionAtAmortizedCostDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis_UnrealizedGainMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis">ci:UnrealizedGainMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis_PortionAtFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis_UnrealizedLossOrWriteDownMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostReportedAmountsByCategoryAxis">ci:UnrealizedLossOrWriteDownMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_OfficeBuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:OfficeBuildingsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_ApartmentBuildingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:ApartmentBuildingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_IndustrialMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:IndustrialMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_HotelsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:HotelsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_RetailFacilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:RetailFacilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_OtherPropertyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:OtherPropertyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_PacificRegionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:PacificRegionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_SouthAtlanticRegionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:SouthAtlanticRegionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_NewEnglandRegionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:NewEnglandRegionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_CentralRegionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:CentralRegionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_MiddleAtlanticMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:MiddleAtlanticMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_MountainMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:MountainMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_OfficeBuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:OfficeBuildingsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_ApartmentBuildingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:ApartmentBuildingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_IndustrialMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:IndustrialMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_HotelsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:HotelsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_RetailFacilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:RetailFacilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_OtherPropertyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ci:OtherPropertyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_PacificRegionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:PacificRegionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_SouthAtlanticRegionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:SouthAtlanticRegionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_NewEnglandRegionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:NewEnglandRegionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_CentralRegionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:CentralRegionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_MiddleAtlanticMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:MiddleAtlanticMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis_MountainMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:MortgageLoansOnRealEstateGeographicLocationOfPropertyAxis">ci:MountainMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioTotalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioTotalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansReservesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansReservesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansReservesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansReservesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommerciaLmortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_OtherLongTermInvestmentsAxis_RealEstateInvestmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_OtherLongTermInvestmentsAxis_SecurityPartnershipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">ci:SecurityPartnershipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_OtherLongTermInvestmentsAxis_InterestRateAndForeignCurrencySwapsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">ci:InterestRateAndForeignCurrencySwapsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_OtherLongTermInvestmentsAxis_MezzanineLoansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">ci:MezzanineLoansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_OtherLongTermInvestmentsAxis_OtherLongTermInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_OtherLongTermInvestmentsAxis_RealEstateInvestmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_OtherLongTermInvestmentsAxis_SecurityPartnershipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">ci:SecurityPartnershipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_OtherLongTermInvestmentsAxis_InterestRateAndForeignCurrencySwapsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">ci:InterestRateAndForeignCurrencySwapsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_OtherLongTermInvestmentsAxis_MezzanineLoansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">ci:MezzanineLoansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_OtherLongTermInvestmentsAxis_OtherLongTermInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:OtherLongTermInvestmentsAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DerivativesDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DerivativesDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20175375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20175375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20117InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20117InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20116375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20116375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2018635InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2021637InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2021637InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2023765InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2023765InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue202383InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue202383InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_DebenturesDue20277875InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:DebenturesDue20277875InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_StepDownNotesDue203383InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:StepDownNotesDue203383InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2036615InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2036615InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_OtherLongTermDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:OtherLongTermDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue20117InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20117InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue20116375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20116375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue20175375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20175375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_DisabilityAndLifeSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:DisabilityAndLifeSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2018635InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue201985InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue20204375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20204375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue20205125InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20205125InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue2021637InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2021637InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue2023765InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2023765InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue202383InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue202383InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_DebenturesDue20277875InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:DebenturesDue20277875InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_StepDownNotesDue203383InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:StepDownNotesDue203383InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_NotesDue2036615InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2036615InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_LongtermDebtTypeAxis_OtherLongTermDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:OtherLongTermDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_DisabilityAndLifeSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:DisabilityAndLifeSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_DisabilityAndLifeSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:DisabilityAndLifeSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_RunOffReinsuranceSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:RunOffReinsuranceSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_RunOffReinsuranceSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:RunOffReinsuranceSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_RunOffReinsuranceSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:RunOffReinsuranceSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_OtherOperationsSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_OtherOperationsSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_OtherOperationsSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_CorporateSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:CorporateSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_CorporateSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:CorporateSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_CorporateSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:CorporateSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_GuaranteedMinimumIncomeBenefitsFairValueGainLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_GuaranteedMinimumIncomeBenefitsFairValueGainLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_RealizedGainLossOnSaleOfInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:RealizedGainLossOnSaleOfInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_RealizedGainLossOnSaleOfInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:RealizedGainLossOnSaleOfInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_FixedMaturitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_FixedMaturitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_PolicyLoansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:PolicyLoansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_OtherLongTermInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_NoninterestExpenseInvestmentAdvisoryFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:NoninterestExpenseInvestmentAdvisoryFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_FixedMaturitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_PolicyLoansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:PolicyLoansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_OtherLongTermInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_NoninterestExpenseInvestmentAdvisoryFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:NoninterestExpenseInvestmentAdvisoryFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_PolicyLoansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:PolicyLoansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_OtherLongTermInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis_NoninterestExpenseInvestmentAdvisoryFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfInvestmentIncomeReportedAmountsByCategoryAxis">us-gaap:NoninterestExpenseInvestmentAdvisoryFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-01-01</xbrli:startDate>
      <xbrli:endDate>2008-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis_FairValueInputsLevel1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis_FairValueInputsLevel2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis_FairValueInputsLevel3Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis_FairValueInputsLevel1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis_FairValueInputsLevel2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis_FairValueInputsLevel3Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsByMeasurementAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_FixedMaturitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_SecuritiesPartnershipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:SecuritiesPartnershipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_GuaranteedDepositAccountContractMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:GuaranteedDepositAccountContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_TotalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:TotalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_FixedMaturitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_SecuritiesPartnershipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:SecuritiesPartnershipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_GuaranteedDepositAccountContractMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:GuaranteedDepositAccountContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_TotalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:TotalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_FixedMaturitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_SecuritiesPartnershipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:SecuritiesPartnershipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_GuaranteedDepositAccountContractMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:GuaranteedDepositAccountContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_TotalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:TotalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_FixedMaturitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_SecuritiesPartnershipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:SecuritiesPartnershipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_GuaranteedDepositAccountContractMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:GuaranteedDepositAccountContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2009_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_TotalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:TotalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2008_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:GreatWestHealthcareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_FixedMaturitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_RealEstateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_SecuritiesPartnershipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:SecuritiesPartnershipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_GuaranteedDepositAccountContractMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:GuaranteedDepositAccountContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_TotalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ci:TotalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Number">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="EPS">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <dei:DocumentType id="ID_15545" contextRef="FROM_Jan01_2010_TO_Dec31_2010">10-K</dei:DocumentType>
  <dei:DocumentPeriodEndDate id="ID_15546" contextRef="FROM_Jan01_2010_TO_Dec31_2010">2010-12-31</dei:DocumentPeriodEndDate>
  <dei:AmendmentFlag id="ID_15547" contextRef="FROM_Jan01_2010_TO_Dec31_2010">false</dei:AmendmentFlag>
  <dei:EntityRegistrantName id="ID_15548" contextRef="FROM_Jan01_2010_TO_Dec31_2010">CIGNA Corporation</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey id="ID_15549" contextRef="FROM_Jan01_2010_TO_Dec31_2010">0000701221</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate id="ID_15550" contextRef="FROM_Jan01_2010_TO_Dec31_2010">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityFilerCategory id="ID_15551" contextRef="FROM_Jan01_2010_TO_Dec31_2010">Large Accelerated Filer</dei:EntityFilerCategory>
  <dei:TradingSymbol id="ID_15552" contextRef="FROM_Jan01_2010_TO_Dec31_2010">CI</dei:TradingSymbol>
  <dei:EntityCurrentReportingStatus id="ID_15554" contextRef="FROM_Jan01_2010_TO_Dec31_2010">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityWellKnownSeasonedIssuer id="ID_15555" contextRef="FROM_Jan01_2010_TO_Dec31_2010">Yes</dei:EntityWellKnownSeasonedIssuer>
  <dei:EntityVoluntaryFilers id="ID_15556" contextRef="FROM_Jan01_2010_TO_Dec31_2010">No</dei:EntityVoluntaryFilers>
  <dei:EntityPublicFloat id="ID_15557_USD_InMillions" decimals="-6" contextRef="AS_OF_Jun30_2010" unitRef="USD">8481000000</dei:EntityPublicFloat>
  <dei:DocumentFiscalYearFocus id="ID_15558" contextRef="FROM_Jan01_2010_TO_Dec31_2010">2010</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus id="ID_15559" contextRef="FROM_Jan01_2010_TO_Dec31_2010">FY</dei:DocumentFiscalPeriodFocus>
  <dei:EntityCommonStockSharesOutstanding id="ID_15635_Shares_AsShown" decimals="INF" contextRef="AS_OF_Jan31_2011" unitRef="Shares">271234488</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:SignificantAcquisitionsAndDisposalsDateOfTransactionForAcquisitionOrDisposal id="ID_15821" contextRef="AS_OF_Dec31_2010_ci_BusinessDispositionAxis_AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionRunOffWorkersCompensationAndPersonalAccidentBusinessMember">2010-12-31</us-gaap:SignificantAcquisitionsAndDisposalsDateOfTransactionForAcquisitionOrDisposal>
  <us-gaap:SignificantAcquisitionsAndDisposalsAcquisitionCostsOrSaleProceeds id="ID_15822_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_BusinessDispositionAxis_AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionRunOffWorkersCompensationAndPersonalAccidentBusinessMember" unitRef="USD">190000000</us-gaap:SignificantAcquisitionsAndDisposalsAcquisitionCostsOrSaleProceeds>
  <us-gaap:SignificantAcquisitionsAndDisposalsGainLossOnSaleOrDisposalNetOfTax id="ID_15823_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_BusinessDispositionAxis_AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionRunOffWorkersCompensationAndPersonalAccidentBusinessMember" unitRef="USD">-20000000</us-gaap:SignificantAcquisitionsAndDisposalsGainLossOnSaleOrDisposalNetOfTax>
  <us-gaap:SignificantAcquisitionsAndDisposalsGainLossOnSaleOrDisposalPretax id="ID_15824_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_BusinessDispositionAxis_AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionRunOffWorkersCompensationAndPersonalAccidentBusinessMember" unitRef="USD">-31000000</us-gaap:SignificantAcquisitionsAndDisposalsGainLossOnSaleOrDisposalPretax>
  <us-gaap:SignificantAcquisitionsAndDisposalsDateOfTransactionForAcquisitionOrDisposal id="ID_15825" contextRef="AS_OF_Dec31_2010_ci_BusinessDispositionAxis_SaleOfWorkersCompensationAndCaseManagementBusinessMember">2010-12-01</us-gaap:SignificantAcquisitionsAndDisposalsDateOfTransactionForAcquisitionOrDisposal>
  <us-gaap:SignificantAcquisitionsAndDisposalsGainLossOnSaleOrDisposalPretax id="ID_15826_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_BusinessDispositionAxis_SaleOfWorkersCompensationAndCaseManagementBusinessMember" unitRef="USD">18000000</us-gaap:SignificantAcquisitionsAndDisposalsGainLossOnSaleOrDisposalPretax>
  <us-gaap:SignificantAcquisitionsAndDisposalsGainLossOnSaleOrDisposalNetOfTax id="ID_15827_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_BusinessDispositionAxis_SaleOfWorkersCompensationAndCaseManagementBusinessMember" unitRef="USD">11000000</us-gaap:SignificantAcquisitionsAndDisposalsGainLossOnSaleOrDisposalNetOfTax>
  <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition id="ID_15828" contextRef="FROM_Jan01_2010_TO_Dec31_2010">August 31, 2010</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition>
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired id="ID_15829_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">100</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid id="ID_15830_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">412000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid>
  <us-gaap:AcquiredFiniteLivedIntangibleAssetAmount id="ID_15831_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">210000000</us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
  <ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeCustomerRelationships id="ID_15832_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010_us-gaap_BusinessAcquisitionAxis_VanbredaMember" unitRef="Number">15</ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeCustomerRelationships>
  <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition id="ID_15833" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember">April 1, 2008</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition>
  <us-gaap:AcquiredFiniteLivedIntangibleAssetAmount id="ID_15837_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember" unitRef="USD">290000000</us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
  <ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeCustomerRelationships id="ID_15838_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember" unitRef="Number">9</ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeCustomerRelationships>
  <ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeInternalUseSoftware id="ID_15839_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember" unitRef="Number">6</ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeInternalUseSoftware>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount id="ID_15840_USD_InMillions" decimals="-5" contextRef="AS_OF_Dec31_2010_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember" unitRef="USD">1100000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
  <ci:BusinessAcquisitionAmortizationPeriodGoodwillTax id="ID_15841_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember" unitRef="Number">15</ci:BusinessAcquisitionAmortizationPeriodGoodwillTax>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptions id="ID_15842_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">93000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptions>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptionsPercentage id="ID_15843_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.013</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptionsPercentage>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactors id="ID_15844_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">51000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactors>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactorsPercentage id="ID_15845_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.007</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactorsPercentage>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrends id="ID_15846_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">42000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrends>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrendsPercentage id="ID_15847_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.006</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrendsPercentage>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptions id="ID_15848_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">43000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptions>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactors id="ID_15850_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">21000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactors>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactorsPercentage id="ID_15851_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="Number">0.003</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactorsPercentage>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrends id="ID_15852_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">22000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrends>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrendsPercentage id="ID_15853_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="Number">0.003</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrendsPercentage>
  <ci:AfterTaxImpactOfPriorYearDevelopmentOnShareholdersNetIncome id="ID_15854_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">26000000</ci:AfterTaxImpactOfPriorYearDevelopmentOnShareholdersNetIncome>
  <ci:BeforeTaxImpactOfPriorYearDevelopmentOnShareholdersNetIncome id="ID_15855_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">39000000</ci:BeforeTaxImpactOfPriorYearDevelopmentOnShareholdersNetIncome>
  <ci:ImpactOfPriorYearDevelopmentOnShareholdersNetIncome id="ID_15856" contextRef="FROM_Jan01_2009_TO_Dec31_2009">not material</ci:ImpactOfPriorYearDevelopmentOnShareholdersNetIncome>
  <ci:EmployeeReductionNumber id="ID_15857_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="Number">2350</ci:EmployeeReductionNumber>
  <ci:SeveranceCostsPreTax id="ID_15858_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">6000000</ci:SeveranceCostsPreTax>
  <ci:SeveranceCostsAfterTax id="ID_15859_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">4000000</ci:SeveranceCostsAfterTax>
  <ci:SeveranceCostsPreTax id="ID_15860_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_HealthCareSegmentMember" unitRef="USD">37000000</ci:SeveranceCostsPreTax>
  <ci:SeveranceCostsAfterTax id="ID_15861_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_HealthCareSegmentMember" unitRef="USD">24000000</ci:SeveranceCostsAfterTax>
  <ci:SeveranceCostsAfterTax id="ID_15862_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_HealthCareSegmentMember" unitRef="USD">27000000</ci:SeveranceCostsAfterTax>
  <ci:SeveranceCostsPreTax id="ID_15863_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_HealthCareSegmentMember" unitRef="USD">44000000</ci:SeveranceCostsPreTax>
  <ci:SeveranceCostsPreTax id="ID_15864_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_DisabilityAndLifeSegmentMember" unitRef="USD">5000000</ci:SeveranceCostsPreTax>
  <ci:SeveranceCostsAfterTax id="ID_15865_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_DisabilityAndLifeSegmentMember" unitRef="USD">4000000</ci:SeveranceCostsAfterTax>
  <ci:SeveranceCostsPreTax id="ID_15866_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_DisabilityAndLifeSegmentMember" unitRef="USD">3000000</ci:SeveranceCostsPreTax>
  <ci:SeveranceCostsAfterTax id="ID_15867_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_DisabilityAndLifeSegmentMember" unitRef="USD">2000000</ci:SeveranceCostsAfterTax>
  <ci:SeveranceCostsPreTax id="ID_15868_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember" unitRef="USD">2000000</ci:SeveranceCostsPreTax>
  <ci:SeveranceCostsAfterTax id="ID_15869_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember" unitRef="USD">1000000</ci:SeveranceCostsAfterTax>
  <ci:SeveranceCostsAfterTax id="ID_15870_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember" unitRef="USD">6000000</ci:SeveranceCostsAfterTax>
  <ci:SeveranceCostsPreTax id="ID_15871_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_SegmentReportingReconcilingItemsForRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember" unitRef="USD">8000000</ci:SeveranceCostsPreTax>
  <ci:ExpectedSeverancePaymentsCompletionDate id="ID_15872" contextRef="FROM_Jan01_2010_TO_Dec31_2010">Substantially all severance is expected to be paid by the end of the second quarter 2011.</ci:ExpectedSeverancePaymentsCompletionDate>
  <ci:GuaranteedMinimumDeathBenefitNotionalAmountOfFuturesContracts id="ID_15873_USD_InBillions" decimals="-8" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">900000000</ci:GuaranteedMinimumDeathBenefitNotionalAmountOfFuturesContracts>
  <ci:GuaranteedMinimumDeathBenefitFuturesContractsGainsLosses id="ID_15874" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;pre-tax losses of $157 million&lt;/font&gt;</ci:GuaranteedMinimumDeathBenefitFuturesContractsGainsLosses>
  <ci:GuaranteedMinimumDeathBenefitFuturesContractsGainsLosses id="ID_15875" contextRef="FROM_Jan01_2009_TO_Dec31_2009">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;pre-tax losses of $282 million&lt;/font&gt;</ci:GuaranteedMinimumDeathBenefitFuturesContractsGainsLosses>
  <ci:GuaranteedMinimumDeathBenefitFuturesContractsGainsLosses id="ID_15876" contextRef="FROM_Jan01_2008_TO_Dec31_2008">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;pre-tax gains of $333 million&lt;/font&gt;</ci:GuaranteedMinimumDeathBenefitFuturesContractsGainsLosses>
  <ci:PartialSurrendersEstimateAnnualElectionRateLow id="ID_15879_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0</ci:PartialSurrendersEstimateAnnualElectionRateLow>
  <ci:PartialSurrendersEstimateAnnualElectionRateHigh id="ID_15880_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.15</ci:PartialSurrendersEstimateAnnualElectionRateHigh>
  <ci:CompanysViewofShortTermInterestRatePerformanceoverFuturePeriodsButConsidersthatCurrentShortTermIneterestRatesareLessthanthisAssumption id="ID_15881_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.05</ci:CompanysViewofShortTermInterestRatePerformanceoverFuturePeriodsButConsidersthatCurrentShortTermIneterestRatesareLessthanthisAssumption>
  <ci:MeanInvestmentPerformanceAssumptionforUnderlyingFixedIncomeMutualFundsBondsAndMoneyMarkets id="ID_15882_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.05</ci:MeanInvestmentPerformanceAssumptionforUnderlyingFixedIncomeMutualFundsBondsAndMoneyMarkets>
  <ci:MeanInvestmentPerformanceAssumptionforUnderlyingEquityandFixedIncomeMutualFundsLow id="ID_15883_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.01</ci:MeanInvestmentPerformanceAssumptionforUnderlyingEquityandFixedIncomeMutualFundsLow>
  <ci:VolatilityAssumptionVaryingByEquityFundTypeLow id="ID_15885_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.16</ci:VolatilityAssumptionVaryingByEquityFundTypeLow>
  <ci:VolatilityAssumptionVaryingByEquityFundTypeHigh id="ID_15886_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.26</ci:VolatilityAssumptionVaryingByEquityFundTypeHigh>
  <ci:VolatilityAssumptionVaryingByBondFundTypeLow id="ID_15887_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.04</ci:VolatilityAssumptionVaryingByBondFundTypeLow>
  <ci:VolatilityAssumptionVaryingByBondFundTypeHigh id="ID_15888_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.1</ci:VolatilityAssumptionVaryingByBondFundTypeHigh>
  <ci:VolatilityAssumptionVaryingByMoneyMarketFundType id="ID_15889_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.02</ci:VolatilityAssumptionVaryingByMoneyMarketFundType>
  <ci:GuaranteedMinimumDeathBenefitContractsDiscountRate id="ID_15890_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.0575</ci:GuaranteedMinimumDeathBenefitContractsDiscountRate>
  <ci:ClaimMortalityAssumptionLow id="ID_15891_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.65</ci:ClaimMortalityAssumptionLow>
  <ci:ClaimMortalityAssumptionHigh id="ID_15892_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.89</ci:ClaimMortalityAssumptionHigh>
  <ci:AnnualImprovementToMortalityTableBase id="ID_15893_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.01</ci:AnnualImprovementToMortalityTableBase>
  <ci:LapseRateAssumptionLow id="ID_15894_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0</ci:LapseRateAssumptionLow>
  <ci:LapseRateAssumptionHigh id="ID_15895_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.24</ci:LapseRateAssumptionHigh>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_15896_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">52000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_15897_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">34000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_15898_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">73000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_15899_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">47000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_15900_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">406000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_15901_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">263000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseImpactsofOverallMarketDeclines id="ID_15902_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">210000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseImpactsofOverallMarketDeclines>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseImpactsofOverallMarketDeclines id="ID_15903_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">136000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseImpactsofOverallMarketDeclines>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseVolatilityRelatedImpacts id="ID_15904_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">182000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseVolatilityRelatedImpacts>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseVolatilityRelatedImpacts id="ID_15905_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">118000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseVolatilityRelatedImpacts>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseInterestRateImpacts id="ID_15906_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">14000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseInterestRateImpacts>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseInterestRateImpacts id="ID_15907_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">9000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengtheningDuetoAdverseInterestRateImpacts>
  <ci:ReinsuranceRecoverableRetirementBenefitsBusiness id="ID_15908_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">1700000000</ci:ReinsuranceRecoverableRetirementBenefitsBusiness>
  <ci:ReinsuranceRecoverableRetirementBenefitsBusinessSecured id="ID_15909" contextRef="AS_OF_Dec31_2010">Secured primarily by fixed maturities equal to or greater than 100% of the reinsured liabilities</ci:ReinsuranceRecoverableRetirementBenefitsBusinessSecured>
  <ci:ReinsuranceRecoverableIndividualLifeAndAnnuityReinsurance id="ID_15910_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">4300000000</ci:ReinsuranceRecoverableIndividualLifeAndAnnuityReinsurance>
  <ci:ReinsuranceRecoverableIndividualLifeAndAnnuityReinsurance id="ID_15911_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2009" unitRef="USD">4400000000</ci:ReinsuranceRecoverableIndividualLifeAndAnnuityReinsurance>
  <ci:ReinsuranceRecoverableIndividualLifeAndAnnuityReinsuranceSecured id="ID_15912_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">3900000000</ci:ReinsuranceRecoverableIndividualLifeAndAnnuityReinsuranceSecured>
  <ci:ReinsuranceRecoverableIndividualLifeAndAnnuityReinsuranceUnsecured id="ID_15913_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">402000000</ci:ReinsuranceRecoverableIndividualLifeAndAnnuityReinsuranceUnsecured>
  <ci:CededReinsuranceRecoverableOngoingOperations id="ID_15914_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">282000000</ci:CededReinsuranceRecoverableOngoingOperations>
  <ci:NumberOfReinsurersOngoingOperations id="ID_15915_Number_AsShown" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">70</ci:NumberOfReinsurersOngoingOperations>
  <ci:ReserveHeldForCededReinsuranceRecoverableOngoingOperations id="ID_15916_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">9000000</ci:ReserveHeldForCededReinsuranceRecoverableOngoingOperations>
  <ci:ReinsuranceRecoverableRunOffReinsurance id="ID_15917_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">261000000</ci:ReinsuranceRecoverableRunOffReinsurance>
  <ci:PercentageOfReinsuranceRecoverablesForRunoffReinsuranceSecured id="ID_15918_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.77</ci:PercentageOfReinsuranceRecoverablesForRunoffReinsuranceSecured>
  <ci:ReserveHeldForReinsuranceRecoverableRunOffReinsurance id="ID_15919_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1000000</ci:ReserveHeldForReinsuranceRecoverableRunOffReinsurance>
  <us-gaap:SegmentReportingInformationGoodwill id="ID_15920_USD_InMillions" decimals="-5" contextRef="AS_OF_Dec31_2010" unitRef="USD">2900000</us-gaap:SegmentReportingInformationGoodwill>
  <us-gaap:GoodwillPeriodIncreaseDecrease id="ID_15921_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">230000000</us-gaap:GoodwillPeriodIncreaseDecrease>
  <us-gaap:SegmentReportingInformationGoodwill id="ID_15922_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_GoodwillBySegmentAxis_HealthCareSegmentMember" unitRef="USD">240000000</us-gaap:SegmentReportingInformationGoodwill>
  <us-gaap:FutureAmortizationExpenseYearOne id="ID_15923_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">214000000</us-gaap:FutureAmortizationExpenseYearOne>
  <us-gaap:FutureAmortizationExpenseYearTwo id="ID_15924_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">179000000</us-gaap:FutureAmortizationExpenseYearTwo>
  <us-gaap:FutureAmortizationExpenseYearThree id="ID_15925_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">139000000</us-gaap:FutureAmortizationExpenseYearThree>
  <us-gaap:FutureAmortizationExpenseYearFour id="ID_15926_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">84000000</us-gaap:FutureAmortizationExpenseYearFour>
  <us-gaap:FutureAmortizationExpenseYearFive id="ID_15927_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">53000000</us-gaap:FutureAmortizationExpenseYearFive>
  <ci:DefinedBenefitPlanCurtailmentsAfterTax id="ID_15929_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">30000000</ci:DefinedBenefitPlanCurtailmentsAfterTax>
  <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetGainLossBeforeTax id="ID_15930_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">301000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetGainLossBeforeTax>
  <ci:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetGainLossAfterTax id="ID_15931_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">189000000</ci:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetGainLossAfterTax>
  <ci:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetLossAfterTaxDueToDiscontinuanceOfMedicarePFFS id="ID_15932_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">8000000</ci:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetLossAfterTaxDueToDiscontinuanceOfMedicarePFFS>
  <ci:ImpactOfHealthCareReformOnPostretirementMedicalPlanOnCompanysResultsOfOperationsOrLiquidity id="ID_15933" contextRef="FROM_Jan01_2010_TO_Dec31_2010">not material</ci:ImpactOfHealthCareReformOnPostretirementMedicalPlanOnCompanysResultsOfOperationsOrLiquidity>
  <us-gaap:DefinedBenefitPlanFundedStatusOfPlan id="ID_15934_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2009" unitRef="USD">-1500000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
  <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation id="ID_15935_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">4700000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
  <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation id="ID_15936_USD_InMillions" decimals="-5" contextRef="AS_OF_Dec31_2009" unitRef="USD">4300000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
  <us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYearDescription id="ID_15937" contextRef="FROM_Jan01_2010_TO_Dec31_2010">Expects to make minimum required and voluntary contributions totaling $250 million</us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYearDescription>
  <us-gaap:DefinedBenefitPlanAmortizationOfNetPriorServiceCostCredit id="ID_15938_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">-38000000</us-gaap:DefinedBenefitPlanAmortizationOfNetPriorServiceCostCredit>
  <ci:DefinedBenefitPlanAmortizationWeightedAveragePeriodInactive id="ID_15939_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010" unitRef="Number">30</ci:DefinedBenefitPlanAmortizationWeightedAveragePeriodInactive>
  <ci:DefinedBenefitPlanAccumulatedBenefitObligationRetireeHealth id="ID_15940_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">296000000</ci:DefinedBenefitPlanAccumulatedBenefitObligationRetireeHealth>
  <ci:DefinedBenefitPlanAccumulatedBenefitObligationRetireeHealth id="ID_15941_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">268000000</ci:DefinedBenefitPlanAccumulatedBenefitObligationRetireeHealth>
  <ci:DefinedBenefitPlanAccumulatedBenefitObligationRetireeLifeInsurance id="ID_15942_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">148000000</ci:DefinedBenefitPlanAccumulatedBenefitObligationRetireeLifeInsurance>
  <ci:DefinedBenefitPlanAccumulatedBenefitObligationRetireeLifeInsurance id="ID_15943_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">150000000</ci:DefinedBenefitPlanAccumulatedBenefitObligationRetireeLifeInsurance>
  <ci:DefinedBenefitPlanOtherPostretirementBenefitsAmortizationOfNetPriorServiceCostCredit id="ID_15944_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">16000000</ci:DefinedBenefitPlanOtherPostretirementBenefitsAmortizationOfNetPriorServiceCostCredit>
  <ci:DefinedBenefitPlanAmortizationweightedAveragePeriodOtherPostretirementBenefits id="ID_15945_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010" unitRef="Number">9</ci:DefinedBenefitPlanAmortizationweightedAveragePeriodOtherPostretirementBenefits>
  <ci:DefinedBenefitPlanAmortizationWeightedAveragePeriodOtherPostretirementBenefitsPriorServiceCosts id="ID_15946_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010" unitRef="Number">3</ci:DefinedBenefitPlanAmortizationWeightedAveragePeriodOtherPostretirementBenefitsPriorServiceCosts>
  <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYear id="ID_15947_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="Number">8.5</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYear>
  <us-gaap:DefinedBenefitPlanDescriptionOfDirectionAndPatternOfChangeForAssumedHealthCareCostTrendRate id="ID_15948" contextRef="FROM_Jan01_2011_TO_Dec31_2011">decreasing 0.5% per year</us-gaap:DefinedBenefitPlanDescriptionOfDirectionAndPatternOfChangeForAssumedHealthCareCostTrendRate>
  <us-gaap:DefinedBenefitPlanTargetAllocationPercentageOfAssetsEquitySecurities id="ID_15950_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.57</us-gaap:DefinedBenefitPlanTargetAllocationPercentageOfAssetsEquitySecurities>
  <us-gaap:DefinedBenefitPlanTargetAllocationPercentageOfAssetsDebtSecurities id="ID_15951_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.2</us-gaap:DefinedBenefitPlanTargetAllocationPercentageOfAssetsDebtSecurities>
  <us-gaap:DefinedBenefitPlanTargetAllocationPercentageOfAssetsRealEstate id="ID_15952_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.08</us-gaap:DefinedBenefitPlanTargetAllocationPercentageOfAssetsRealEstate>
  <us-gaap:DefinedBenefitPlanTargetAllocationPercentageOfAssetsOther id="ID_15953_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.15</us-gaap:DefinedBenefitPlanTargetAllocationPercentageOfAssetsOther>
  <ci:DefinedBenefitPlanAssetsInvestedInSeparateAccountsOfAffiliates id="ID_15954_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">2800000000</ci:DefinedBenefitPlanAssetsInvestedInSeparateAccountsOfAffiliates>
  <ci:DefinedBenefitPlanAssetsInvestedinSeparateAccountsOfNonAffiliates id="ID_15955_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">400000000</ci:DefinedBenefitPlanAssetsInvestedinSeparateAccountsOfNonAffiliates>
  <ci:DefinedBenefitPlanActualReturnOnPlanAssetsLevelThreeOtherPostretirementBenefits id="ID_15956_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1000000</ci:DefinedBenefitPlanActualReturnOnPlanAssetsLevelThreeOtherPostretirementBenefits>
  <ci:DefinedBenefitPlanLevelThreeNetWithdrawalsOtherPostretirementBenefits id="ID_15957_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">-2000000</ci:DefinedBenefitPlanLevelThreeNetWithdrawalsOtherPostretirementBenefits>
  <ci:DefinedBenefitPlanActualReturnOnPlanAssetsLevelThreeOtherPostretirementBenefits id="ID_15958_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">2000000</ci:DefinedBenefitPlanActualReturnOnPlanAssetsLevelThreeOtherPostretirementBenefits>
  <ci:DefinedBenefitPlanLevelThreeNetWithdrawalsOtherPostretirementBenefits id="ID_15959_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">-2000000</ci:DefinedBenefitPlanLevelThreeNetWithdrawalsOtherPostretirementBenefits>
  <ci:DefinedBenefitPlanMarketRelatedValueOfPensionPlanAssets id="ID_15960_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">3400000000</ci:DefinedBenefitPlanMarketRelatedValueOfPensionPlanAssets>
  <ci:DefinedBenefitPlanMarketValueOfPensionPlanAssets id="ID_15961_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">3200000000</ci:DefinedBenefitPlanMarketValueOfPensionPlanAssets>
  <us-gaap:DeferredCompensationArrangementWithIndividualEmployerContribution id="ID_15962_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">69000000</us-gaap:DeferredCompensationArrangementWithIndividualEmployerContribution>
  <us-gaap:DeferredCompensationArrangementWithIndividualEmployerContribution id="ID_15963_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">36000000</us-gaap:DeferredCompensationArrangementWithIndividualEmployerContribution>
  <us-gaap:DeferredCompensationArrangementWithIndividualEmployerContribution id="ID_15964_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">34000000</us-gaap:DeferredCompensationArrangementWithIndividualEmployerContribution>
  <ci:UnrealizedAppreciationSettlementAnnuity id="ID_15965_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">443000000</ci:UnrealizedAppreciationSettlementAnnuity>
  <ci:UnrealizedAppreciationLevel3SettlementAnnuity id="ID_15966_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">74000000</ci:UnrealizedAppreciationLevel3SettlementAnnuity>
  <ci:PercentReinsuredExternallyGuaranteedMinimumIncomeBenefits id="ID_15967_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.55</ci:PercentReinsuredExternallyGuaranteedMinimumIncomeBenefits>
  <ci:LiabilityForFutureCostofReinsuranceGuaranteedMinimumIncomeBenefitsAssets id="ID_15968_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">15000000</ci:LiabilityForFutureCostofReinsuranceGuaranteedMinimumIncomeBenefitsAssets>
  <ci:OtherDerivativeInterestRateAndForeignCurrencySwapHedges id="ID_15969_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">16000000</ci:OtherDerivativeInterestRateAndForeignCurrencySwapHedges>
  <ci:OtherDerivativeInterestRateSwapNotHedges id="ID_15970_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">3000000</ci:OtherDerivativeInterestRateSwapNotHedges>
  <ci:UnrealizedAppreciationSettlementAnnuity id="ID_15971_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">274000000</ci:UnrealizedAppreciationSettlementAnnuity>
  <ci:UnrealizedAppreciationLevel3SettlementAnnuity id="ID_15972_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">38000000</ci:UnrealizedAppreciationLevel3SettlementAnnuity>
  <ci:PercentReinsuredExternallyGuaranteedMinimumIncomeBenefits id="ID_15973_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="Number">55</ci:PercentReinsuredExternallyGuaranteedMinimumIncomeBenefits>
  <ci:LiabilityForFutureCostofReinsuranceGuaranteedMinimumIncomeBenefitsAssets id="ID_15974_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">15000000</ci:LiabilityForFutureCostofReinsuranceGuaranteedMinimumIncomeBenefitsAssets>
  <ci:OtherDerivativeInterestRateAndForeignCurrencySwapHedges id="ID_15975_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">12000000</ci:OtherDerivativeInterestRateAndForeignCurrencySwapHedges>
  <ci:OtherDerivativeInterestRateSwapNotHedges id="ID_15976_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">4000000</ci:OtherDerivativeInterestRateSwapNotHedges>
  <ci:PercentLevel2FixedMaturitiesEquitySecurities id="ID_15977_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.93</ci:PercentLevel2FixedMaturitiesEquitySecurities>
  <ci:PercentLevel2InvestmentsForeignBondsBrokerQuote id="ID_15978" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;Less than 1%&lt;/font&gt;</ci:PercentLevel2InvestmentsForeignBondsBrokerQuote>
  <ci:PercentLevel3FixedMaturitiesEquitySecurities id="ID_15979_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.06</ci:PercentLevel3FixedMaturitiesEquitySecurities>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsGuaranteedClaimInterestRate id="ID_15980_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.0271</ci:GuaranteedMinimumIncomeBenefitsAssumptionsGuaranteedClaimInterestRate>
  <ci:GuaranteedMinimumIncomeBenefitsContractuallyGuaranteedClaimInterestRateFloor id="ID_15981_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.03</ci:GuaranteedMinimumIncomeBenefitsContractuallyGuaranteedClaimInterestRateFloor>
  <ci:MutualFundInvestmentsPercentModeledOnInsufficientMarketObservableData id="ID_15982_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.54</ci:MutualFundInvestmentsPercentModeledOnInsufficientMarketObservableData>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsEquityFundVolatilityRateLowEnd id="ID_15983_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.17</ci:GuaranteedMinimumIncomeBenefitsAssumptionsEquityFundVolatilityRateLowEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsEquityFundVolatilityRateHighEnd id="ID_15984_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.31</ci:GuaranteedMinimumIncomeBenefitsAssumptionsEquityFundVolatilityRateHighEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsBondFundVolatilityRateLowEnd id="ID_15985_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.04</ci:GuaranteedMinimumIncomeBenefitsAssumptionsBondFundVolatilityRateLowEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsBondFundVolatilityRateHighEnd id="ID_15986_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.12</ci:GuaranteedMinimumIncomeBenefitsAssumptionsBondFundVolatilityRateHighEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsMoneyMarketFundVolatilityRateLowEnd id="ID_15987_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.01</ci:GuaranteedMinimumIncomeBenefitsAssumptionsMoneyMarketFundVolatilityRateLowEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsMoneyMarketFundVolatilityRateHighEnd id="ID_15988_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.02</ci:GuaranteedMinimumIncomeBenefitsAssumptionsMoneyMarketFundVolatilityRateHighEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeMortalityRate id="ID_15989_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.7</ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeMortalityRate>
  <ci:AnnualPercentImprovementTableGroupAnnuityMortality id="ID_15990_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.01</ci:AnnualPercentImprovementTableGroupAnnuityMortality>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProducTandGuaranteeLapseRateLowEnd id="ID_15991_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.02</ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProducTandGuaranteeLapseRateLowEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeLapseRateHighEnd id="ID_15992_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.17</ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeLapseRateHighEnd>
  <ci:ProbabilityOfAnnuitizingVariableAnnuityImmediatelyAfterWaitingPeriodExpiration id="ID_15993_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.8</ci:ProbabilityOfAnnuitizingVariableAnnuityImmediatelyAfterWaitingPeriodExpiration>
  <ci:ProbabilityOfAnnuitizingVariableAnnuityInSecondAnnualBenefitOpportunity id="ID_15994_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.3</ci:ProbabilityOfAnnuitizingVariableAnnuityInSecondAnnualBenefitOpportunity>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityLow id="ID_15995_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">5</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityLow>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityHigh id="ID_15996_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">110</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityHigh>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetLow id="ID_15997_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">10</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetLow>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetHigh id="ID_15998_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">85</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetHigh>
  <ci:PensionPlanAssetsIncludedInNonGuaranteedSeparateAccounts id="ID_15999_USD_InBillions" decimals="-8" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">2800000000</ci:PensionPlanAssetsIncludedInNonGuaranteedSeparateAccounts>
  <ci:PensionPlanAssetsIncludedInLevel3NonGuaranteedSeparateAccounts id="ID_16000_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">557000000</ci:PensionPlanAssetsIncludedInLevel3NonGuaranteedSeparateAccounts>
  <ci:PensionPlanAssetsIncludedInNonGuaranteedSeparateAccounts id="ID_16001_USD_InBillions" decimals="-8" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">2600000000</ci:PensionPlanAssetsIncludedInNonGuaranteedSeparateAccounts>
  <ci:PensionPlanAssetsIncludedInLevel3NonGuaranteedSeparateAccounts id="ID_16002_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">517000000</ci:PensionPlanAssetsIncludedInLevel3NonGuaranteedSeparateAccounts>
  <ci:PolicyholderGainsLossesAttributableToInstrumentsStillHeld id="ID_16003" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;Gains of $53 million&lt;/font&gt;</ci:PolicyholderGainsLossesAttributableToInstrumentsStillHeld>
  <ci:PolicyholderGainsLossesAttributableToInstrumentsStillHeld id="ID_16004" contextRef="FROM_Jan01_2009_TO_Dec31_2009">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;Losses of $92 million&lt;/font&gt;</ci:PolicyholderGainsLossesAttributableToInstrumentsStillHeld>
  <ci:ImpairedCommercialMortgageLoans id="ID_16005_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">158000000</ci:ImpairedCommercialMortgageLoans>
  <ci:ImpairedCommercialMortgageLoansCarriedAtFairValue id="ID_16006_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">134000000</ci:ImpairedCommercialMortgageLoansCarriedAtFairValue>
  <ci:RealizedInvestmentLossesCommercialMortgageLoans id="ID_16007_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-24000000</ci:RealizedInvestmentLossesCommercialMortgageLoans>
  <ci:ImpairedRealEstateEntitiesCarriedAtCost id="ID_16008_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">35000000</ci:ImpairedRealEstateEntitiesCarriedAtCost>
  <ci:ImpairedRealEstateEntitiesCarriedAtFairValue id="ID_16009_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-21000000</ci:ImpairedRealEstateEntitiesCarriedAtFairValue>
  <ci:RealizedInvestmentLossesRealEstateEntities id="ID_16010_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-14000000</ci:RealizedInvestmentLossesRealEstateEntities>
  <ci:ImpairedCommercialMortgageLoans id="ID_16011_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">143000000</ci:ImpairedCommercialMortgageLoans>
  <ci:ImpairedCommercialMortgageLoansCarriedAtFairValue id="ID_16012_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">126000000</ci:ImpairedCommercialMortgageLoansCarriedAtFairValue>
  <ci:RealizedInvestmentLossesCommercialMortgageLoans id="ID_16013_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-17000000</ci:RealizedInvestmentLossesCommercialMortgageLoans>
  <ci:ImpairedRealEstateEntitiesCarriedAtCost id="ID_16014_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">48000000</ci:ImpairedRealEstateEntitiesCarriedAtCost>
  <ci:ImpairedRealEstateEntitiesCarriedAtFairValue id="ID_16015_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">12000000</ci:ImpairedRealEstateEntitiesCarriedAtFairValue>
  <ci:RealizedInvestmentLossesRealEstateEntities id="ID_16016_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-36000000</ci:RealizedInvestmentLossesRealEstateEntities>
  <ci:PercentUnrestrictedContractholderDepositFunds id="ID_16017_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.45</ci:PercentUnrestrictedContractholderDepositFunds>
  <us-gaap:AvailableForSaleSecuritiesPledgedAsCollateral id="ID_16018_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">98000000</us-gaap:AvailableForSaleSecuritiesPledgedAsCollateral>
  <us-gaap:AvailableForSaleSecuritiesPledgedAsCollateral id="ID_16019_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">197000000</us-gaap:AvailableForSaleSecuritiesPledgedAsCollateral>
  <ci:SettlementAnnuityInvestments id="ID_16020_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">2500000000</ci:SettlementAnnuityInvestments>
  <ci:GrossUnrealizedAppreciationSettlementAnnuityInvestments id="ID_16021_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">-476000000</ci:GrossUnrealizedAppreciationSettlementAnnuityInvestments>
  <ci:GrossUnrealizedDepreciationSettlementAnnuityInvestments id="ID_16022_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">-33000000</ci:GrossUnrealizedDepreciationSettlementAnnuityInvestments>
  <ci:SettlementAnnuityInvestments id="ID_16023_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2009" unitRef="USD">2300000000</ci:SettlementAnnuityInvestments>
  <ci:GrossUnrealizedAppreciationSettlementAnnuityInvestments id="ID_16024_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">326000000</ci:GrossUnrealizedAppreciationSettlementAnnuityInvestments>
  <ci:GrossUnrealizedDepreciationSettlementAnnuityInvestments id="ID_16025_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">-52000000</ci:GrossUnrealizedDepreciationSettlementAnnuityInvestments>
  <ci:FixedMaturitiesCommitmentsToPurchase id="ID_16026_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">14000000</ci:FixedMaturitiesCommitmentsToPurchase>
  <ci:LoansReceivableCommercialRealEstateRealEstateInvestments id="ID_16027_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_MoreThanThreeAndWithinFourYearsFromBalanceSheetDateMember" unitRef="USD">612000000</ci:LoansReceivableCommercialRealEstateRealEstateInvestments>
  <ci:LoansReceivableCommercialRealEstateRealEstateInvestments id="ID_16028_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_MoreThanFiveYearsFromBalanceSheetDateAndThereafterMember" unitRef="USD">1535000000</ci:LoansReceivableCommercialRealEstateRealEstateInvestments>
  <ci:LoansReceivableCommercialRealEstateRealEstateInvestments id="ID_16029_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_OneYearFromBalanceSheetDateMember" unitRef="USD">518000000</ci:LoansReceivableCommercialRealEstateRealEstateInvestments>
  <ci:LoansReceivableCommercialRealEstateRealEstateInvestments id="ID_16030_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_MoreThanTwoAndWithinThreeYearsFromBalanceSheetDateMember" unitRef="USD">547000000</ci:LoansReceivableCommercialRealEstateRealEstateInvestments>
  <ci:LoansReceivableCommercialRealEstateRealEstateInvestments id="ID_16031_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_FiveYearsAndThereafterAxis_MoreThanFourAndWithinFiveYearsFromBalanceSheetDateMember" unitRef="USD">274000000</ci:LoansReceivableCommercialRealEstateRealEstateInvestments>
  <ci:CommercialMortgageLoansCommitmentsToExtendCredit id="ID_16032_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">63000000</ci:CommercialMortgageLoansCommitmentsToExtendCredit>
  <ci:FinancingReceivableCreditQualityDebtServiceCoverage id="ID_16033" contextRef="FROM_Jan01_2010_TO_Dec31_2010">1.38</ci:FinancingReceivableCreditQualityDebtServiceCoverage>
  <ci:FinancingReceivableCreditQualityLoanToValueRatio id="ID_16034_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.74</ci:FinancingReceivableCreditQualityLoanToValueRatio>
  <ci:FinancingReceivableCreditQualityDebtServiceCoverage id="ID_16035" contextRef="FROM_Jan01_2009_TO_Dec31_2009">1.48</ci:FinancingReceivableCreditQualityDebtServiceCoverage>
  <ci:FinancingReceivableCreditQualityLoanToValueRatio id="ID_16036_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="Number">0.77</ci:FinancingReceivableCreditQualityLoanToValueRatio>
  <ci:ProblemAndPotentialProblemMortgageLoans id="ID_16037_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">383000000</ci:ProblemAndPotentialProblemMortgageLoans>
  <ci:ProblemAndPotentialProblemMortgageLoans id="ID_16038_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">397000000</ci:ProblemAndPotentialProblemMortgageLoans>
  <ci:IncreaseToCommercialMortgageLoanValuationReservePreTax id="ID_16039_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">24000000</ci:IncreaseToCommercialMortgageLoanValuationReservePreTax>
  <ci:IncreaseToCommercialMortgageLoanValuationReserveAfterTax id="ID_16040_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">15000000</ci:IncreaseToCommercialMortgageLoanValuationReserveAfterTax>
  <ci:AverageRecordedInvestmentImpairedCommercialMortgageLoans id="ID_16041_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">169000000</ci:AverageRecordedInvestmentImpairedCommercialMortgageLoans>
  <ci:AverageRecordedInvestmentImpairedCommercialMortgageLoans id="ID_16042_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">116000000</ci:AverageRecordedInvestmentImpairedCommercialMortgageLoans>
  <ci:PreTaxInterestIncomeRecognizedOnImpairedCommercialMortgageLoans id="ID_16043" contextRef="FROM_Jan01_2009_TO_Dec31_2009">Not Significant</ci:PreTaxInterestIncomeRecognizedOnImpairedCommercialMortgageLoans>
  <ci:CarryingValueOfNonIncomeProducingRealEstateInvestments id="ID_16044_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">49000000</ci:CarryingValueOfNonIncomeProducingRealEstateInvestments>
  <ci:CarryingValueOfNonIncomeProducingRealEstateInvestments id="ID_16045_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">55000000</ci:CarryingValueOfNonIncomeProducingRealEstateInvestments>
  <ci:RealEstateInvestmentsCommitmentsToContributeAdditionalEquity id="ID_16046_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">11000000</ci:RealEstateInvestmentsCommitmentsToContributeAdditionalEquity>
  <ci:CarryingValueOfNonIncomeProducingRealEstateEntitiesAndSecuritiesPartnerships id="ID_16047_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">169000000</ci:CarryingValueOfNonIncomeProducingRealEstateEntitiesAndSecuritiesPartnerships>
  <ci:CarryingValueOfNonIncomeProducingRealEstateEntitiesAndSecuritiesPartnerships id="ID_16048_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">121000000</ci:CarryingValueOfNonIncomeProducingRealEstateEntitiesAndSecuritiesPartnerships>
  <ci:LimitedLiabilityEntitiesCommitmentsToContributeAdditionalEquity id="ID_16049_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">224000000</ci:LimitedLiabilityEntitiesCommitmentsToContributeAdditionalEquity>
  <ci:EntitiesHoldingSecuritiesDiversifiedByIssuerAndMaturityDateCommitmentsToContributeAdditionalEquity id="ID_16050_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">297000000</ci:EntitiesHoldingSecuritiesDiversifiedByIssuerAndMaturityDateCommitmentsToContributeAdditionalEquity>
  <ci:OtherLongTermInvestmentAmountsPercentageCommitedToBeDisbursed id="ID_16051_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.55</ci:OtherLongTermInvestmentAmountsPercentageCommitedToBeDisbursed>
  <ci:CorporateSecuritiesIncludedInShortTermInvestments id="ID_16052_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">1100000000</ci:CorporateSecuritiesIncludedInShortTermInvestments>
  <ci:FederalGovernmentSecuritiesIncludedInShortTermInvestments id="ID_16053_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">137000000</ci:FederalGovernmentSecuritiesIncludedInShortTermInvestments>
  <ci:MoneyMarketFundsIncludedInShortTermInvestments id="ID_16054_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">40000000</ci:MoneyMarketFundsIncludedInShortTermInvestments>
  <ci:CorporateSecuritiesIncludedInShortTermInvestments id="ID_16055_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">624000000</ci:CorporateSecuritiesIncludedInShortTermInvestments>
  <ci:FederalGovernmentSecuritiesIncludedInShortTermInvestments id="ID_16056_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">402000000</ci:FederalGovernmentSecuritiesIncludedInShortTermInvestments>
  <ci:MoneyMarketFundsIncludedInShortTermInvestments id="ID_16057_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">104000000</ci:MoneyMarketFundsIncludedInShortTermInvestments>
  <ci:FairValueConcentrationOfRiskInvestmentsDescription id="ID_16058" contextRef="AS_OF_Dec31_2009">Did not have a concentration of investments</ci:FairValueConcentrationOfRiskInvestmentsDescription>
  <ci:NetPositionOfInstrumentsWithCreditRiskRelatedContingentFeatures id="ID_16059_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">25000000</ci:NetPositionOfInstrumentsWithCreditRiskRelatedContingentFeatures>
  <ci:NetPositionOfInstrumentsWithCreditRiskRelatedContingentFeatures id="ID_16060_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">29000000</ci:NetPositionOfInstrumentsWithCreditRiskRelatedContingentFeatures>
  <ci:EffectOfOtherDerivatives id="ID_16061" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;not material&lt;/font&gt;</ci:EffectOfOtherDerivatives>
  <ci:EffectOfOtherDerivatives id="ID_16062" contextRef="FROM_Jan01_2009_TO_Dec31_2009">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;not material&lt;/font&gt;</ci:EffectOfOtherDerivatives>
  <ci:NetPositionOfInstrumentsWithTerminationProvisions id="ID_16063" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;No net liability position&lt;/font&gt;</ci:NetPositionOfInstrumentsWithTerminationProvisions>
  <ci:NetPositionOfInstrumentsWithTerminationProvisions id="ID_16064" contextRef="FROM_Jan01_2009_TO_Dec31_2009">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;No net liability position&lt;/font&gt;</ci:NetPositionOfInstrumentsWithTerminationProvisions>
  <ci:InterestRateSwapsCashFlowHedgeParValue id="ID_16065_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">153000000</ci:InterestRateSwapsCashFlowHedgeParValue>
  <ci:InterestRateSwapsCashFlowHedgeParValue id="ID_16066_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">160000000</ci:InterestRateSwapsCashFlowHedgeParValue>
  <ci:ForeignCurrencySwapsCashFlowHedgeParValue id="ID_16067_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">159000000</ci:ForeignCurrencySwapsCashFlowHedgeParValue>
  <ci:ForeignCurrencySwapsCashFlowHedgeParValue id="ID_16068_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">179000000</ci:ForeignCurrencySwapsCashFlowHedgeParValue>
  <ci:InterestRateAndForeignCurrencySwapsCashFlowHedgeParValue id="ID_16069_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">64000000</ci:InterestRateAndForeignCurrencySwapsCashFlowHedgeParValue>
  <ci:InterestRateAndForeignCurrencySwapsCashFlowHedgeParValue id="ID_16070_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">54000000</ci:InterestRateAndForeignCurrencySwapsCashFlowHedgeParValue>
  <ci:PurchasedOptionsDesignatedCashFlowAccountingHedgeSurrenderValue id="ID_16071_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">312000000</ci:PurchasedOptionsDesignatedCashFlowAccountingHedgeSurrenderValue>
  <ci:OtherComprehensiveIncomeGainTreasuryLockDesignatedAccountingHedge id="ID_16072_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">14000000</ci:OtherComprehensiveIncomeGainTreasuryLockDesignatedAccountingHedge>
  <ci:NetcumulativeLossTreasuryLockDesignatedAccountingHedge id="ID_16073_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-26000000</ci:NetcumulativeLossTreasuryLockDesignatedAccountingHedge>
  <ci:FairValueEffectPurchasedOptionsAccountingHedge id="ID_16074" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;not significant&lt;/font&gt;</ci:FairValueEffectPurchasedOptionsAccountingHedge>
  <ci:DerivativeReclassificationAdjustment id="ID_16075" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;not significant&lt;/font&gt;</ci:DerivativeReclassificationAdjustment>
  <ci:UnitedStatesDollarEquivalentFutuesNotcashFlowaCcountingHedge id="ID_16076_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">892000000</ci:UnitedStatesDollarEquivalentFutuesNotcashFlowaCcountingHedge>
  <ci:UnitedStatesDollarEquivalentFutuesNotcashFlowaCcountingHedge id="ID_16077_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1058000000</ci:UnitedStatesDollarEquivalentFutuesNotcashFlowaCcountingHedge>
  <ci:InterestRateSwapsNonCashFlowHedgeParValue id="ID_16078_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">45000000</ci:InterestRateSwapsNonCashFlowHedgeParValue>
  <ci:InterestRateSwapsNonCashFlowHedgeParValue id="ID_16079_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">76000000</ci:InterestRateSwapsNonCashFlowHedgeParValue>
  <ci:PotentialUndiscountedPaymentsWrittenOptionsGuaranteedMinimumIncomeBenefits id="ID_16080_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1134000000</ci:PotentialUndiscountedPaymentsWrittenOptionsGuaranteedMinimumIncomeBenefits>
  <ci:PotentialUndiscountedPaymentsWrittenOptionsGuaranteedMinimumIncomeBenefits id="ID_16081_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1183000000</ci:PotentialUndiscountedPaymentsWrittenOptionsGuaranteedMinimumIncomeBenefits>
  <ci:PotentialUndiscountedPaymentsPurchaseOptionsGuaranteedMinimumIncomeBenefits id="ID_16082_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">624000000</ci:PotentialUndiscountedPaymentsPurchaseOptionsGuaranteedMinimumIncomeBenefits>
  <ci:PotentialUndiscountedPaymentsPurchaseOptionsGuaranteedMinimumIncomeBenefits id="ID_16083_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">651000000</ci:PotentialUndiscountedPaymentsPurchaseOptionsGuaranteedMinimumIncomeBenefits>
  <ci:NetInvestmentIncomeNotReflectedInRevenuesSeparateAccounts id="ID_16084_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">163000000</ci:NetInvestmentIncomeNotReflectedInRevenuesSeparateAccounts>
  <ci:NetInvestmentIncomeNotReflectedInRevenuesSeparateAccounts id="ID_16085_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">22000000</ci:NetInvestmentIncomeNotReflectedInRevenuesSeparateAccounts>
  <ci:NetInvestmentIncomeNotReflectedInRevenuesSeparateAccounts id="ID_16086_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">148000000</ci:NetInvestmentIncomeNotReflectedInRevenuesSeparateAccounts>
  <ci:CreditRelatedImpairmentsOnDebtSecuritiesNetQualitative id="ID_16087" contextRef="FROM_Jan01_2010_TO_Dec31_2010">Not significant</ci:CreditRelatedImpairmentsOnDebtSecuritiesNetQualitative>
  <ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNetQualitative id="ID_16088" contextRef="FROM_Jan01_2010_TO_Dec31_2010">Not significant</ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNetQualitative>
  <ci:RealizedInvestmentGainsLossesOnHybridSecurities id="ID_16091_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">7000000</ci:RealizedInvestmentGainsLossesOnHybridSecurities>
  <ci:RealizedInvestmentGainsLossesOnHybridSecurities id="ID_16092_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">13000000</ci:RealizedInvestmentGainsLossesOnHybridSecurities>
  <ci:RealizedInvestmentGainsLossesOnHybridSecurities id="ID_16093_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-31000000</ci:RealizedInvestmentGainsLossesOnHybridSecurities>
  <ci:TenderOfferPriceAndDiscountRate id="ID_16094" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember">The tender price equaled the present value of the remaining principal and interest payments on the Notes being redeemed, discounted at a rate equal to the 10 year Treasury rate plus a fixed spread of 100 basis points.</ci:TenderOfferPriceAndDiscountRate>
  <ci:BasisPointsAddedToTreasuryRate id="ID_16095_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember" unitRef="Number">100</ci:BasisPointsAddedToTreasuryRate>
  <ci:DebtTenderPricingYield id="ID_16096_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember" unitRef="Number">4.128</ci:DebtTenderPricingYield>
  <ci:AmountOfDebtTendered id="ID_16097_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember" unitRef="USD">99000000</ci:AmountOfDebtTendered>
  <ci:RepaymentsOfDebt id="ID_16098_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember" unitRef="USD">130000000</ci:RepaymentsOfDebt>
  <ci:PaymentsOfDebtExtinguishmentCosts id="ID_16099_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember" unitRef="USD">-21000000</ci:PaymentsOfDebtExtinguishmentCosts>
  <ci:TenderOfferPriceAndDiscountRate id="ID_16100_Number" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember">The tender price equaled the present value of the remaining principal and interest payments on the Notes being redeemed, discounted at a rate equal to the 10 year Treasury rate plus a fixed spread of 45 basis points.</ci:TenderOfferPriceAndDiscountRate>
  <ci:DebtTenderPricingYield id="ID_16101_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember" unitRef="Number">3.923</ci:DebtTenderPricingYield>
  <ci:AmountOfDebtTendered id="ID_16102_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember" unitRef="USD">169000000</ci:AmountOfDebtTendered>
  <ci:BasisPointsAddedToTreasuryRate id="ID_16103_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember" unitRef="Number">45</ci:BasisPointsAddedToTreasuryRate>
  <ci:RepaymentsOfDebt id="ID_16104_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember" unitRef="USD">-198000000</ci:RepaymentsOfDebt>
  <ci:PaymentsOfDebtExtinguishmentCosts id="ID_16105_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember" unitRef="USD">-18000000</ci:PaymentsOfDebtExtinguishmentCosts>
  <ci:LongTermDebtFaceValue id="ID_16106_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20204375InterestMember" unitRef="USD">250000000</ci:LongTermDebtFaceValue>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="ID_16107_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20204375InterestMember" unitRef="Number">4.375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <ci:DebtInstrumentInterestRateBasisEffectiveRate id="ID_16108_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20204375InterestMember" unitRef="Number">5.1</ci:DebtInstrumentInterestRateBasisEffectiveRate>
  <ci:LongTermDebtFaceValue id="ID_16109_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20205125InterestMember" unitRef="USD">300000000</ci:LongTermDebtFaceValue>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="ID_16110_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20205125InterestMember" unitRef="Number">5.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <ci:DebtInstrumentInterestRateBasisEffectiveRate id="ID_16111_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue20205125InterestMember" unitRef="Number">5.36</ci:DebtInstrumentInterestRateBasisEffectiveRate>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="ID_16113_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember" unitRef="Number">8.5</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <ci:DebtInstrumentInterestRateBasisEffectiveRate id="ID_16114_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember" unitRef="Number">9.9</ci:DebtInstrumentInterestRateBasisEffectiveRate>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths id="ID_16115_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">452000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo id="ID_16116_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">3000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree id="ID_16117_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">3000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour id="ID_16118_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">23000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive id="ID_16119_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive id="ID_16120_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">2359000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
  <ci:CommercialPaperWeightedAverageInterestRate id="ID_16121_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.38</ci:CommercialPaperWeightedAverageInterestRate>
  <ci:CommercialPaperMaximumAuthorized id="ID_16122_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">500000000</ci:CommercialPaperMaximumAuthorized>
  <ci:RevolvingCreditAndLetterOfCreditAgreement id="ID_16123_USD_InBillions" decimals="-7" contextRef="AS_OF_Dec31_2010" unitRef="USD">1750000000</ci:RevolvingCreditAndLetterOfCreditAgreement>
  <ci:LettersofCreditCurrentBorrowingCapacity id="ID_16124_USD_InBillions" decimals="-7" contextRef="AS_OF_Dec31_2010" unitRef="USD">1250000000</ci:LettersofCreditCurrentBorrowingCapacity>
  <ci:CreditFacilityMaximumBorrowingCapacity id="ID_16125_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">2000000000</ci:CreditFacilityMaximumBorrowingCapacity>
  <ci:LettersOfCreditOutstandingAmount id="ID_16126_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">82000000</ci:LettersOfCreditOutstandingAmount>
  <ci:CreditFacilityRemainingBorrowingCapacity id="ID_16127_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">1700000000</ci:CreditFacilityRemainingBorrowingCapacity>
  <ci:ShortTermAndLongTermDebtOutstanding id="ID_16128_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">2800000000</ci:ShortTermAndLongTermDebtOutstanding>
  <ci:PreferredStockSharesOutstandingQualitative id="ID_16129" contextRef="AS_OF_Dec31_2010">No shares of preferred stock</ci:PreferredStockSharesOutstandingQualitative>
  <ci:PreferredStockSharesOutstandingQualitative id="ID_16130" contextRef="AS_OF_Dec31_2009">No shares of preferred stock</ci:PreferredStockSharesOutstandingQualitative>
  <us-gaap:CommonStockParOrStatedValuePerShare id="ID_16131_USD_PerShare" decimals="2" contextRef="AS_OF_Dec31_2010" unitRef="USD">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="ID_16132_Shares_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010" unitRef="Shares">600000</us-gaap:CommonStockSharesAuthorized>
  <ci:StatutoryAccountingPracticesAmountOnDepositWithStateDepartmentsOfInsurance id="ID_16133_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">319000000</ci:StatutoryAccountingPracticesAmountOnDepositWithStateDepartmentsOfInsurance>
  <us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments id="ID_16134_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">1500000000</us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments>
  <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired id="ID_16135_USD_InBillions" decimals="-9" contextRef="AS_OF_Dec31_2010" unitRef="USD">5000000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
  <ci:StatutoryAccountingPracticesAmountPermittedLendingAuthorityOfLifeInsuranceSubsidiaryToParent id="ID_16136_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">600000000</ci:StatutoryAccountingPracticesAmountPermittedLendingAuthorityOfLifeInsuranceSubsidiaryToParent>
  <ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncome id="ID_16137_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">31000000</ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncome>
  <ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncomeSouthKorea id="ID_16138_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">20000000</ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncomeSouthKorea>
  <ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncomeHongKong id="ID_16139_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">11000000</ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncomeHongKong>
  <ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncomeHongKongImplementation id="ID_16140_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">6000000</ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncomeHongKongImplementation>
  <ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncomeSouthKorea id="ID_16141_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">23000000</ci:TaxBenefitPermanentlyInvestedOverseasShareholdersNetIncomeSouthKorea>
  <ci:TaxBenefitPermanentlyInvestedOverseasCumulativeUnrecognizedDeferredTaxLiabilities id="ID_16142_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">54000000</ci:TaxBenefitPermanentlyInvestedOverseasCumulativeUnrecognizedDeferredTaxLiabilities>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic id="ID_16143_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">205000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign id="ID_16144_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
  <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate id="ID_16145_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">29000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued id="ID_16146_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">14000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued id="ID_16147_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">13000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued id="ID_16148_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008" unitRef="USD">19000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
  <ci:IncomeTaxExaminationPenaltiesAndInterestBenefit id="ID_16149_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">13000000</ci:IncomeTaxExaminationPenaltiesAndInterestBenefit>
  <ci:IncomeTaxExaminationPenaltiesReducedFromExaminationEffectingShareholdersNetIncome id="ID_16150_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">21000000</ci:IncomeTaxExaminationPenaltiesReducedFromExaminationEffectingShareholdersNetIncome>
  <ci:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthorityContinuingOperations id="ID_16151_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">20000000</ci:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthorityContinuingOperations>
  <ci:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthorityDiscontinuedOperations id="ID_16152_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1000000</ci:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthorityDiscontinuedOperations>
  <ci:IncomeTaxExaminationPenaltiesReducedFromExaminationIncomeTaxExpense id="ID_16153_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">17000000</ci:IncomeTaxExaminationPenaltiesReducedFromExaminationIncomeTaxExpense>
  <ci:IncomeTaxExaminationPenaltiesReducedFromExaminationPretaxCharge id="ID_16154_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">9000000</ci:IncomeTaxExaminationPenaltiesReducedFromExaminationPretaxCharge>
  <ci:EffectiveIncomeTaxRateProvisionOnShareholdersNetIncome id="ID_16155_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">10000000</ci:EffectiveIncomeTaxRateProvisionOnShareholdersNetIncome>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="ID_16156_Shares_InMillions" decimals="-5" contextRef="AS_OF_Dec31_2010" unitRef="Shares">7500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="ID_16157_Shares_InMillions" decimals="-5" contextRef="AS_OF_Dec31_2009" unitRef="Shares">23300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="ID_16158_Shares_InMillions" decimals="-5" contextRef="AS_OF_Dec31_2008" unitRef="Shares">28500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod id="ID_16159" contextRef="FROM_Jan01_2010_TO_Dec31_2010">one to five years</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationDating id="ID_16160" contextRef="FROM_Jan01_2010_TO_Dec31_2010">no later than 10 years from grant date</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationDating>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardCompensationCost id="ID_16161_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">18000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardCompensationCost>
  <ci:ShareBasedCompensationArrangementsFairValueOfVestedRestrictedStock id="ID_16166_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">18000000</ci:ShareBasedCompensationArrangementsFairValueOfVestedRestrictedStock>
  <ci:ShareBasedCompensationArrangementsFairValueOfVestedRestrictedStock id="ID_16167_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">10000000</ci:ShareBasedCompensationArrangementsFairValueOfVestedRestrictedStock>
  <ci:ShareBasedCompensationArrangementsFairValueOfVestedRestrictedStock id="ID_16168_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008" unitRef="USD">35000000</ci:ShareBasedCompensationArrangementsFairValueOfVestedRestrictedStock>
  <ci:NumberOfEmployeesHoldingRestrictedStockGrantsAndUnits id="ID_16169_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010" unitRef="Number">3000</ci:NumberOfEmployeesHoldingRestrictedStockGrantsAndUnits>
  <ci:NumberOfRestrictedStockGrantsAndUnitsHeld id="ID_16170_Shares_InMillions" decimals="-5" contextRef="AS_OF_Dec31_2010" unitRef="Shares">4300000</ci:NumberOfRestrictedStockGrantsAndUnitsHeld>
  <us-gaap:EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedAwards id="ID_16171_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">65000000</us-gaap:EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedAwards>
  <ci:ShareBasedCompensationArrangementByShareBasedPaymentRestrcitedStockAwardAwardVestingPeriod id="ID_16173" contextRef="FROM_Jan01_2010_TO_Dec31_2010">two to five years</ci:ShareBasedCompensationArrangementByShareBasedPaymentRestrcitedStockAwardAwardVestingPeriod>
  <ci:NumberOfEmployeesHoldingStrategicPerformanceSharesGrantsAndUnits id="ID_16174_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010" unitRef="Number">61</ci:NumberOfEmployeesHoldingStrategicPerformanceSharesGrantsAndUnits>
  <ci:NumberOfStrategicPerformanceSharesGrantsAndUnitsHeld id="ID_16175_Shares_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010" unitRef="Shares">430000</ci:NumberOfStrategicPerformanceSharesGrantsAndUnitsHeld>
  <ci:EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedStrategicPerformanceSharesAwards id="ID_16176_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">11000000</ci:EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedStrategicPerformanceSharesAwards>
  <ci:EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedStrategicPerformanceSharesAwardsWeightedAveragePeriodOfRecognition id="ID_16177_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">2</ci:EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedStrategicPerformanceSharesAwardsWeightedAveragePeriodOfRecognition>
  <us-gaap:LeaseAndRentalExpense id="ID_16178_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">127000000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:LeaseAndRentalExpense id="ID_16179_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">138000000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:LeaseAndRentalExpense id="ID_16180_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">131000000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="ID_16181_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">496000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="ID_16182_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">105000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="ID_16183_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">93000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="ID_16184_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">70000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears id="ID_16185_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">56000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears id="ID_16186_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">48000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter id="ID_16187_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">124000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <ci:OtherOperatingExpenseOutsourcedServiceAgreements id="ID_16188_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">114000000</ci:OtherOperatingExpenseOutsourcedServiceAgreements>
  <ci:OtherOperatingExpenseOutsourcedServiceAgreements id="ID_16189_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">115000000</ci:OtherOperatingExpenseOutsourcedServiceAgreements>
  <ci:OtherOperatingExpenseOutsourcedServiceAgreements id="ID_16190_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">113000000</ci:OtherOperatingExpenseOutsourcedServiceAgreements>
  <ci:ServicePeriodOutsourcedServiceArrangementsWithThirdPartiesRangeLow id="ID_16191_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">7</ci:ServicePeriodOutsourcedServiceArrangementsWithThirdPartiesRangeLow>
  <ci:ServicePeriodOutsourcedServiceArrangementsWithThirdPartiesRangeHigh id="ID_16192_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">8</ci:ServicePeriodOutsourcedServiceArrangementsWithThirdPartiesRangeHigh>
  <ci:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignPercentage id="ID_16193_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.13</ci:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignPercentage>
  <ci:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignPercentage id="ID_16194_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="Number">0.09</ci:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignPercentage>
  <ci:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignPercentage id="ID_16195_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="Number">0.36</ci:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignPercentage>
  <ci:MedicarePartDFees id="ID_16196_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">57000000</ci:MedicarePartDFees>
  <ci:MedicarePartDFees id="ID_16197_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">41000000</ci:MedicarePartDFees>
  <ci:MedicarePartDFees id="ID_16198_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">69000000</ci:MedicarePartDFees>
  <ci:SouthKoreanPercentageOfInternationalSegmentsRevenues id="ID_16199_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.32</ci:SouthKoreanPercentageOfInternationalSegmentsRevenues>
  <ci:SouthKoreanPercentageOfInternationalSegmentsEarnings id="ID_16200_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.49</ci:SouthKoreanPercentageOfInternationalSegmentsEarnings>
  <ci:SouthKoreanPercentageOfInternationalSegmentsRevenues id="ID_16201_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2009" unitRef="Number">0.29</ci:SouthKoreanPercentageOfInternationalSegmentsRevenues>
  <ci:SouthKoreanPercentageOfInternationalSegmentsEarnings id="ID_16202_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2009" unitRef="Number">0.49</ci:SouthKoreanPercentageOfInternationalSegmentsEarnings>
  <ci:GuaranteedBenefitObligationsWrittenInTheCompanysSeparateAccounts id="ID_16203_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2010" unitRef="USD">1300000000</ci:GuaranteedBenefitObligationsWrittenInTheCompanysSeparateAccounts>
  <ci:PercentageOfBenefitObligationGuaranteesAssociatedWithTheSoldRetirementBenefitsBusiness id="ID_16204_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.75</ci:PercentageOfBenefitObligationGuaranteesAssociatedWithTheSoldRetirementBenefitsBusiness>
  <ci:GuaranteeObligationsMaximumExposureGuaranteedMinimumIncomeBenefits id="ID_16205_USD_InBillions" decimals="-8" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1100000000</ci:GuaranteeObligationsMaximumExposureGuaranteedMinimumIncomeBenefits>
  <ci:IndemnificationObligationsToLenders id="ID_16208_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">168000000</ci:IndemnificationObligationsToLenders>
  <ci:LiabilitiesRequiredIndemnificationObligationsRealEstateJointVentures id="ID_16209" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;No Liabilities&lt;/font&gt;</ci:LiabilitiesRequiredIndemnificationObligationsRealEstateJointVentures>
  <ci:PaidClaimsReceivableFromAcquiredBusiness id="ID_16210" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;19&lt;/font&gt;</ci:PaidClaimsReceivableFromAcquiredBusiness>
  <ci:MaximumGuaranteeForLeaseShortfall id="ID_16211_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">44000000</ci:MaximumGuaranteeForLeaseShortfall>
  <ci:GuaranteeForLeaseShortfallExpiring2012 id="ID_16212_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">28000000</ci:GuaranteeForLeaseShortfallExpiring2012>
  <ci:GuaranteeForLeaseShortfallExpiring2016 id="ID_16213_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">16000000</ci:GuaranteeForLeaseShortfallExpiring2016>
  <ci:GuaranteeLiabilityForLeaseShortfall id="ID_16214_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">11000000</ci:GuaranteeLiabilityForLeaseShortfall>
  <ci:LiabilitiesRequiredIndemnificationObligationsAcquisitionsAndDispositions id="ID_16215" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;no liabilities&lt;/font&gt;</ci:LiabilitiesRequiredIndemnificationObligationsAcquisitionsAndDispositions>
  <ci:BankingServiceGuaranteesMaximumExposure id="ID_16216_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">366000000</ci:BankingServiceGuaranteesMaximumExposure>
  <ci:PreTaxAdministrativeServiceBankAccountCharge id="ID_16217_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">3000000</ci:PreTaxAdministrativeServiceBankAccountCharge>
  <ci:PreTaxAdministrativeServiceBankAccountCharge id="ID_16218_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">0</ci:PreTaxAdministrativeServiceBankAccountCharge>
  <ci:PercentReductionBankServiceGuarantees id="ID_16219_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.92</ci:PercentReductionBankServiceGuarantees>
  <ci:LiabilitiesRequiredBankServiceGuarantees id="ID_16220" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 10pt;COLOR: #000000;"&gt;13 percent&lt;/font&gt;</ci:LiabilitiesRequiredBankServiceGuarantees>
  <ci:EstimatedPotentialGuarantyFundAssessmentsRange id="ID_16221" contextRef="FROM_Jan01_2010_TO_Dec31_2010">Up to $40 million after-tax</ci:EstimatedPotentialGuarantyFundAssessmentsRange>
  <ci:BrokerCompensationRiskOfLoss id="ID_16222" contextRef="FROM_Jan01_2010_TO_Dec31_2010">immaterial</ci:BrokerCompensationRiskOfLoss>
  <ci:PensionPlanLitigationChargePreTax id="ID_16223_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">82000000</ci:PensionPlanLitigationChargePreTax>
  <ci:PensionPlanLitigationChargeAfterTax id="ID_16224_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">53000000</ci:PensionPlanLitigationChargeAfterTax>
  <ci:ContributionToNonProfit id="ID_16225_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">10000000</ci:ContributionToNonProfit>
  <ci:IngenixNotPossibleToEstimateRangeOfLoss id="ID_16226" contextRef="FROM_Jan01_2010_TO_Dec31_2010">not possible to estimate range</ci:IngenixNotPossibleToEstimateRangeOfLoss>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_16227_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Mar31_2010" unitRef="USD">5000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_16228_USD_InMillions" decimals="-6" contextRef="FROM_Apr01_2010_TO_Jun30_2010" unitRef="USD">-104000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_16229_USD_InMillions" decimals="-6" contextRef="FROM_Jul01_2010_TO_Sep30_2010" unitRef="USD">-10000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_16230_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2010_TO_Dec31_2010" unitRef="USD">85000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityLossOnReinsuranceTransaction id="ID_16231_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2010_TO_Dec31_2010" unitRef="USD">-20000000</ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityLossOnReinsuranceTransaction>
  <ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityResolutionFederalTaxMatter id="ID_16232_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2010_TO_Dec31_2010" unitRef="USD">101000000</ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityResolutionFederalTaxMatter>
  <ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityLossEarlyExtinguishmentDebt id="ID_16233_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2010_TO_Dec31_2010" unitRef="USD">-39000000</ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityLossEarlyExtinguishmentDebt>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_16234_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Mar31_2009" unitRef="USD">23000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityCompletionIRSExamination id="ID_16235_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Mar31_2009" unitRef="USD">20000000</ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityCompletionIRSExamination>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_16236_USD_InMillions" decimals="-6" contextRef="FROM_Apr01_2009_TO_Jun30_2009" unitRef="USD">110000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityPensionCurtailmentGain id="ID_16237_USD_InMillions" decimals="-6" contextRef="FROM_Apr01_2009_TO_Jun30_2009" unitRef="USD">30000000</ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityPensionCurtailmentGain>
  <ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityCostReductionProgram id="ID_16238_USD_InMillions" decimals="-6" contextRef="FROM_Apr01_2009_TO_Jun30_2009" unitRef="USD">-9000000</ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityCostReductionProgram>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_16239_USD_InMillions" decimals="-6" contextRef="FROM_Jul01_2009_TO_Sep30_2009" unitRef="USD">16000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityCostReductionProgram id="ID_16240_USD_InMillions" decimals="-6" contextRef="FROM_Jul01_2009_TO_Sep30_2009" unitRef="USD">-7000000</ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityCostReductionProgram>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_16241_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2009_TO_Dec31_2009" unitRef="USD">60000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityCostReductionProgram id="ID_16242_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2009_TO_Dec31_2009" unitRef="USD">-13000000</ci:QuarterlyFinancialInformationQuarterlyChargesAndCreditsAmountAffectingComparabilityCostReductionProgram>
  <ci:LongTermDebtFaceValue id="ID_16282_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember" unitRef="USD">350000000</ci:LongTermDebtFaceValue>
  <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate id="ID_17967_Number_Percentage" decimals="INF" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">0.05</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate>
  <ci:MeanInvestmentPerformanceAssumptionforUnderlyingEquityandFixedIncomeMutualFundsHigh id="ID_18125_Number_Percentage" decimals="INF" contextRef="AS_OF_Dec31_2010" unitRef="Number">0.03</ci:MeanInvestmentPerformanceAssumptionforUnderlyingEquityandFixedIncomeMutualFundsHigh>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ID_18128_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">4.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ID_18129_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">14.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <ci:GreatWestBusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet id="ID_18218_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2008" unitRef="USD">1500000000</ci:GreatWestBusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed id="ID_18219_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2008_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember" unitRef="USD">100000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired id="ID_18220_USD_InBillions" decimals="-8" contextRef="AS_OF_Dec31_2008_us-gaap_BusinessAcquisitionAxis_GreatWestHealthcareMember" unitRef="USD">1400000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ID_18239_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">11.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedAwardsWeightedAveragePeriodOfRecognition id="ID_18264_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">3</us-gaap:EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedAwardsWeightedAveragePeriodOfRecognition>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ID_18265_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <ci:PremiumsEarnedNetFeesAndCommissions id="ID_7723_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">18393000000</ci:PremiumsEarnedNetFeesAndCommissions>
  <ci:PremiumsEarnedNetFeesAndCommissions id="ID_7724_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">16041000000</ci:PremiumsEarnedNetFeesAndCommissions>
  <ci:PremiumsEarnedNetFeesAndCommissions id="ID_7725_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">16253000000</ci:PremiumsEarnedNetFeesAndCommissions>
  <us-gaap:NetInvestmentIncome id="ID_7726_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1105000000</us-gaap:NetInvestmentIncome>
  <us-gaap:NetInvestmentIncome id="ID_7727_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1014000000</us-gaap:NetInvestmentIncome>
  <us-gaap:NetInvestmentIncome id="ID_7728_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1063000000</us-gaap:NetInvestmentIncome>
  <us-gaap:SalesRevenueGoodsNet id="ID_7729_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1420000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet id="ID_7730_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1282000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet id="ID_7731_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1204000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:OtherIncome id="ID_7732_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">260000000</us-gaap:OtherIncome>
  <us-gaap:OtherIncome id="ID_7733_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">120000000</us-gaap:OtherIncome>
  <us-gaap:OtherIncome id="ID_7734_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">751000000</us-gaap:OtherIncome>
  <ci:OtherRealizedInvestmentGainsLosses id="ID_7738_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">76000000</ci:OtherRealizedInvestmentGainsLosses>
  <ci:OtherRealizedInvestmentGainsLosses id="ID_7739_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">4000000</ci:OtherRealizedInvestmentGainsLosses>
  <ci:OtherRealizedInvestmentGainsLosses id="ID_7740_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">43000000</ci:OtherRealizedInvestmentGainsLosses>
  <us-gaap:RealizedInvestmentGainsLosses id="ID_7741_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">75000000</us-gaap:RealizedInvestmentGainsLosses>
  <us-gaap:RealizedInvestmentGainsLosses id="ID_7742_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-43000000</us-gaap:RealizedInvestmentGainsLosses>
  <us-gaap:RealizedInvestmentGainsLosses id="ID_7743_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-170000000</us-gaap:RealizedInvestmentGainsLosses>
  <us-gaap:Revenues id="ID_7744_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">21253000000</us-gaap:Revenues>
  <us-gaap:Revenues id="ID_7745_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">18414000000</us-gaap:Revenues>
  <us-gaap:Revenues id="ID_7746_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">19101000000</us-gaap:Revenues>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare id="ID_7747_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">8570000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare id="ID_7748_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">6927000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare id="ID_7749_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">7252000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredOther id="ID_7750_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">3663000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredOther>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredOther id="ID_7751_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">3407000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredOther>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredOther id="ID_7752_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">4285000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredOther>
  <us-gaap:CostOfGoodsSold id="ID_7753_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1169000000</us-gaap:CostOfGoodsSold>
  <us-gaap:CostOfGoodsSold id="ID_7754_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1036000000</us-gaap:CostOfGoodsSold>
  <us-gaap:CostOfGoodsSold id="ID_7755_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">961000000</us-gaap:CostOfGoodsSold>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_7756_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">55000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_7757_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-304000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_7758_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">690000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <us-gaap:OtherCostAndExpenseOperating id="ID_7759_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">5926000000</us-gaap:OtherCostAndExpenseOperating>
  <us-gaap:OtherCostAndExpenseOperating id="ID_7760_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">5450000000</us-gaap:OtherCostAndExpenseOperating>
  <us-gaap:OtherCostAndExpenseOperating id="ID_7761_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">5531000000</us-gaap:OtherCostAndExpenseOperating>
  <us-gaap:BenefitsLossesAndExpenses id="ID_7762_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">19383000000</us-gaap:BenefitsLossesAndExpenses>
  <us-gaap:BenefitsLossesAndExpenses id="ID_7763_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">16516000000</us-gaap:BenefitsLossesAndExpenses>
  <us-gaap:BenefitsLossesAndExpenses id="ID_7764_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">18719000000</us-gaap:BenefitsLossesAndExpenses>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="ID_7765_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1870000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="ID_7766_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1898000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="ID_7767_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">382000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:CurrentIncomeTaxExpenseBenefit id="ID_7768_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">331000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit id="ID_7769_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">275000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit id="ID_7770_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">313000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="ID_7771_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">190000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="ID_7772_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">319000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="ID_7773_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-221000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="ID_7774_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">521000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="ID_7775_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">594000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="ID_7776_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">92000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="ID_7777_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1349000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="ID_7778_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1304000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="ID_7779_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">290000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="ID_7780_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="ID_7781_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="ID_7782_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">4000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:ProfitLoss id="ID_7783_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1349000000</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="ID_7784_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1305000000</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="ID_7785_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">294000000</us-gaap:ProfitLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_7786_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">4000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_7787_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_7788_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLoss id="ID_7789_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1345000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="ID_7790_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1302000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="ID_7791_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">292000000</us-gaap:NetIncomeLoss>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare id="ID_7792_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromContinuingOperations id="ID_7793_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1345000000</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:IncomeLossFromContinuingOperations id="ID_7794_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1301000000</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:IncomeLossFromContinuingOperations id="ID_7795_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">288000000</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_8019_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">4.93</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_8020_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">4.75</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_8021_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1.04</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare id="ID_8022_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare id="ID_8023_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare id="ID_8024_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:EarningsPerShareBasic id="ID_8025_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">4.93</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic id="ID_8026_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">4.75</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic id="ID_8027_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1.05</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare id="ID_8028_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">4.89</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare id="ID_8029_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">4.73</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare id="ID_8030_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare id="ID_8031_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare id="ID_8032_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:EarningsPerShareDiluted id="ID_8033_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">4.89</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted id="ID_8034_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">4.73</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted id="ID_8035_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1.05</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CommonStockDividendsPerShareDeclared id="ID_8036_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">0.04</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:CommonStockDividendsPerShareDeclared id="ID_8037_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">0.04</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:CommonStockDividendsPerShareDeclared id="ID_8038_USD_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">0.04</us-gaap:CommonStockDividendsPerShareDeclared>
  <ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet id="ID_15631_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-1000000</ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet>
  <ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet id="ID_15632_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-47000000</ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet>
  <ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet id="ID_15633_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-213000000</ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="ID_7796_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">14709000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesEquitySecurities id="ID_7797_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">127000000</us-gaap:AvailableForSaleSecuritiesEquitySecurities>
  <us-gaap:LoansReceivableCommercialRealEstate id="ID_7798_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">3486000000</us-gaap:LoansReceivableCommercialRealEstate>
  <us-gaap:LoansInsurancePolicy id="ID_7799_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1581000000</us-gaap:LoansInsurancePolicy>
  <us-gaap:RealEstateInvestments id="ID_7800_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">112000000</us-gaap:RealEstateInvestments>
  <us-gaap:OtherLongTermInvestments id="ID_7801_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">759000000</us-gaap:OtherLongTermInvestments>
  <us-gaap:OtherShortTermInvestments id="ID_7802_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">174000000</us-gaap:OtherShortTermInvestments>
  <us-gaap:Investments id="ID_7803_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">20948000000</us-gaap:Investments>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="ID_7804_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">13443000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesEquitySecurities id="ID_7805_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">113000000</us-gaap:AvailableForSaleSecuritiesEquitySecurities>
  <us-gaap:LoansReceivableCommercialRealEstate id="ID_7806_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">3522000000</us-gaap:LoansReceivableCommercialRealEstate>
  <us-gaap:LoansInsurancePolicy id="ID_7807_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">1549000000</us-gaap:LoansInsurancePolicy>
  <us-gaap:RealEstateInvestments id="ID_7808_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">124000000</us-gaap:RealEstateInvestments>
  <us-gaap:OtherLongTermInvestments id="ID_7809_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">595000000</us-gaap:OtherLongTermInvestments>
  <us-gaap:OtherShortTermInvestments id="ID_7810_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">493000000</us-gaap:OtherShortTermInvestments>
  <us-gaap:Investments id="ID_7811_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">19839000000</us-gaap:Investments>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_7812_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1605000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AccruedInvestmentIncomeReceivable id="ID_7813_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">235000000</us-gaap:AccruedInvestmentIncomeReceivable>
  <us-gaap:PremiumsAndOtherReceivablesNet id="ID_7814_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1318000000</us-gaap:PremiumsAndOtherReceivablesNet>
  <us-gaap:ReinsuranceRecoverables id="ID_7815_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">6495000000</us-gaap:ReinsuranceRecoverables>
  <us-gaap:DeferredPolicyAcquisitionCosts id="ID_7816_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1122000000</us-gaap:DeferredPolicyAcquisitionCosts>
  <us-gaap:PropertyPlantAndEquipmentNet id="ID_7817_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">912000000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Goodwill id="ID_7819_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">3119000000</us-gaap:Goodwill>
  <us-gaap:OtherAssets id="ID_7820_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1238000000</us-gaap:OtherAssets>
  <us-gaap:SeparateAccountAssets id="ID_7821_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">7908000000</us-gaap:SeparateAccountAssets>
  <us-gaap:Assets id="ID_7822_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">45682000000</us-gaap:Assets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_7823_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">924000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AccruedInvestmentIncomeReceivable id="ID_7824_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">238000000</us-gaap:AccruedInvestmentIncomeReceivable>
  <us-gaap:PremiumsAndOtherReceivablesNet id="ID_7825_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">1361000000</us-gaap:PremiumsAndOtherReceivablesNet>
  <us-gaap:ReinsuranceRecoverables id="ID_7826_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">6597000000</us-gaap:ReinsuranceRecoverables>
  <us-gaap:DeferredPolicyAcquisitionCosts id="ID_7827_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">943000000</us-gaap:DeferredPolicyAcquisitionCosts>
  <us-gaap:PropertyPlantAndEquipmentNet id="ID_7828_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">862000000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Goodwill id="ID_7830_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">2876000000</us-gaap:Goodwill>
  <us-gaap:OtherAssets id="ID_7831_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">1056000000</us-gaap:OtherAssets>
  <us-gaap:SeparateAccountAssets id="ID_7832_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">7288000000</us-gaap:SeparateAccountAssets>
  <us-gaap:Assets id="ID_7833_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">43013000000</us-gaap:Assets>
  <us-gaap:PolicyholderContractDeposits id="ID_7834_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">8509000000</us-gaap:PolicyholderContractDeposits>
  <us-gaap:LiabilityForFuturePolicyBenefits id="ID_7835_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">8147000000</us-gaap:LiabilityForFuturePolicyBenefits>
  <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet id="ID_7836_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">4017000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth id="ID_7837_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1246000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth>
  <us-gaap:UnearnedPremiums id="ID_7838_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">416000000</us-gaap:UnearnedPremiums>
  <ci:InsuranceAndContractholderLiabilities id="ID_7839_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">22335000000</ci:InsuranceAndContractholderLiabilities>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent id="ID_7840_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">5936000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:OtherShortTermBorrowings id="ID_7841_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">552000000</us-gaap:OtherShortTermBorrowings>
  <us-gaap:LongTermDebt id="ID_7842_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">2288000000</us-gaap:LongTermDebt>
  <us-gaap:OtherLiabilities id="ID_7843_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">0</us-gaap:OtherLiabilities>
  <us-gaap:SeparateAccountsLiability id="ID_7844_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">7908000000</us-gaap:SeparateAccountsLiability>
  <us-gaap:Liabilities id="ID_7845_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">39019000000</us-gaap:Liabilities>
  <us-gaap:PolicyholderContractDeposits id="ID_7846_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">8484000000</us-gaap:PolicyholderContractDeposits>
  <us-gaap:LiabilityForFuturePolicyBenefits id="ID_7847_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">8136000000</us-gaap:LiabilityForFuturePolicyBenefits>
  <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet id="ID_7848_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">3968000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth id="ID_7849_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">921000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth>
  <us-gaap:UnearnedPremiums id="ID_7850_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">427000000</us-gaap:UnearnedPremiums>
  <ci:InsuranceAndContractholderLiabilities id="ID_7851_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">21936000000</ci:InsuranceAndContractholderLiabilities>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent id="ID_7852_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">5797000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:OtherShortTermBorrowings id="ID_7853_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">104000000</us-gaap:OtherShortTermBorrowings>
  <us-gaap:LongTermDebt id="ID_7854_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">2436000000</us-gaap:LongTermDebt>
  <us-gaap:OtherLiabilities id="ID_7855_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">23000000</us-gaap:OtherLiabilities>
  <us-gaap:SeparateAccountsLiability id="ID_7856_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">7288000000</us-gaap:SeparateAccountsLiability>
  <us-gaap:Liabilities id="ID_7857_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">37584000000</us-gaap:Liabilities>
  <us-gaap:CommonStockValue id="ID_7858_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">88000000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="ID_7859_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">88000000</us-gaap:CommonStockValue>
  <ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleFixedSecuritiesAdjustmentNetOfTax id="ID_7860_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">529000000</ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleFixedSecuritiesAdjustmentNetOfTax>
  <ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleFixedSecuritiesAdjustmentNetOfTax id="ID_7861_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">378000000</ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleFixedSecuritiesAdjustmentNetOfTax>
  <ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleEquitySecuritiesAdjustmentNetOfTax id="ID_7862_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">3000000</ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleEquitySecuritiesAdjustmentNetOfTax>
  <ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleEquitySecuritiesAdjustmentNetOfTax id="ID_7863_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">4000000</ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleEquitySecuritiesAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax id="ID_7864_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">-24000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax id="ID_7865_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">-30000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="ID_7866_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">25000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="ID_7867_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">-12000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax id="ID_7868_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1147000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax id="ID_7869_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">958000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_7870_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">-614000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_7871_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">-618000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="ID_7872_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">9879000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="ID_7873_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">8625000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:TreasuryStockValue id="ID_7874_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">5242000000</us-gaap:TreasuryStockValue>
  <us-gaap:TreasuryStockValue id="ID_7875_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">5192000000</us-gaap:TreasuryStockValue>
  <us-gaap:StockholdersEquity id="ID_7876_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">6645000000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="ID_7877_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">5417000000</us-gaap:StockholdersEquity>
  <us-gaap:MinorityInterest id="ID_7878_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">18000000</us-gaap:MinorityInterest>
  <us-gaap:MinorityInterest id="ID_7879_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">12000000</us-gaap:MinorityInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_7880_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_7881_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">5429000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:LiabilitiesAndStockholdersEquity id="ID_7882_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">45682000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="ID_7883_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">43013000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <ci:ShareholdersEquityPerShare id="ID_7884_USD_PerShare" decimals="2" contextRef="AS_OF_Dec31_2010" unitRef="USD">24.44</ci:ShareholdersEquityPerShare>
  <ci:ShareholdersEquityPerShare id="ID_7885_USD_PerShare" decimals="2" contextRef="AS_OF_Dec31_2009" unitRef="USD">19.75</ci:ShareholdersEquityPerShare>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="ID_7886_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">13445000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="ID_7887_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">12580000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <ci:AvailableForSaleSecuritiesEquitySecuritiesCost id="ID_7888_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">144000000</ci:AvailableForSaleSecuritiesEquitySecuritiesCost>
  <ci:AvailableForSaleSecuritiesEquitySecuritiesCost id="ID_7889_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">137000000</ci:AvailableForSaleSecuritiesEquitySecuritiesCost>
  <us-gaap:CommonStockParOrStatedValuePerShare id="ID_7891_USD_PerShare" decimals="2" contextRef="AS_OF_Dec31_2009" unitRef="USD">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesIssued id="ID_7892_Shares_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="Shares">351000000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="ID_7893_Shares_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="Shares">351000000</us-gaap:CommonStockSharesIssued>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="ID_8195_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">2534000000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="ID_8196_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">2514000000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:CommitmentsAndContingencies2009 id="ID_18116" contextRef="FROM_Jan01_2010_TO_Dec31_2010">--</us-gaap:CommitmentsAndContingencies2009>
  <us-gaap:CommitmentsAndContingencies2009 id="ID_18117" contextRef="FROM_Jan01_2009_TO_Dec31_2009">--</us-gaap:CommitmentsAndContingencies2009>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet id="ID_18118_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">782000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet id="ID_18119_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">1029000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8245_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">88000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8246_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">88000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8247_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">88000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8248_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">2514000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8249_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">2502000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8250_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">2474000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8251_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-618000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8252_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">8625000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8253_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">-5192000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8254_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">-5298000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8255_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">-4978000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8256_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8257_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8258_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="ID_8265_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">20000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="ID_8266_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">12000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="ID_8267_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">28000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8274_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">151000000</ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8275_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">543000000</ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8276_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-287000000</ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8277_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-1000000</ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8278_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-3000000</ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8280_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">150000000</us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8281_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">540000000</us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease id="ID_8283_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">6000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease id="ID_8284_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-17000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8286_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">37000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8287_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">48000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8288_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-121000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8289_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-189000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_8290_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-97000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease id="ID_8292_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease id="ID_8293_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">474000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease id="ID_8294_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-1125000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:NetIncomeLoss id="ID_8304_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">1345000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="ID_8305_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">1302000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="ID_8306_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">292000000</us-gaap:NetIncomeLoss>
  <us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice id="ID_8307_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">-80000000</us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice>
  <us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice id="ID_8308_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">-58000000</us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice>
  <us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice id="ID_8309_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">-20000000</us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice>
  <us-gaap:TreasuryStockValueAcquiredCostMethod id="ID_8313_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">201000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:TreasuryStockValueAcquiredCostMethod id="ID_8314_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:TreasuryStockValueAcquiredCostMethod id="ID_8315_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">378000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued id="ID_8316_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">151000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued id="ID_8317_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">106000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued id="ID_8318_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">58000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_8319_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">4000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_8320_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_8321_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest id="ID_8322_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest id="ID_8323_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">3000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest id="ID_8324_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">-2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8325_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-1074000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8326_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">51000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8327_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">7374000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8328_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2007_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">7113000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8332_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">2534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8335_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-614000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8338_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">9879000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8341_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">-5242000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8344_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_ShareholderComprehensiveIncomeLossAndShareholdersEquityMember" unitRef="USD">6645000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8345_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_us-gaap_StatementEquityComponentsAxis_ShareholderComprehensiveIncomeLossAndShareholdersEquityMember" unitRef="USD">5417000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8346_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008_us-gaap_StatementEquityComponentsAxis_ShareholderComprehensiveIncomeLossAndShareholdersEquityMember" unitRef="USD">3592000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8347_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_8350_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008" unitRef="USD">3598000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <ci:OtherComprehensiveIncomeImplementationEffectOfOtti id="ID_15636_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">0</ci:OtherComprehensiveIncomeImplementationEffectOfOtti>
  <ci:OtherComprehensiveIncomeImplementationEffectOfOtti id="ID_15637_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-18000000</ci:OtherComprehensiveIncomeImplementationEffectOfOtti>
  <ci:OtherComprehensiveIncomeImplementationEffectOfOtti id="ID_15638_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">0</ci:OtherComprehensiveIncomeImplementationEffectOfOtti>
  <ci:RetainedEarningsImplementationEffectOfOtti id="ID_15639_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">0</ci:RetainedEarningsImplementationEffectOfOtti>
  <ci:RetainedEarningsImplementationEffectOfOtti id="ID_15640_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">18000000</ci:RetainedEarningsImplementationEffectOfOtti>
  <ci:RetainedEarningsImplementationEffectOfOtti id="ID_15641_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">0</ci:RetainedEarningsImplementationEffectOfOtti>
  <us-gaap:DividendsCommonStockCash id="ID_17968_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">-11000000</us-gaap:DividendsCommonStockCash>
  <us-gaap:DividendsCommonStockCash id="ID_17969_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">-11000000</us-gaap:DividendsCommonStockCash>
  <us-gaap:DividendsCommonStockCash id="ID_17970_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">-11000000</us-gaap:DividendsCommonStockCash>
  <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_18003_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-723000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_18241_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">0</ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease id="ID_18242_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-287000000</us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt id="ID_7933_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">822000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt id="ID_7934_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">927000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt id="ID_7935_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1459000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity id="ID_7936_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">4000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity id="ID_7937_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">22000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity id="ID_7938_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">6000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity>
  <us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable id="ID_7939_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">63000000</us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable>
  <us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable id="ID_7940_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">61000000</us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable>
  <us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable id="ID_7941_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">48000000</us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable>
  <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments id="ID_7942_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1102000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
  <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments id="ID_7943_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">910000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
  <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments id="ID_7944_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">492000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities id="ID_7945_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1084000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities id="ID_7946_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1100000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities id="ID_7947_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">872000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
  <us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond id="ID_7948_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">70000000</us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond>
  <us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond id="ID_7949_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">94000000</us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond>
  <us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond id="ID_7950_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">98000000</us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt id="ID_7951_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">2587000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt id="ID_7952_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">2916000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt id="ID_7953_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">2681000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity id="ID_7954_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">12000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity id="ID_7955_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">14000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity id="ID_7956_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">18000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity>
  <us-gaap:PaymentsToAcquireMortgageNotesReceivable id="ID_7957_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">239000000</us-gaap:PaymentsToAcquireMortgageNotesReceivable>
  <us-gaap:PaymentsToAcquireMortgageNotesReceivable id="ID_7958_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">175000000</us-gaap:PaymentsToAcquireMortgageNotesReceivable>
  <us-gaap:PaymentsToAcquireMortgageNotesReceivable id="ID_7959_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">488000000</us-gaap:PaymentsToAcquireMortgageNotesReceivable>
  <us-gaap:PaymentsToAcquireOtherInvestments id="ID_7960_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">810000000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsToAcquireOtherInvestments id="ID_7961_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1187000000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsToAcquireOtherInvestments id="ID_7962_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">776000000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="ID_7963_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">300000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="ID_7964_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">307000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="ID_7965_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">257000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired id="ID_7966_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">344000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired id="ID_7967_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired id="ID_7968_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1319000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities id="ID_7969_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">195000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities id="ID_7970_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities id="ID_7971_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">8000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="ID_7972_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-1342000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="ID_7973_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-1485000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="ID_7974_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-2572000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:AdditionsToContractHoldersFunds id="ID_7975_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1295000000</us-gaap:AdditionsToContractHoldersFunds>
  <us-gaap:AdditionsToContractHoldersFunds id="ID_7976_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1312000000</us-gaap:AdditionsToContractHoldersFunds>
  <us-gaap:AdditionsToContractHoldersFunds id="ID_7977_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1305000000</us-gaap:AdditionsToContractHoldersFunds>
  <us-gaap:WithdrawalFromContractHoldersFunds id="ID_7978_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1205000000</us-gaap:WithdrawalFromContractHoldersFunds>
  <us-gaap:WithdrawalFromContractHoldersFunds id="ID_7979_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1223000000</us-gaap:WithdrawalFromContractHoldersFunds>
  <us-gaap:WithdrawalFromContractHoldersFunds id="ID_7980_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1214000000</us-gaap:WithdrawalFromContractHoldersFunds>
  <us-gaap:ProceedsFromRepaymentsOfBankOverdrafts id="ID_7981_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">59000000</us-gaap:ProceedsFromRepaymentsOfBankOverdrafts>
  <us-gaap:ProceedsFromRepaymentsOfBankOverdrafts id="ID_7982_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">53000000</us-gaap:ProceedsFromRepaymentsOfBankOverdrafts>
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt id="ID_7984_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt id="ID_7985_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-199000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt id="ID_7986_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">298000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="ID_7987_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">543000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="ID_7988_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">346000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="ID_7989_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">297000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:RepaymentsOfLongTermDebt id="ID_7990_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">270000000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:RepaymentsOfLongTermDebt id="ID_7991_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1000000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:RepaymentsOfLongTermDebt id="ID_7992_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">0</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:PaymentsForRepurchaseOfCommonStock id="ID_7993_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">201000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsForRepurchaseOfCommonStock id="ID_7994_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsForRepurchaseOfCommonStock id="ID_7995_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">378000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ID_7996_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">64000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ID_7997_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">30000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ID_7998_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">37000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:PaymentsOfDividendsCommonStock id="ID_7999_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">11000000</us-gaap:PaymentsOfDividendsCommonStock>
  <us-gaap:PaymentsOfDividendsCommonStock id="ID_8000_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">11000000</us-gaap:PaymentsOfDividendsCommonStock>
  <us-gaap:PaymentsOfDividendsCommonStock id="ID_8001_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">14000000</us-gaap:PaymentsOfDividendsCommonStock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="ID_8002_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">274000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="ID_8003_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">307000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="ID_8004_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">314000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="ID_8005_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">6000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="ID_8006_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">15000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="ID_8007_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-26000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="ID_8008_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">681000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="ID_8009_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-418000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="ID_8010_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-628000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_8011_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2007" unitRef="USD">1970000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_8012_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008" unitRef="USD">1342000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:IncomeTaxesPaidNet id="ID_8013_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-326000000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:IncomeTaxesPaidNet id="ID_8014_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-220000000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:IncomeTaxesPaidNet id="ID_8015_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-366000000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:InterestPaid id="ID_8016_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-180000000</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="ID_8017_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-158000000</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="ID_8018_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-140000000</us-gaap:InterestPaid>
  <us-gaap:DepreciationDepletionAndAmortization id="ID_15560_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">292000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="ID_15561_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">244000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="ID_15562_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">268000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:GainLossOnSaleOfInvestments id="ID_15563_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">75000000</us-gaap:GainLossOnSaleOfInvestments>
  <us-gaap:GainLossOnSaleOfInvestments id="ID_15564_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-43000000</us-gaap:GainLossOnSaleOfInvestments>
  <us-gaap:GainLossOnSaleOfInvestments id="ID_15565_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-170000000</us-gaap:GainLossOnSaleOfInvestments>
  <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes id="ID_15566_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-190000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
  <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes id="ID_15567_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-319000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
  <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes id="ID_15568_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">221000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
  <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal id="ID_15569_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">13000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
  <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal id="ID_15570_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">32000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
  <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal id="ID_15571_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">38000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="ID_15573_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-62000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="ID_15575_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-219000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInReinsuranceRecoverable id="ID_15576_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-37000000</us-gaap:IncreaseDecreaseInReinsuranceRecoverable>
  <us-gaap:IncreaseDecreaseInReinsuranceRecoverable id="ID_15578_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-63000000</us-gaap:IncreaseDecreaseInReinsuranceRecoverable>
  <us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts id="ID_15579_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">156000000</us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts>
  <us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts id="ID_15581_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">74000000</us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="ID_15582_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">3000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="ID_15584_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">860000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInInsuranceLiabilities id="ID_15585_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">325000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
  <us-gaap:IncreaseDecreaseInInsuranceLiabilities id="ID_15587_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">485000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="ID_15588_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-272000000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="ID_15590_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1466000000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable id="ID_15591_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">2000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable id="ID_15593_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-72000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet id="ID_15594_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-5000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
  <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet id="ID_15595_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-44000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
  <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet id="ID_15596_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">16000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="ID_15597_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1743000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="ID_15599_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">745000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="ID_15601_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1656000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:ProceedsFromRepaymentsOfBankOverdrafts id="ID_17999_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-17000000</us-gaap:ProceedsFromRepaymentsOfBankOverdrafts>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="ID_18026_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-49000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInReinsuranceRecoverable id="ID_18027_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-30000000</us-gaap:IncreaseDecreaseInReinsuranceRecoverable>
  <us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts id="ID_18028_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">109000000</us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="ID_18029_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-452000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInInsuranceLiabilities id="ID_18030_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-357000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="ID_18031_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-1321000000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable id="ID_18032_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">55000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="ID_8059" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &amp;#8212; Summary of Significant Accounting Policies&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;A.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Basis of Presentation&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Consolidated F&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;inancial &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tatements include th&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e accounts of CIGNA Corporation and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; its significant subsidiaries&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Intercompany transactions and accounts have been eliminated in consolidation.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;These Consolidated Financial S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tatements were prepared in conformity with accounting principles generally accepted in the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;United States of America&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8220;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GAAP&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8221;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;).  Amounts recorded in the Consolidated F&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;inancial &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tatements &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;necessarily &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;reflect management's estimates and assumptions about medical costs, investment valuation, interest rates and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;other factors.  Significant estimates are discussed throughout these Notes; however, actual results could differ from those estimates.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  The impact of a change in estimate is generally included in earnings in the period of adjustment.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In preparing these Consolidated Financial S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tatements, the Company has evaluated events that occurred between the balance &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;sheet date and February 2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, 2011&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and determined there were no other items to disclose.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Certain reclassifications have been made to prior period amounts to conform to the current presentation.  In addition, certain amounts have been restated as a result of the adoption of new accounting pronouncements.&lt;/font&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <ci:DeferredAcquisitionCostsPolicy id="ID_16243" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Deferred acquisition costs.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;In October 2010, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) amended guidance (AS&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;U&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2010-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;26&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;) for the accounting of costs related to the acquisition or renewal of insurance contracts to require costs such as certain sales compensation or telemarketing costs that are related to unsuccessful efforts and any indirect costs to be expensed as incurred.  This new guidance must be implemented on January 1, 2012 or may be implemented earlier an&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;d any changes to the Company's Consolidated Financial S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tatements may be recognized prospectively for acquisition costs incurred beginning in 2012 or through retrospective adjustment of comparative prior periods.  The Company's deferred acquisition costs arise from sales and renewal activities primarily in its International segment and, to a lesser extent, the Health Care and corporate-owned life insurance businesses. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Because the new requirements further restrict the types of costs that are deferrable, the Company expects more of its acquisition costs to be expensed when incurred under the new guidance.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;continues to&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; evaluat&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; these new requirements to determine the timing, method and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;estimated&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; effects of their implementation. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:DeferredAcquisitionCostsPolicy>
  <ci:VariableInterestEntitiesPolicyTextBlock id="ID_16244" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Variable interest entities.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  Effective January 1, 2010, the Company adopted the FASB's amended guidance that requires ongoing qualitative analysis to determine whether a variable interest entity must be consolidated based on the entity's purpose and design, the Company's ability to direct the entity's activities that most significantly impact its economic performance, and the Company's right or obligation to participate in that performance (ASC 810).  A variable interest entity is insufficiently capitalized or is not controlled by its equity owners through voting or similar rights.  These amendments must be applied to qualifying special-purpose entities and troubled debt restructures formerly excluded from such analysis.  On adoption and through December 31, 2010, the Company was not required to consolidate any variable interest entities and there were no effects to its results of operations or financial condition.  Although consolidation was not required, disclosures about the Company's involvement with variable interest entities have been provided in Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;14&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:VariableInterestEntitiesPolicyTextBlock>
  <us-gaap:TransfersAndServicingOfFinancialAssetsTextBlock id="ID_16245" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Transfers of financial assets.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Effective January 1, 2010, the Company adopted the FASB's guidance for accounting for transfers of financial assets (ASC 860) that changes the requirements for recognizing the transfer of financial assets and requires additional disclosures about a transferor's continuing involvement in transferred assets.  The guidance also eliminates th&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; concept of a &amp;#8220;qualifying special purpose entity&amp;#8221; when assessing transfers of financial instruments.  On adoption, there were no effects to the Company's results of operations or financial condition.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</us-gaap:TransfersAndServicingOfFinancialAssetsTextBlock>
  <ci:FairValueOfFinancialInstrumentsPolicyTextBlock id="ID_16246" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Fair value measurements.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  The Company adopted the FASB's updated guidance on fair value measurements (ASU 2010-06) in the first quarter of 2010, which requires separate disclosures of significant transfers between levels in the fair value hierarchy.  See Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;11&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for additional information.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Effective January 1, 2008, the Company adopted the FASB's fair value disclosure and measurement guidance (ASC 820) that expands disclosures about fair value measurements and clarifies how to measure fair value by focusing on the price that would be received when selling an asset or paid to transfer a liability (exit price&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;).&amp;#160;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;At adoption, the Company was required to change certain assumptions used to estimate the fair values of GMIB assets and liabilities.  Because there is no market for these contracts, the assumptions used to estimate their fair values at adoption were determined using a hypothetical market participant's view of exit price, rather than using historical market data and actual experience to establish the Company's future expectations.&amp;#160;&amp;#160;Certain of these assumptions (primarily related to annuitant behavior) have limited or no observable market data so determining an exit price requires the Company to exercise significant judgment and make critical accounting estimates.  On adoption, the Company recorded a charge of $131 million after-tax, net of reinsurance ($202 million pre-tax), in Run-off Reinsurance.  The Company's results of operations related to this business are expected to continue to be volatile in future periods because several underlying assumptions (primarily interest rates) will be based on current market-observable inputs which will likely change each period.&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;A&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;mendments to this guidance in 2008 and 2009 had no effect on the Company's Consolidated Financial Statements.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;See Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;11&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for additional information.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:FairValueOfFinancialInstrumentsPolicyTextBlock>
  <ci:OtherThanTemporaryImpairmentsFixedMaturitiesPolicyTextBlock id="ID_16247" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Other-than-temporary impairments. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;On April 1, 2009, the Company adopted the FASB's updated guidance for evaluating whether an impairment is other than temporary for fixed maturities with declines in fair value below amortized cost (ASC 320).  A reclassification adjustment from retained earnings to accumulated other comprehensive income was required for previously impaired fixed maturities that had a non-credit loss as of the date of adoption, net of related tax effects.   &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The cumulative effect of adoption increased the Company's retained earnings in 2009 with an offsetting decrease to accumulated other comprehensive income of $18 million, with no overall change to shareholders' equity. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; See &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Note 12 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;(A) &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for information on the Company's other-than-temporary impairments including additional required disclosures.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:OtherThanTemporaryImpairmentsFixedMaturitiesPolicyTextBlock>
  <ci:NoncontrollingInterestInSubsidiariesPolicyTextBlock id="ID_16248" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Noncontrolling interests in subsidiaries.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Effective January 1, 2009, the Company adopted the FASB's updated guidance on accounting for noncontrolling interests (ASC 810) through retroactive restatement of prior financial statements and reclassified&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;noncontrolling interest &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;as of January 1, 2007&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;from Accounts payable, accrued expenses and other liabilities to Noncontrolling interest in total &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;equity.  In addition, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net income attributable to the noncontrolling inter&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;est of $2 million in 2008 and $3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million in 2007&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; has been reclassified to be included in net income, with a reduction to net income to determine net income attributable to the Company's shareholder&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s (&amp;#8220;shareholders' net income&amp;#8221;).  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:NoncontrollingInterestInSubsidiariesPolicyTextBlock>
  <us-gaap:EarningsPerSharePolicyTextBlock id="ID_16249" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Earnings per share.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Effective January 1, 2009, the Company adopted the FASB's updated earnings per share guidance (ASC 260) for determining participating securities that requires unvested restricted stock awards containing rights to nonforfeitable dividends to be included in the denominator of both basic and diluted earnings per share (&amp;#8220;EPS&amp;#8221;) calculations.  Prior period EPS data were restated in 2009 to reflect the adoption of this&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; guidance.  As part of this restatement, basic EPS for the full year 2008 was adjusted to $1.04 per share (originally reported as $1.05 per share).&lt;/font&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <ci:FixedMaturitiesAndEquitySecuritiesInvestmentPolicyTextBlock id="ID_16250" contextRef="FROM_Jan01_2010_TO_Dec31_2010">Fixed maturities and equity securities. Fixed maturities primarily include bonds, mortgage and other asset-backed securities and preferred stocks redeemable by the investor.  Equity securities include common stocks and preferred stocks that are non-redeemable or redeemable only at the option of the issuer.  These investments are primarily classified as available for sale and are carried at fair value with changes in fair value recorded in accumulated other comprehensive income (loss) within shareholders&amp;#8217; equity.  &amp;#160;Beginning April 1, 2009, when the Company determines it does not expect to recover the amortized cost basis of fixed maturities with declines in fair value (even if it does not intend to sell or will not be required to sell these fixed maturities), the credit portion of the impairment loss is recognized in net income and the non-credit portion, if any, is recognized in a separate component of shareholders&amp;#8217; equity.  The credit portion is the difference between the amortized cost basis of the fixed maturity and the net present value of its projected future cash flows.  Projected future cash flows are based on qualitative and quantitative factors, including probability of default, and the estimated timing and amount of recovery.  For mortgage and asset-backed securities, estimated future cash flows are based on assumptions about the collateral attributes including prepayment speeds, default rates and changes in value.  Equity securities and, prior to April 1, 2009, fixed maturities were considered impaired, and their cost basis was written down to fair value through earnings, when management did not expect to recover the amortized cost, or if the Company could not demonstrate its intent or ability to hold the investment until full recovery.  Fixed maturities and equity securities also include trading and certain hybrid securities that are carried at fair value with changes in fair value reported in realized investment gains and losses. The Company has irrevocably elected the fair value option for these securities to simplify accounting and mitigate volatility in results of operations and financial condition. Hybrid securities include certain preferred stock and debt securities with call or conversion options.   
</ci:FixedMaturitiesAndEquitySecuritiesInvestmentPolicyTextBlock>
  <ci:CommercialMortgageLoansInvestmentPolicyTextBlock id="ID_16251" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Commercial mortgage loans.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Mortgage loans held by the Company are made exclusively to commercial borrowers.  Generally, commercial mortgage loans are carried at unpaid principal balances and are issued at a fixed rate of interest.  Commercial mortgage loans are considered impaired when it is probable that the Company will not collect amounts due according to the terms of the original loan agreement.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company assesses the impairment of loans individually for all loans in the portfolio&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Impaired loans are carried at the lower of unpaid principal or fair value of the underlying collateral.  Valuation reserves reflect any changes in fair value.  The Company estimates the fair value of the underlying collateral using internal valuations generally based on&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; discounted cash flow analyses.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:CommercialMortgageLoansInvestmentPolicyTextBlock>
  <ci:PolicyLoansReceivablePolicyTextBlock id="ID_16252" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Policy loans.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  Policy loans are carried at unpaid principal balances&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; plus accumulated interest&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; The loans are collateralized by insurance policy cash values and therefore have no exposure to credit loss.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:PolicyLoansReceivablePolicyTextBlock>
  <ci:RealEstateHeldForDevelopmentAndSalePolicyTextBlock id="ID_16253" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Real estate.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Investment real estate can be &amp;#8220;held and used&amp;#8221; or &amp;#8220;held for sale&amp;#8221;.  The Company accounts for real estate as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Real estate "held and used" is expected to be held longer than one year and includes real estate acquired through the foreclosure of commercial mortgage loans.  The Company carries real estate held and used at depreciated cost less any write-downs to fair value due to impairment and assesses impairment when cash flows indicate that the carrying value may not be recoverable.  Depreciation is generally calculated using the straight-line method based on the estimated useful life of the particular real estate asset. &lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Real estate is "held for sale" when a buyer's investigation is completed, a deposit has been received and the sale is expected to be completed within the next year.  Real estate held for sale is carried at the lower of carrying value or current fair value, less estimated costs to sell, and is not depreciated.  Valuation reserves reflect any changes in fair value.&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company uses several methods to determine the fair value of real estate, but relies primarily on discounted cash flow analyses and, in some cases, third&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;party appraisals.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;At the time of foreclosure, properties are reclassified from commercial mortgage loans to real estate or other long-term investments depending on the ownership of the underlying assets.  The Company rehabilitates, re-leases and sells foreclosed properties.  Thi&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s process usually takes from three to five&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; years unless management considers a near-term sale preferable&lt;/font&gt;&lt;font style="font-family:Stone Serif;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;When foreclosed real estate is recapitalized through a joint venture including a contribution of new equity from a third-party investor, the asset is accounted for as a partnership investment &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;in good standing &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;reported in other long-term investments.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:RealEstateHeldForDevelopmentAndSalePolicyTextBlock>
  <ci:OtherLongTermInvestmentsPolicyTextBlock id="ID_16254" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Other long-term investments.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Other long-term investments include investments in unconsolidated entities.  These entities include certain limited partnerships and limited liability companies holding real estate, securities or loans.  These investments are carried at cost plus the Company's ownership percentage of reported income or loss in cases where the Co&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;mpany has significant influence,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;o&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;therwise&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; the investment is carried at cost&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;I&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ncome from certain entities is reported on a one quarter lag&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;depending on when their financial information is received. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Also included in other long-term investments are loans to unconsolidated real estate entities secured by the equity interests of these real estate entities, which are carried at unpaid principal balances (mezzanine loans).&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;These other long-term investments are considered impaired, and written down to their fair value, when cash flows indicate that the carrying value may not be recoverable.  Fair value is generally determined based on a discounted cash flow analysis&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Additionally, other long-term investments include interest rate and foreign currency swaps carried at fair value.  See Note 13 for information on the Company's accounting policies for these derivative financial instruments.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:OtherLongTermInvestmentsPolicyTextBlock>
  <ci:ShortTermInvestmentsPolicyTextblock id="ID_16255" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Short-term investments. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Investments with maturities of greater than 90 days but less than one year from time of purchase are classified as short-term, available for sale and carried at fair value, which approximates cost.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:ShortTermInvestmentsPolicyTextblock>
  <ci:NetInvestmentIncomePolicyTextBlock id="ID_16256" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Net investment income.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  When interest and principal payments on investments are current, the Company recognizes interest income when it is earned.  The Company stops recognizing interest income when interest payments are delinquent&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; based on contractual terms&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; or when certain terms (interest rate or maturity date) of the investment have been restructured.  Net investment income on these investments is only recognized when interest payments are actually received. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Interest and dividends on trading and hybrid securities are included in net investment income&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; when &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;they are &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;earned&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:NetInvestmentIncomePolicyTextBlock>
  <ci:InvestmentGainsAndLossesPolicyTextBlock id="ID_16257" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Investment gains and losses.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  Realized investment gains and losses result from sales, investment asset write-downs, changes in the fair values of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; trading and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;hybrid securities and certain derivatives and changes in valuation reserves&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; based on specifically identified assets.  Realized investment gains and losses on the disposition of certain directly owned real estate investments are eliminated from ongoing operations and reported in discontinued operations when the operations and cash flows of the underlying assets are clearly distinguishable and the Company has no significant continuing involvement in the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ir&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; operations.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Unrealized gains and losses on fixed maturities and equity securities carried at fair value (excluding trading and hybrid securities) and certain derivatives are included in accumulated other comprehensive income (loss), net of: &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;amounts required to adjust future policy benefits&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; run-off settlement annuity business&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;; and&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;deferred income taxes.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:InvestmentGainsAndLossesPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock id="ID_16258" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:36px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Cash equivalents consist of short-term investments w&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ith&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; matur&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ities&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; three months or less from the time of purchase&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that are &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;classified as held to maturity and carried at amortized cost&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  The Company reclassifi&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;es cash overdraft positions to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;accounts payable, accrued &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;expenses and other liabilities &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;when the legal right of offset does not exist.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <ci:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffOfUncollectiblePremiumsPolicyTextBlock id="ID_16259" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:36px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Premiums, Accounts and Notes Receivable and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Reinsurance Recoverables&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Premiums, accounts and notes receivable are reported net of an allow&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;a&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;nce for doubtful accounts of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;49&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million as of December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and $43&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million as of December 31, 2009.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Reinsurance recoverables are estimates of amounts that the Company will receive from reinsurers and are recorded net of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;an allowance for&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;unrecoverable reinsurance of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million as of December 31, 2010 and $15&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million as of December 31, 2009&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  The Company estimates these allowances for doubtful accounts for premiums, accounts and notes receivable, as well as for reinsurance recoverables, using management's best estimate of collectibility, taking into consideration the aging of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;these amounts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, historical collection patterns and other economic factors&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffOfUncollectiblePremiumsPolicyTextBlock>
  <ci:CapitalizationOfDeferredPolicyAcquisitionCostsPolicyTextBlock id="ID_16260" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman Bold;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;F&lt;/font&gt;&lt;font style="font-family:Stone Serif;font-size:10pt;"&gt;.    &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Deferred Policy Acquisition Costs&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Acquisition costs include sales compensation, commissions,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; direct response marketing, telemarketing,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; premium taxes and other costs that the Company incurs in connection with new and renewal business.  Depending on the product line they relate to, the Company records acquisition costs in different ways.  Acquisition costs for:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;Universal life products&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; are deferred and amortized in proportion to the present value of total estimated gross profits over the expected lives of the contracts.&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;Supplemental health&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;, life and accident&amp;#160;insurance (&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;primarily&amp;#160;individual international&amp;#160;products) and group health&amp;#160;and accident&amp;#160;insurance products&lt;/font&gt;&lt;font style="font-family:Arial;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;are deferred and amortized, generally in proportion to the ratio of periodic revenue to the estimated total revenues over the contract periods.&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;Other products&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; are expensed as incurred.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;For universal life&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and other individual products, management estimates the present value of future revenues less expected payments.  For group health &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and accident insurance &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;products, management estimates the sum of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;unearned premiums and anticipated net investment income &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;less &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;future expected claims and related costs.  If management's estimates &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of these sums &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;are less than the deferred costs, the Company reduces deferred policy acquisition&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; costs and records an expense.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company recorded amortization for policy acquisition costs of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;312&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, $299&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2009&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and $314&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2008&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;in other operating expenses&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  There are no deferred policy acquisition costs attributable to the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;sold &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;individual life insurance and annuity&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;retirement &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;businesses &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;run-off reinsurance operations.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:CapitalizationOfDeferredPolicyAcquisitionCostsPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="ID_16261" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Property and Equipment &lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Property and equipment is carried at cost less accumulated depreciation.  When applicable, cost includes interest, real estate taxes and other costs incurred during construction.  Also included in this category is internal-use software that is acquired, developed or modified solely to meet the Company's internal needs, with no plan to market externally.  Costs directly related to acquiring, developing or modifying internal-use software are capitalized&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;T&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he Company calculates depreciation and amortization principally using the straight-line method &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;generally &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;based on the esti&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;mated useful life of each asset&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; as follows: buildings and im&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;provements, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to 40 years; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;purchased &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;software, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;five&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; years&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;; internally developed software; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;seven&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; years&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; furniture and equipment (including computer equipment&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to 10 years&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Improvements to leased facilities are depreciated over the remaining lease term or the estimated life of the improvement.  If the Company determines the carrying value of a long-lived asset is not recoverable, an impairment charge is recorded.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;See Note 9 for additional information.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <ci:GoodwillAndIntangibleAssetsGoodwillPolicyTextBlock id="ID_16262" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Goodwill &lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Goodwill represents the excess of the cost of businesses acquired over the fair value of their net assets. Goodwill primarily relates to the Health Care segment ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2.9&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;b&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;illion) and, to a lesser extent, the International segment ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;4&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million).  The Company evaluates goodwill for impairment &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;at least &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;annually during the third quarter at the reporting unit level, based on discounted cash flow analyses and writes it down through results of operations if impaired.  Consistent with prior years, the Company's evaluations of goodwill associated with the Health Care segment used the best information available at the time, including reasonable assumptions and projections consistent with those used in its annual planning process.  The discounted cash flow analyses used a range of discount rates that correspond with the Company's weighted average cost of capital, consistent with that used for investment decisions considering the specific and detailed operating plans and strategies within the Health Care segment. The resulting discounted cash flow analysis indicated an estimated fair value for the Health Care segment&amp;#160;exceeding its carrying value, including goodwill and other intangibles.  Finally, the Company determined that no events or circumstances occurred subsequent to the annual evaluation of goodwill that would more likely than not reduce the fair value of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;its reporting units&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; below &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;their&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; carrying value&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;See Note 9 for additional information.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:GoodwillAndIntangibleAssetsGoodwillPolicyTextBlock>
  <ci:SeparateAccountAssetsAndLiabilitiesPolicyTextBlock id="ID_16263" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;J&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Separate Account Assets and Liabilities&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Separate account assets and liabilities are contractholder funds maintained in accounts with specific investment objectives. The assets of these accounts are legally segregated and are not subject to claims that arise out of any of the Company's other businesses.  These separate account assets are carried at fair value with equal amounts for related separate account liabilities.  The investment income, gains and losses of these accounts generally accrue to the contractholders and are not included in the Company's revenues and expenses. Fees earned for asset management services are reported in premiums and fees.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:SeparateAccountAssetsAndLiabilitiesPolicyTextBlock>
  <ci:ContractholderDepositFundsPolicyTextBlock id="ID_16264" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;K&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Contractholder Deposit Funds&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:5pt; margin-bottom:5pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Liabilities for contractholder deposit funds primarily includes deposits received from customers for investment-related and universal life products and investment earnings on their fund balances.  These liabilities are adjusted to reflect administrative charges and, for universal life fund balances, mortality charges.  In addition, this caption includes premium stabilization reserves that are insurance experience refunds for group contracts that are left with the Company to pay future premiums, deposit administration funds that are used to fund nonpension retiree insurance programs, retained asset accounts and annuities or supplementary contracts without significant life contingencies. Interest credited on these funds is accrued ratably over the contract period. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&amp;#160;&lt;/li&gt;&lt;/ul&gt;</ci:ContractholderDepositFundsPolicyTextBlock>
  <ci:LiabilityReserveEstimatePolicyTextBlock id="ID_16265" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Future Policy Benefits &lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Future policy benefits are liabilities for the present value of estimated future obligations under long-term life and supplemental health insurance policies and annuity products currently in force.  These obligations are estimated using actuarial methods and primarily consist of reserves for annuity contracts, life insurance benefits, guaranteed minimum death benefit&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (&amp;#8220;GMDB&amp;#8221;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; contracts and certain life, accident and health insurance products in our International operations.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Obligations for annuities represent specified periodic benefits to be paid to an individual or groups of individuals over their remaining lives.  Obligations for life insurance policies represent benefits to be paid to policyholders, net of future premiums to be received.  Management estimates these obligations based on assumptions as to premiums, interest rates, mortality and surrenders, allowing for adverse deviation.  Mortality, morbidity, and surrender assumptions are based on either the Company's own experience or actuarial tables.  Interest rate assumptions are based on management's judgment considering the Company's experience and future expectations, and range fro&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;m &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1.25&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;%.  Obligations for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the run-off settlement &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;annuit&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;y business&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; include adjustments for investment&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; returns consistent with requirements of GAAP when a premium deficiency exists. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Certain reinsurance contracts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; contain&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMDB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;under variable annuities issued by other insurance companies.  These obligations represent the guaranteed death benefit in excess of the contractholder's account values (based on underlying equity and bond mutual fund investments).  These obligations are estimated based on assumptions regarding lapse, partial surrenders, mortality, interest rates (mean investment performance and discount rate), market volatility as well as investment returns and premiums, consistent with the requirements of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GAAP&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; when a premium deficiency exists.  Lapse, partial surrenders, mortality, interest rates and volatility are based on management's judgment considering the Company's experience and future expectations.  The results of futures contracts &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;used in the GMDB equity hedge program &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;are reflected in the liability calculation as a component of investment returns.  See also Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;7&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for additional information.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:LiabilityReserveEstimatePolicyTextBlock>
  <ci:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicyTextBlock id="ID_16266" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Unpaid Claims and Claims Expenses &lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Liabilities for unpaid claims and claim expenses are estimates of payments to be made under insurance coverages (primarily long-term disability, workers' compensation and life and health) for reported claims and for losses incurred but not yet reported.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company develops these estimates for losses incurred but not yet reported using actuarial principles and assumptions based on historical and projected claim incidence patterns, claim size&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, subrogation recoveries&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and the length of time over which payments are expected to be made.  The Company consistently applies these actuarial principles and assumptions each reporting period, with consideration given to the variability of these factors, and recognizes the actuarial best estimate of the ultimate liability within a level of confidence, as required by actuarial standards of practice, which require that the liabilities be adequate under moderately adverse conditions.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company's estimate of the liability for disability claims reported but not yet paid is primarily calculated as the present value of expected benefit payments to be made over the estimated time period that a policyholder remains disabled.  The Company estimates the expected time period that a policyholder may be disabled by analyzing the rate at which an open claim is expected to close (claim resolution rate).  Claim resolution rates may vary based upon the length of time a policyholder is disabled, the covered benefit period, cause of disability, benefit design and the policyholder's age, gender and income level.  The Company uses historical resolution rates combined with an analysis of current trends and operational factors to develop current estimates of resolution rates&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The reserve for the gross monthly disability benefits due to a policyholder &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;reduced&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;offset&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;by the income that the policyholder receives under other benefit programs, such as Social Security Disability Income, worker's compensation, statutory disability or other group disability benefit plans.  For awards of such offsets that have not been finalized, the Company estimates the probability and amount of the offset based on the Company's experience over the past three to five years.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;T&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he Company discounts certain claim liabilities related to group long-term disability and workers' compensation&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; because b&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;enefit payments may be made over&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;xtended period&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  Discount rate assumptions are based on projected investment returns for the asset portfolios that support these liabilities and range from &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;3.80&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;7.25&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;%.  When estimates change, the Company records the adjustment in benefits and expenses in the period in which the change in estimate is identified.  Discounted liabilities associated with the long-term disability and certain workers' compensation businesses were $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;3.1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; billion at &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2009&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicyTextBlock>
  <ci:HealthCareMedicalClaimsPayablePolicyTextBlock id="ID_16267" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;N.   &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Health Care Medical Claims Payable&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Medical claims payable for the Health Care segment include both reported claims and estimates for losses incurred but not yet reported.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company develops estimates for Health Care medical claims payable using actuarial principles and assumptions consistently applied each reporting period, and recognizes the actuarial best estimate of the ultimate liability within a level of confidence, as required by actuarial standards of practice, which require that the liabilities be adequate under moderately adverse conditions. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The liability &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is primarily calculated using  &amp;#8220;completion factors&amp;#8221; (a measure of the time to process claims), which are developed by comparing the date claims were incurred, generally the date services were provided, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;to the date claims were paid. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company uses historical completion factors combined with an analysis of current trends and operational factors to develop current estimates of completion factors.  The Company estimates the liability for claims incurred in each month by applying the current estimates of completion factors to the current paid claims data. This approach implicitly assumes that historical completion rates will be a useful indicator for the current period.  It is possible that the actual completion rates for the current period will develop differently from historical patterns, which could have a material impact on the Company's medical claims payable and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shareholders' &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net income.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Completion factors are impacted by several key items including changes in: 1) electronic (auto-adjudication) versus manual claim processing, 2) provider claims submission rates, 3) membership and 4) the mix of products.  As noted, the Company uses historical completion factors combined with an analysis of current trends and operational factors to develop current estimates of completion factors.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt; In addition, for the more recent months, the Company also relies on medical cost trend analysis, which reflects expected claim payment patterns and other relevant operational considerations.  Medical cost trend is primarily impacted by medical service utilization  and unit costs, which are affected by changes in the level and mix of medical benefits offered, including inpatient, outpatient and pharmacy, the impact of copays and deductibles, changes in provider practices and changes in consumer demographics and consumption behavior.   &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Despite reflecting both historical and emerging trends in setting reserves, it is possible that the actual medical trend for the current period will develop differently from expect&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ations&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, which could have a material impact on the Company's medical claims payable and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shareholders' &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net income.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;For each reporting period, the Company evaluates key assumptions by comparing the assumptions used in establishing the medical claims payable to actual experience. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;When actual experience differs from the assumptions used in establishing the liability, medical claims payable are increased or decreased through current period &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shareholders'&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net income. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Additionally, the Company evaluates expected future developments and emerging trends which may impact key assumptions.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; The estimation process involves considerable judgment, reflecting the variability inherent in forecasting future claim payments.  These estimates are highly sensitive to changes in the Company's key assumptions, specifically completion factors, and medical cost trends.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:HealthCareMedicalClaimsPayablePolicyTextBlock>
  <ci:RevenueRecognitionPremiumsEarnedPolicyTextBlock id="ID_16268" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Unearned Premiums and Fees&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Premiums for life, accident and health insurance are recognized as revenue on a pro rata basis over the contract period.  Fees for mortality and contract administration of universal life products are recognized ratably over the coverage period. The unrecognized portion of these amounts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; received&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; is recorded as unearned premiums and fees.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:RevenueRecognitionPremiumsEarnedPolicyTextBlock>
  <ci:AccountsPayableAccruedExpensesOtherLiabilitiesPolicyTextBlock id="ID_16269" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Accounts Payable, Accrued Expenses and Other Liabilities&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Accounts payable, accrued expenses and other liabilities consist principally of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;liabilities for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;pension, other postretirement and postemployment benefits&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (see Note 10)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, self-insured &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;exposures&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,  incentive compensation&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and various insurance-related &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;items&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, including amounts related to reinsurance contracts and insurance-related assessments that management can reasonably estimate.  Accounts payable, accrued expenses and other liabilities also include certain overdraft positions and the loss position of certain derivatives&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, primarily &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMIB &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;contracts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (see Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;13&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;).  Legal costs to defend the Company's litigation and arbitration matters are expensed when incurred&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;in&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; cases &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for which &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Company cannot reasonably estimate the ultimate cost to defend&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;In&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; cases &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for which &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Company can reasonably estimate the cost to defend, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;these &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;costs &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;are&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; recognized when the claim is reported.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:AccountsPayableAccruedExpensesOtherLiabilitiesPolicyTextBlock>
  <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock id="ID_16270" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Translation of Foreign Currencies&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company generally conducts its international business through foreign operating entities that maintain assets and liabilities in local currencies, which are generally their functional currencies.  The Company uses exchange rates as of the balance sheet date to translate assets and liabilities into U.S. dollars.  Translation gains or losses on functional currencies, net of applicable taxes, are recorded in accumulated other &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;comprehensive&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; income (loss).  The Company uses average &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;monthly &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;exchange rates during the year to translate revenues and expenses into U.S. dollars.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
  <ci:PremiumsReceivableBasisOfAccountingPolicyTextBlock id="ID_16271" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Premiums and Fees, Revenues and Related Expenses&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Premiums for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;group&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;life, accident and health insurance and managed care coverages are recognized as revenue on a pro rata basis over the contract period.  Benefits and expenses are recognized when incurred.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Premiums and fees include revenue from experience-rated contracts where revenue is based on the estimated ultimate claim, and in some cases, administrative cost experience of the contract.  For these contracts, premium revenue includes an adjustment for experience-rated refunds which is calculated &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;according to contract terms &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;using the customer's experience (including estimates of incurred but not reported claims)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Premiums for&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;individual life&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, accident and health&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; insurance and annuity products, excluding universal life and investment-related products,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;are recognized as revenue when due.  Benefits and expenses are matched with premiums.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Premiums and fees received for CIGNA's Medicare Advantage Plans and Medicare Part D products from customers and the Centers for Medicare and Medicaid Services (CMS) are recognized as revenue ratably over the contract period.  CMS provides risk adjusted premium payments for the Medicare Advantage Plans and Medicare Part D products, based on the demographics and health severity of enrollees.  The Company recognizes periodic changes to risk adjusted premiums as revenue when the amounts are determinable and collection is reasonably assured.  Additionally, Medicare Part D includes payments from CMS for risk sharing adjustments.  The risk sharing adjustments, which are estimated quarterly based on claim experience, compare actual incurred drug benefit costs to estimated costs submitted in original contracts and may result in more or less revenue from CMS.   Final revenue adjustments are determined through an annual settlement with CMS that occurs after the contract year.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Revenue for investment-related products is recognized as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Net investment income on assets supporting investment-related products is recognized as earned. &lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Contract fees, which are based upon related administrative expenses, are recognized in premiums and fees as they are earned ratably over the contract period.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Benefits and expenses for investment-related products consist primarily of income credited to policyholders in accordance with contract provisions.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Revenue for universal life products is recognized as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Net investment income on assets supporting universal life products is recognized as earned.&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Fees for mortality&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and surrender charges&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; are recognized as assessed, which is as earned.&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Administration fees are recognized as services are provided.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Benefits and expenses for universal life products consist of benefit claims in excess of policyholder account balances.  Expenses are recognized when claims are submitted, and income is credited&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to policyholders&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in accordance with contract provisions. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Contract fees and expenses for administrative services only programs and pharmacy programs and services are recognized as services are provided.  Mail order pharmacy revenues and cost of goods sold are recognized as each prescription is shipped.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:PremiumsReceivableBasisOfAccountingPolicyTextBlock>
  <ci:ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock id="ID_16272" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Stock Compensation&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company records compensation expense for stock awards and options over their vesting periods &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;primarily &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;based on the estimated fair value &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;at the grant date.  Compensation expense is recorded for&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; stock options&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; over their vesting period based on fair value at the grant date&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; which is calculated using an option-pricing model.  Compensation expense is recorded for restricted stock grants and units over their vesting periods based on fair value, which is equal to the market price of the Company's common stock on the date of grant.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  Compensation expense for str&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ategic performance shares &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is recorded over the performance period.  For&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;strategic performance shares &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;with&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; payment&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;dependent&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; on &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;market condition, fair value is determined at the grant date using a &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Monte Carlo&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; simulation model and not subsequently adjusted regardless of the final outcome.  For &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;strategic performance shares&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; with &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;payment dependent&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; on &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;performance conditions, expense is initially accrued based on the most likely outcome, but evaluated for adjustment each period for updates in the expected outcome.  At the end of the performance period, expense is trued up to the actual outcome (number of shares awarded times the share price at the grant date).&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock>
  <ci:PolicyholdersDividendPolicyTextBlock id="ID_16273" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Participating Business&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company's participating life insurance policies entitle policyholders to earn dividends that represent a portion of the earnings of the Company's life insurance subsidiaries.  Participating insuran&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ce accoun&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ted for approximately 1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of the Company's total life insurance in force at the end of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2009&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and approximately 2% of the Company's total life insurance in force at the end of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2008&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:PolicyholdersDividendPolicyTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock id="ID_16274" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Income Taxes&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company and its domestic subsidiaries file a consolidated &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;United States&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; federal income tax return.  The Company's foreign subsidiaries file tax returns in accordance with foreign law.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;U.S.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; taxation of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;these &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;foreign &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;subsidiaries&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; may differ in timing and amount from taxation under foreign laws.  Reportable amounts, including credits for foreign tax paid by th&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ese subsidiaries&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, are reflected in the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;U.S.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; tax return of the affiliates' domestic parent.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company recognizes deferred income taxes when &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the financial statement and tax-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;based carrying values of assets and liabilities are different and recognizes deferred income tax liabilities on the unremitted earnings of foreign subsidiaries&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; that are not permanently invested overseas&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;For subsidiaries whose earnings are considered permanently invested overseas, income taxes are accrued at the local foreign tax rate. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; The Company establishes valuation allowances against deferred tax assets if it is more likely than not that the deferred tax asset will not be realized.  The need for a valuation allowance is determined based on the evaluation of various factors, including expectations of future earnings and management's judgment.  Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;20&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; contains detailed information about the Company's income taxes. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company recognizes interim period income taxes by estimating an annual effective tax rate and applying it to year-to-date results.  The estimated annual effective tax rate is periodically updated throughout the year based on actual results to date and an updated projection of full year income.  Although the effective tax rate approach is generally used for interim periods, taxes on significant, unusual and infrequent items are recognized at the statutory tax rate entirely in the period the amounts are realized.  &lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock id="ID_8213" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Note 3 &amp;#8212; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;A&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;cquisitions&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;and Dispositions&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:12pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company may from time to time acquire or dispose of assets, subsidiaries or lines of business.&amp;#160;&amp;#160;Significant transactions are described below.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Reinsurance &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;of Run-off Workers' Compensation and Personal Accident  Business&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;On December 31, 2010, the Company &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ssentially&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; exited&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; from its workers' compensation and personal accident reinsurance business by purchasing retrocessional coverage from a &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Bermuda&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; subsidiary of Enstar Group Limited and transferring administration of this business to the reinsurer. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Under the reinsurance agreement, CIGNA is indemnified for l&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;iabilities with respect to its &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;workers&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;'&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; compensation and personal accident reinsurance business to the extent that &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;these &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;liabilities do not exceed 190% of the December 31 net reserves.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:12pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company believes that the risk of loss beyond this maximum aggregate is remote.  The reinsurance arrangement is secured by assets held in trust.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Cash consideration paid to the reinsurer was $190 million.    The net effect of this transaction was an af&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ter-tax loss of $20 million ($31&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million pre-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tax), primarily reported in other operating expenses in the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Run-off Reinsurance segment.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Sale&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt; of Workers' Compensation and Case Management Business&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;On December 1, 2010 the Company completed the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; sale&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of its &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;w&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;orkers' &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;c&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ompensation and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;c&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ase &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;m&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;anagement business to GENEX Holdings, Inc. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; The Company recognized an after-tax gain on sale of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;11&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;18&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million pre-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tax) which was reported in other revenues in the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Disability and Life segment&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.   &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Proceeds of the sale were received in preferred stock of GENEX Holdings, Inc., resulting in the Company becoming a minority shareholder in GENEX Holdings, Inc. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;This investment is classified in other long-term investments and accounted for using the equity method of accounting.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:36px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Acquisition of  Vanbreda International&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt; On August 31, 2010, the Company acquired 100% of the voting stock of Vanbreda International NV (Vanbreda International), based in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Antwerp&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Belgium&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for a cash purchase price of  $41&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million.  Vanbreda International specializes in providing worldwide medical insurance and employee benefits to intergovernmental and non-governmental organizations, including international humanitarian operations, as well as corporate clients.  Vanbreda International's strong presence in Europe complements the Company's position in providing expatriate benefits primarily to corporate clients in North America, as well as &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Europe and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Asia&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In accordance with GAAP, the total &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;p&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;urchase price has been allocated to the tangible and intangible net assets acquired based on management's estimates of their fair values&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Accordingly, approximately $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;210 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;million was allocated to intangible assets, primarily customer relationships.  The weighted average amortization period is &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; years. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The condensed balance sheet at the acquisition date was as follows:  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Investments&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 39&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 73&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Premiums, accounts and notes receivable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 22&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Property and equipment &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (71)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 229&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other assets, including other intangibles&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 220&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Total assets acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 513&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Accounts payable, accrued expenses and other liabilities&lt;/font&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 101&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Total liabilities acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 101&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 614px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net assets acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 412&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Goodwill is allocated to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;International segment.   For foreign tax purposes, the acquisition of Vanbreda International is being treated as a stock purchase. Accordingly, goodwill and other intangible assets will not be amortized for foreign tax purposes but may reduce the taxability of earnings repatriated to the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;U.S.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; by Vanbreda International.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The results of Vanbreda International are included in the Company's Consolidated Financial Statements from the date of acquisition.  The pro forma effect on total revenues and net income assuming the acquisition had occurred as of January 1, 2009 was not material to the Company's total revenues and shareholders' net income for the years ended December 31, 2010 or 2009. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:36px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Great-West Healthcare Acquisition&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;On April 1, 2008, the Company acquired the Healthcare division of Great-West Life and Annuity, Inc. (&amp;#8220;Great-West Healthcare&amp;#8221;) through 100% indemnity reinsurance agreements and the acquisition of certain affiliates and other assets and liabilities of Great-West Healthcare. The purchase price of approximately $1.5 billion consisted of a payment to the seller of approximately $1.4 billion for the net assets acquired and the assumption of net liabilities under the reinsurance agreement of approximately $0.1 billion.&amp;#160;&amp;#160;Great-West Healthcare primarily sells medical plans on a self-funded basis with stop loss coverage to select and regional employer groups.&amp;#160;&amp;#160;Great-West Healthcare's offerings also include the following specialty products:&amp;#160;&amp;#160;stop loss, life, disability, medical, dental, vision, prescription drug coverage, and accidental death and dismemberment insurance.&amp;#160;&amp;#160;The acquisition, which was accounted for as a purchase, was financed through a combination of cash and the issuance of both short and long-term debt.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In accordance with the FASB's guidance on accounting for business combinations, the Company completed its allocation of the total purchase price to the tangible and intangible net assets acquired&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;based on management's estimates of their fair values.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Accordingly, approximately $290 million was allocated to intangible assets, primarily customer relationships and internal-use software. The weighted average amortization period was 9 years for customer relationships and 6 years for internal-use software. The remainder, net of&amp;#160;tangible net assets acquired, was goodwill which approximated $1.1 billion and was allocated entirely to the Health Care segment. Substantially all of the goodwill is tax deductible and is being amortized over 15 years for federal income tax purposes. &lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
  <us-gaap:SignificantAcquisitionsAndDisposalsType id="ID_16275" contextRef="FROM_Jan01_2010_TO_Dec31_2010">essentially exited</us-gaap:SignificantAcquisitionsAndDisposalsType>
  <us-gaap:SignificantAcquisitionsAndDisposalsDescription id="ID_16276" contextRef="FROM_Jan01_2010_TO_Dec31_2010">On December 31, 2010, the Company essentially exited from its workers' compensation and personal accident reinsurance business by purchasing retrocessional coverage from a Bermuda subsidiary of Enstar Group Limited and transferring administration of this business to the reinsurer. Under the reinsurance agreement, CIGNA is indemnified for liabilities with respect to its workers&amp;#8217; compensation and personal accident reinsurance business to the extent that these liabilities do not exceed 190% of the December 31 net reserves. The Company believes that the risk of loss beyond this maximum aggregate is remote.  The reinsurance arrangement is secured by assets held in trust.  
On December 1, 2010 the Company completed the sale of its workers&amp;#8217; compensation and case management business to GENEX Holdings, Inc. </us-gaap:SignificantAcquisitionsAndDisposalsDescription>
  <ci:SignificantAcquisitionsAndDisposalsSegment id="ID_16277" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_BusinessDispositionAxis_SaleOfWorkersCompensationAndCaseManagementBusinessMember">Run-off Reinsurance segment.
Disability and Life segment</ci:SignificantAcquisitionsAndDisposalsSegment>
  <us-gaap:SignificantAcquisitionsAndDisposalsType id="ID_16278" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_BusinessDispositionAxis_SaleOfWorkersCompensationAndCaseManagementBusinessMember">&amp;#160;sale</us-gaap:SignificantAcquisitionsAndDisposalsType>
  <us-gaap:SignificantAcquisitionsAndDisposalsDescription id="ID_16279" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_BusinessDispositionAxis_SaleOfWorkersCompensationAndCaseManagementBusinessMember">Proceeds of the sale were received in preferred stock of GENEX Holdings, Inc., resulting in the Company becoming a minority shareholder in GENEX Holdings, Inc. </us-gaap:SignificantAcquisitionsAndDisposalsDescription>
  <ci:VanbredaProvisionalCondensedBalanceSheetTableTextBlock id="ID_15720" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Investments&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 39&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 73&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Premiums, accounts and notes receivable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 22&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Property and equipment &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (71)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 229&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other assets, including other intangibles&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 220&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Total assets acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 513&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Accounts payable, accrued expenses and other liabilities&lt;/font&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 101&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Total liabilities acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 101&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 614px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net assets acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 412&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:VanbredaProvisionalCondensedBalanceSheetTableTextBlock>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsMarketableSecurities id="ID_16283_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010" unitRef="USD">39000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsMarketableSecurities>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents id="ID_16284_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010" unitRef="USD">73000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables id="ID_16285_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010" unitRef="USD">22000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment id="ID_16286_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010" unitRef="USD">1000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet id="ID_16287_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010" unitRef="USD">-71000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount id="ID_16288_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010" unitRef="USD">229000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets id="ID_16289_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010" unitRef="USD">220000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet id="ID_16290_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010_us-gaap_BusinessAcquisitionAxis_VanbredaMember" unitRef="USD">412000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed id="ID_16291_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010_us-gaap_BusinessAcquisitionAxis_VanbredaMember" unitRef="USD">101000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed>
  <ci:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayableAccruedExpensesOtherLiabilities id="ID_16292_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010_us-gaap_BusinessAcquisitionAxis_VanbredaMember" unitRef="USD">101000000</ci:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayableAccruedExpensesOtherLiabilities>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired id="ID_16293_USD_InMillions" decimals="-6" contextRef="AS_OF_Sep30_2010_us-gaap_BusinessAcquisitionAxis_VanbredaMember" unitRef="USD">513000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired>
  <us-gaap:EarningsPerShareTextBlock id="ID_8235" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Note 4 &amp;#8212; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;E&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;arnings&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; P&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;er&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;hare&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Basic and diluted earnings per share were computed as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 95px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(Dollars in millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Basic&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 95px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Dilution&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' income from continuing operations&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,345&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,345&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 272,866&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 272,866&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Common stock equivalents &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,421&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,421&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 272,866&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,421&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 275,287&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4.93&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.04)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4.89&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' income from continuing operations&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,301&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,301&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 274,058&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 274,058&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Common stock equivalents &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,299&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,299&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 274,058&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,299&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 275,357&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4.75&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.02)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4.73&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' income from continuing operations&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 288&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 288&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 277,317&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 277,317&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Common stock equivalents &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,526&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,526&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 277,317&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,526&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 278,843&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.04&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.01)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.03&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;As described in Note 2, effective in 2009, the Company adopted the FASB's new guidance for determining participating securities which requires the Company's unvested restricted stock awards to be included in weighted average shares instead of being considered a common stock equivalent&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and restated 2008 EPS&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect would have increased diluted earnings per share (antidilutive) as their exercise price was greater than the average share price of the Company's common stock for the period.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 496px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:496px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 496px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:496px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Antidilutive options&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;6.3&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;8.8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;6.3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <ci:ScheduleOfEarningsPerShareBasicAndDilutedByCommonClassTextBlock id="ID_15721" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 95px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(Dollars in millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Basic&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 95px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Dilution&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' income from continuing operations&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,345&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,345&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 272,866&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 272,866&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Common stock equivalents &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,421&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,421&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 272,866&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,421&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 275,287&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4.93&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.04)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4.89&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' income from continuing operations&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,301&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,301&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 274,058&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 274,058&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Common stock equivalents &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,299&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,299&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 274,058&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,299&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 275,357&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4.75&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.02)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4.73&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' income from continuing operations&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 288&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 288&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 405px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:405px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 277,317&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 277,317&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Common stock equivalents &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,526&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,526&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 277,317&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,526&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 278,843&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td colspan="2"  style="width: 447px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:447px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.04&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.01)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.03&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:ScheduleOfEarningsPerShareBasicAndDilutedByCommonClassTextBlock>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_16294_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="Shares">272866000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_16295_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">275287000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_16296_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Shares">2421000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_16297_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="Shares">274058000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_16298_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="Shares">277317000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_16299_EPS_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="EPS">4.89</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_16303_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">274058000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_16304_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">1299000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_16305_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">275357000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_16306_EPS_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="EPS">4.73</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_16308_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">277317000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_16309_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">1526000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_16310_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">278843000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_16311_EPS_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="EPS">1.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_16312_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">1526000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_16313_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">1526000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_16314_EPS_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="EPS">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_16315_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">1299000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_16316_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">1299000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_16317_EPS_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="EPS">-0.02</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_16318_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">2421000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_16319_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">2421000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_16320_EPS_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="EPS">-0.04</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_16322_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="Shares">274058000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_16323_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="Shares">277317000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_16368_EPS_PerShare" decimals="2" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="EPS">4.93</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_16369_EPS_PerShare" decimals="2" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="EPS">4.75</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_16370_EPS_PerShare" decimals="2" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="EPS">1.04</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_17996_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="Shares">272866000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_17997_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">272866000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock id="ID_15722" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 496px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:496px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 496px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:496px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Antidilutive options&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;6.3&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;8.8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;6.3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="ID_16324_Shares_InMillions" decimals="-5" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Shares">6300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="ID_16325_Shares_InMillions" decimals="-5" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="Shares">8800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="ID_16326_Shares_InMillions" decimals="-5" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="Shares">6300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealthDisclosureTextBlock id="ID_8217" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;N&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ote&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;&amp;#8212; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;H&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ealth&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; C&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;are&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; M&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;edical&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; C&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;laims &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;P&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ayable&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Medical claims payable for the Health Care segment reflects estimates of the ultimate cost of claims that have been incurred but not yet reported, those which have been reported but not yet paid (reported claims in process) and other medical expense payable, which primarily comprises accruals for provider incentives and other amounts payable to providers. Incurred but not yet reported comprises the majority of the reserve balance as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Incurred but not yet reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,067&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 790&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Reported claims in process&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 164&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 114&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 530px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other medical expense payable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 15&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 17&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Medical claims payable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,246&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 921&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Activity in medical claims payable was as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1,&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 921&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 924&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 975&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  Reinsurance and other amounts  recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 206&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 211&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 258&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 715&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 713&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 717&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 3px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Acquired April 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 90&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 5px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Incurred claims related to:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Current year&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,663&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,970&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,312&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Prior years&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (93)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (43)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (60)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Total incurred&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,570&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,927&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,252&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Paid claims related to:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Current year&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,682&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,278&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,716&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Prior years&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 593&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 647&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 630&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Total paid&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,275&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,925&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,346&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at December 31, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,010&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 715&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 713&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add:  Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 236&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 206&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 211&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at December 31, &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,246&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 921&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 924&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to cover incurred but not reported and pending claims for minimum premium products and certain administrative services only business where the right of offset does not exist.&amp;#160;See Note 8 for additional information on reinsurance. For the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;year ended&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; December 31, 2010, actual experience differed from the Company's key assumptions resulting in favorable incurred claims related to prior years' medical claims payable of $93 million, or 1.3% of the current year incurred claims as reported for the year ended December 31, 2009. Actual completion factors resulted in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;a reduction&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in medical claims payable of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;51&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million, or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0.7%&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of the current year incurred claims as reported for the year ended December 31, 2009 for the insured book of business. Actual medical cost trend resulted in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;a reduction&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in medical claims payable of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;42&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million, or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0.6%&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of the current year incurred claims as reported for the year ended December 31, 2009 for the insured book of business.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;For the year ended December 31, 2009, actual experience differed from the Company's key assumptions, resulting in favorable incurred claims related to prior year&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s' medical claims payable of $43 million, or 0.6&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% of the current year incurred claims as reported for the year ended December 31, 2008.&amp;#160;Actual completion factors resulted in a reduction of the medical claims payabl&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e of $21&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million, or 0.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% of the current year incurred claims as reported for the year ended December 31, 2008 for the insured book of business.&amp;#160;Actual medical cost trend resulted in a reduction of t&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he medical claims payable of $22 million, or 0.3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% of the current year incurred claims as reported for the year ended December 31, 2008 for the insured book of business.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The favorable impact in 2010 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; primarily due to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;lower&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; utilization levels that occurred in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;late&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; 2009 and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the release of the provision fo&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;r moderately adverse conditions.  This provision &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is a component of the assumptions for both completion factors and medical cost trend, established for claims incurred related to prior years.&amp;#160;Th&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; release was substantially offset by the provision for moderately adverse conditions established for claims incurred related to the current year.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  The favorable impact in 2009 was primarily due to the release of the provision for moderately adverse conditions.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The corresponding impact of prior year development&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; was an increase to&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shareholders' &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net income &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of $26 million after-tax ($39 million pre-tax)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the year ended December 31, 2010 and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;was not material to shareholders' net income for the year ended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2009&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. The change in the amount of the incurred claims related to prior years in the medical claims payable liability does not directly correspond to an increase or decrease in the Company's &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shareholders' &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net income recognized for the following reasons:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;First&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, the Company consistently recognizes the actuarial best estimate of the ultimate liability within a level of confidence, as required by actuarial standards of practice, which require that the liabilities be adequate under moderately adverse conditions.&amp;#160;As the Company establishes the liability for each incurral year, the Company ensures that its assumptions appropriately consider moderately adverse conditions. When a portion of the development related to the prior year incurred claims is of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;fset by an increase determined&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; appropriate to address moderately adverse conditions for the current year incurred claims, the Company does not consider that offset amount as having any impact on &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shareholders' &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net income&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Second&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, while changes&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in reserves for the Company's guaranteed c&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ost products do directly affect shareholders' net income, changes in reserves for the Company's retrospectively experience-rated business do not always impact shareholders' net income.  For the Company's retrospectively experience-rate&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;d&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; business only adjustments to medical claims payable on accounts in deficit affect shareholders' net income. An increase or decrease to medical claims payable on accounts in deficit, in effect, accrues to the Company and directly impacts shareholders' net income. An account is in deficit when the accumulated medical costs and administrative charges, including profit charges, exceed the accumulated premium received. Adjustments to medical claims payable on accounts in surplus accrue directly to the policyholder with no impact on the Company's shareholders' net income. An account is in surplus when the accumulated premium received exceeds the accumulated medical costs and administrative charges, including profit charges.&lt;/font&gt;&lt;/p&gt;</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealthDisclosureTextBlock>
  <ci:MedicalClaimsPayableLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIbnrClaimsAmount id="ID_16327_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1067000000</ci:MedicalClaimsPayableLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIbnrClaimsAmount>
  <ci:MedicalClaimsPayableReportedClaimsInProcess id="ID_16328_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">164000000</ci:MedicalClaimsPayableReportedClaimsInProcess>
  <ci:MedicalClaimsPayableOtherMedicalExpensePayable id="ID_16329_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">15000000</ci:MedicalClaimsPayableOtherMedicalExpensePayable>
  <ci:MedicalClaimsPayableLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIbnrClaimsAmount id="ID_16330_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">790000000</ci:MedicalClaimsPayableLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIbnrClaimsAmount>
  <ci:MedicalClaimsPayableReportedClaimsInProcess id="ID_16331_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">114000000</ci:MedicalClaimsPayableReportedClaimsInProcess>
  <ci:MedicalClaimsPayableOtherMedicalExpensePayable id="ID_16332_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">17000000</ci:MedicalClaimsPayableOtherMedicalExpensePayable>
  <ci:MedicalClaimsPayableSummaryTextBlock id="ID_18254" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Incurred but not yet reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,067&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 790&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Reported claims in process&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 164&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 114&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 530px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other medical expense payable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 15&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 17&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Medical claims payable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,246&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 921&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:MedicalClaimsPayableSummaryTextBlock>
  <ci:MedicalReinsuranceAndOtherAmountRecoverables id="ID_16333_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">206000000</ci:MedicalReinsuranceAndOtherAmountRecoverables>
  <ci:MedicalReinsuranceAndOtherAmountRecoverables id="ID_16334_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2007_TO_Dec31_2007" unitRef="USD">258000000</ci:MedicalReinsuranceAndOtherAmountRecoverables>
  <ci:MedicalReinsuranceAndOtherAmountRecoverables id="ID_16335_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">211000000</ci:MedicalReinsuranceAndOtherAmountRecoverables>
  <ci:AcquiredNet id="ID_16337_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">0</ci:AcquiredNet>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear id="ID_16338_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">8663000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear id="ID_16339_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">6970000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear id="ID_16340_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">7312000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears id="ID_16341_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-93000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear id="ID_16343_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">7682000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear id="ID_16344_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">6278000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear id="ID_16345_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">6716000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears id="ID_16346_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">593000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears id="ID_16347_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">647000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears id="ID_16348_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">630000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid id="ID_16349_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">8275000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid id="ID_16350_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">6925000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid id="ID_16351_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">7346000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid>
  <ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable id="ID_16352_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1010000000</ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable>
  <ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable id="ID_16353_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">715000000</ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable>
  <ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable id="ID_16354_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">713000000</ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable>
  <ci:MedicalReinsuranceAndOtherAmountRecoverables id="ID_16355_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">236000000</ci:MedicalReinsuranceAndOtherAmountRecoverables>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth id="ID_16356_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008" unitRef="USD">924000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears id="ID_16358_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-60000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears>
  <ci:AcquiredNet id="ID_16360_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008" unitRef="USD">90000000</ci:AcquiredNet>
  <ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable id="ID_16361_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2007_TO_Dec31_2007" unitRef="USD">717000000</ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth id="ID_16362_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2007" unitRef="USD">975000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth>
  <ci:AcquiredNet id="ID_16365_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">0</ci:AcquiredNet>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears id="ID_16366_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-43000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears>
  <ci:ScheduleOfIncreaseDecreaseInlLabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseTextBlock id="ID_18256" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1,&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 921&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 924&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 975&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  Reinsurance and other amounts  recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 206&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 211&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 258&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 715&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 713&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 717&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 3px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Acquired April 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 90&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 5px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Incurred claims related to:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Current year&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,663&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,970&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,312&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Prior years&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (93)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (43)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (60)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Total incurred&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,570&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,927&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,252&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Paid claims related to:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Current year&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,682&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,278&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,716&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Prior years&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 593&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 647&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 630&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Total paid&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,275&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,925&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,346&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at December 31, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,010&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 715&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 713&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add:  Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 236&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 206&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 211&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at December 31, &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,246&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 921&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 924&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:ScheduleOfIncreaseDecreaseInlLabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseTextBlock>
  <ci:CostReductionTextBlock id="ID_15607" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;6&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8212; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;Initiatives to Lower Operating Expenses &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;As part of its strategy, the Company has undertaken several initiatives to realign its organization and consolidate support functions in an effort to increase efficiency and responsiveness to customers and to reduce costs.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;During 2008 and 2009, the Company conducted a comprehensive review to reduce the operating expens&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;es of its ongoing businesses (&amp;#8220;cost reduction p&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;rogram&amp;#8221;).  As a result, the Company recognized severance-related and real estate charges in other operating expenses.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Severance charges in 2008 and 2009 resulted from reductions of approximately 2,350 positions in the Company's workforce.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Cost reduction activities associated with these charges are substantially complete as of December 31, 2010.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;In 2010, the Company recorded an incremental pre-tax charge of $6 million ($4 million after-tax) to reflect actual severance experience differing from&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;prior&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; assumptions&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Cost reduction activity for 2008, 2009 and 2010 was as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Pre-tax&lt;/font&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt; (In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Severance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Real Estate&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Fourth Quarter 2008 charge (balance carried to January 1, 2009)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 44&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 11&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 55&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Second Quarter&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 14&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 14&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Third Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 10&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 10&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Fourth Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 20&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 20&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Subtotal - 2009 charges&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 44&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 44&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  Payments &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 55&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 58&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance, December 31, 2009&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 33&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 41&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: change in estimate to severance accrual&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 6&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 6&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  2010 Payments &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  First Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;10&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;11&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Second Quarter&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;13&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Third Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Fourth Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance, December 31, 2010&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 9&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 9&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Health Care segment r&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ecorded&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; substantially all of the 2010 charge,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $37 million pre-tax ($24&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million after-tax) of the 2009 charges &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $44 million pre-tax ($27 million after-tax) of the 2008 charge.  The remainder of the 2009 and 2008 charges were reported as follows:  Disability and Life:&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $5 million pre-tax ($4 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;million after-tax&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in 2009 and $3 million pre-tax ($2 million after-tax) in 2008; and International: $2 million pre-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tax ($1 million&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; after-tax&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in 2009 and $8 million pre-tax ($6 million after-tax) in 2008.  Substantially all severance is expected to be paid by the end of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the second quarter of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;201&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:CostReductionTextBlock>
  <ci:CostReductionRollforwardTextBlock id="ID_15725" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Pre-tax&lt;/font&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt; (In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Severance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Real Estate&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Fourth Quarter 2008 charge (balance carried to January 1, 2009)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 44&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 11&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 55&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Second Quarter&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 14&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 14&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Third Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 10&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 10&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Fourth Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 20&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 20&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Subtotal - 2009 charges&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 44&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 44&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  Payments &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 55&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 58&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance, December 31, 2009&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 33&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 41&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: change in estimate to severance accrual&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 6&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 6&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  2010 Payments &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  First Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;10&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;11&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Second Quarter&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;13&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Third Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Fourth Quarter &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance, December 31, 2010&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Arial;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 9&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 9&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:CostReductionRollforwardTextBlock>
  <ci:LiabilityForCostReductionInitiative id="ID_16371_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember" unitRef="USD">44000000</ci:LiabilityForCostReductionInitiative>
  <ci:LiabilityForCostReductionInitiative id="ID_16372_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">11000000</ci:LiabilityForCostReductionInitiative>
  <ci:LiabilityForCostReductionInitiativeCurrentYearCharges id="ID_16374_USD_InMillions" decimals="-6" contextRef="FROM_Jul01_2009_TO_Sep30_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember" unitRef="USD">10000000</ci:LiabilityForCostReductionInitiativeCurrentYearCharges>
  <ci:LiabilityForCostReductionInitiativeCurrentYearCharges id="ID_16375_USD_InMillions" decimals="-6" contextRef="FROM_Jul01_2009_TO_Sep30_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">0</ci:LiabilityForCostReductionInitiativeCurrentYearCharges>
  <ci:LiabilityForCostReductionInitiativeCurrentYearCharges id="ID_16377_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember" unitRef="USD">20000000</ci:LiabilityForCostReductionInitiativeCurrentYearCharges>
  <ci:LiabilityForCostReductionInitiativeCurrentYearCharges id="ID_16378_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">0</ci:LiabilityForCostReductionInitiativeCurrentYearCharges>
  <ci:LiabilityForCostReductionInitiative id="ID_16380_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember" unitRef="USD">33000000</ci:LiabilityForCostReductionInitiative>
  <ci:LiabilityForCostReductionInitiative id="ID_16381_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">8000000</ci:LiabilityForCostReductionInitiative>
  <ci:ChargeToReflectActualSeveranceExperience id="ID_16383_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember" unitRef="USD">6000000</ci:ChargeToReflectActualSeveranceExperience>
  <ci:ChargeToReflectActualSeveranceExperience id="ID_16384_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">0</ci:ChargeToReflectActualSeveranceExperience>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16386_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Mar31_2010" unitRef="USD">10000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16387_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Mar31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">1000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16389_USD_InMillions" decimals="-6" contextRef="FROM_Apr01_2010_TO_Jun30_2010" unitRef="USD">8000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16390_USD_InMillions" decimals="-6" contextRef="FROM_Apr01_2010_TO_Jun30_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">5000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16392_USD_InMillions" decimals="-6" contextRef="FROM_Jul01_2010_TO_Sep30_2010" unitRef="USD">7000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16393_USD_InMillions" decimals="-6" contextRef="FROM_Jul01_2010_TO_Sep30_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">1000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16395_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2010_TO_Dec31_2010" unitRef="USD">5000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16396_USD_InMillions" decimals="-6" contextRef="FROM_Oct01_2010_TO_Dec31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">1000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:LiabilityForCostReductionInitiative id="ID_16398_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember" unitRef="USD">9000000</ci:LiabilityForCostReductionInitiative>
  <ci:LiabilityForCostReductionInitiative id="ID_16399_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">0</ci:LiabilityForCostReductionInitiative>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16401_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_EmployeeSeveranceMember" unitRef="USD">55000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:LiabilityForCostReductionInitiativeCurrentYearPayments id="ID_16402_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009_ci_CostReductionRollforwardBySeveranceAndRealEstateAxis_RealEstateMember" unitRef="USD">3000000</ci:LiabilityForCostReductionInitiativeCurrentYearPayments>
  <ci:GuaranteedMinimumDeathBenefitsDisclosureTextBlock id="ID_8221" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;N&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ote&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;7&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;&amp;#8213;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;Guaranteed Minimum Death Benefit Contracts&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company's reinsurance operations, which were discontinued in 2000 and are now an inactive business in run-off mode, reinsured a guaranteed minimum death benefit&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8220;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMDB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8221;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, also known as variable annuity death benefits&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8220;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;VADBe&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8221;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, under certain variable annuities issued by other insurance companies.&amp;#160;&amp;#160;These variable annuities are essentially investments in mutual funds combined with a death benefit.&amp;#160;&amp;#160;The Company has equity and other market exposures as a result of this product.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;In periods of declining equity markets and in periods of flat equity markets following a decline, the Company's liabilities for these guaranteed minimum death benefits increase.  Conversely, in periods of rising equity markets, the Company's liabilities for these guaranteed minimum death benefits decrease.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In order&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to substantially reduce the equity market exposures relating to guaranteed minimum death benefit contracts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, the Company operates a dynamic hedge program (&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8220;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMDB equity hedge&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; program&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8221;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;), using&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; exchange-traded futures contracts.&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The hed&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;g&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; program is designed to offset both positive and negative impacts of changes in equity markets on the GMDB liability.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;In addition, the Company uses foreign currency futures contracts to reduce the international equity market and foreign currency risks associated with this business.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The hedg&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; program involves detailed, daily monitoring of equity market movements and rebalancing the futures contracts within established parameters.  While the hedge program is actively managed, it may not exactly offset changes in the GMDB liability due to, among other things, divergence between the performance of the underlying mutual funds and the hed&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;g&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; instruments, high levels of volatility in the equity markets, and differences between actual contractholder behavior and what is assumed.  The performance of the underlying mutual funds compared to the hed&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;g&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; instruments is further impacted by a time lag, since the data is not reported and incorporated into the required hedge position on a real time basis.  Although this hedge program does not qualify for GAAP hedge accounting, it is an economic hedge because it &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is designed&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to reduce&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;effective in reducing equity market exposures resulting from this product.  The results of the futures contracts are included in other revenue and amounts reflecting corresponding changes in liabilities for these &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMDB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; contracts are included in benefits and expenses.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  The notional amount of futures contract positions held by the Company at December 31, 2010 was $0.9 billion.  The Company recorded in other revenues pre-tax &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;losses of $157 million in 2010 and $282 million in 2009, compared with &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;pre-tax gains of $333 million in 2008 from these futures contracts.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In 2000, the Company determined that t&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he GMDB reinsurance business &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;wa&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s premium deficient&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; because the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;recorded future policy benefit reserve was less than the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;expected present value of future claims and expenses &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;less&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; the expected present value of future premiums and investment income using revised assumptions based on actual and expected experience.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;T&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he Company &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;test&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for premium deficiency by &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;review&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ing its reserve each quarter&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; using current market conditions and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;its long-term &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;assumptions. Under premium deficiency accounting&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; if the recorded reserve is determined insufficient, an increase to the reserve is reflected as a charge to current period income. Consistent with GAAP, the Company does not recognize gains on premium deficient long duration products.   &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company had future policy benefit reserves for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMDB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; contracts of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1.1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; billion as of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, and $1.3 b&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;illion as of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2009&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The determination of liabilities for GMDB requires the Company to make critical accounting estimates.&amp;#160;&amp;#160;The Company estimates its liabilities for GMDB exposures using a complex internal model run using many scenarios and based on assumptions regarding lapse, future partial surrenders, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;claim &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;mortality&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (deaths that result in claims)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, interest rates (mean investment performance and discount rate) and volatility.  Lapse refers to the full surrender of an annuity prior to a contractholder's death.  Future partial surrender refers to the fact that most contractholders have the ability to withdraw substantially all of their mutual fund investments while retaining the death benefit coverage in effect at the time of the withdrawal.  Mean investment performance &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for underlying equity mutual funds &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;refers to market rates &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;expected &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;to be earned &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;on the hedging instruments &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;over the life of the GMDB equity hedge program, and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for underlying fixed income mutual funds refers to the expected market return over the life of the contracts.  M&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;arket volatility refers to market fluctuation.  These assumptions are based on the Company's experience and future expectations over the long-term period, consistent with the long-term nature of this product.  The Company regularly evaluates these assumptions and changes its estimates if actual experience or other evidence suggests that assumptions should be revised.&amp;#160;&amp;#160;If actual experience differs from the assumptions (including lapse, future partial surrenders, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;claim &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;mortality, interest rates and volatility) used in estimating these liabilities, the result could have a material adverse effect on the Company's consolidated results of operations, and in certain situations, could have a material adverse effect on the Company's&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; financial condition.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The following provides information about the Company's reserving methodology and assumptions for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMDB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The reserves represent estimates of the present value of net amounts expected to be paid, less the present value of net future premiums.&amp;#160;&amp;#160;Included in net amounts expected to be paid is the excess of the guaranteed death benefits over the values of the contractholders' accounts (based on underlying equity and bond mutual fund investments).&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The reserves include an estimate for partial surrenders that essentially lock in the death benefit for a particular policy based on annual &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;election rates that vary from 0 to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% depending on the net amount at risk for each policy and whether surrender charges apply.&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;assumed &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;mean investment performance &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for the underlying equity mutual funds considers &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Company's GMDB equity hedge program using futures contracts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, and is based on the Company's view that short-te&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;rm interest rates will average 5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% over future periods&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, but considers that current short-term rates are less tha&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;n 5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;%&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The mean investment performance assumption for the underlying fixed income mutual fun&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ds (bonds and money market) is 5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% based on a review of historical returns.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Th&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e investment performance for underlying equity and fixed income mutual funds&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; is reduce&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;d by fund fees ranging from 1 to 3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% across all funds.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The volatility assumption &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;based on a review of historical monthly returns for each key index (e.g. S&amp;amp;P 500) over a period of at least ten years.  Volatility represents the dispersion of historical returns compared to the average historical return (standard deviation) for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;each index.  The assumption is 16% to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;26&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;%, varying by equity fund type; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;4% to 10&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;%, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;varying by bond fund type; and 2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% for money market funds.  These volatility assumptions are used along with the mean investment performance assumption to project future return scenarios.&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The discount rate is 5.75&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;%.&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;claim &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;mortality assumption is &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;65&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;89&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% of the 1994 Group Annuity Mortality table, with 1% annual improvement beginning January 1, 2000.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  The assumption reflects that for certain contracts, a spousal beneficiary is allowed to elect to continue a contract by becoming its new owner, thereby postponing the death claim rather than receiving the death benefit currently.  For certain issuers of these contracts, the claim mortality assumption depends on age, gender, and net amount at risk for the policy. &lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The lapse rate assumption is 0% to 2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;4&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;%, depending on contract type, policy duration and the ratio of the net amount at risk to account value.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;During 2010, the Company performed its periodic review of assumptions resulting in a charge of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;52&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million pre-tax ($34 million after-tax) to strengthen GMDB reserves.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;During&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; 2010 current short-term interest rates had declined from the level anticipated at December 31, 2009, leading the Company to increase reserves.  Interest rate risk is not covered by the GMDB equity hedge program discussed &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;above&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  The Company also updated the lapse assumption for policies that have already taken or may take a significant partial withdrawal, which had a lesser reserve impact.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;During 2009, the Company reported a charge of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;73&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million pre-tax ($47 million after-tax) to strengthen GMDB reserves.  The reserve strengthening primarily reflected an increase in the provision for future partial surrenders due to market declines, adverse volatility-related impacts due to turbulent equity market conditions, and interest rate impacts.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;During &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2008&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, the Company &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;recorded additional benefits expenses of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;4&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;06 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;million pre-tax ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;26&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;million after-tax)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;to strengthen GMDB reserves &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;following &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;an &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;analysis of experience and reserve assumptions&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  The &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;amounts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;were&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;primarily &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;due to&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;adverse impacts of overall market declines of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;210&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million pre-tax ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;136&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million after-tax)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;adverse volatility-related impacts due to turbulent equity market conditions total&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ing&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;182 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;million pre-tax ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;118&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million after-tax)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;adverse interest rate impacts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;14&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million pre-tax ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;9&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million after-tax). &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;    &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Activity in future policy benefit reserves for these &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMDB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; contracts was as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1,  &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,285&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,609&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 848&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add:  Unpaid Claims&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 36&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 34&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 21&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 83&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,268&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,560&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 850&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Incurred benefits&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (20)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (122)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 822&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Paid benefits&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 124&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 170&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 112&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending balance, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,124&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,268&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,560&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  Unpaid Claims&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 37&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 36&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 34&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 51&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 83&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at December 31,&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,138&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,285&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,609&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Benefits paid and incurred are net of ceded amounts.&amp;#160;&amp;#160;Incurred benefits reflect the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;(&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;favorable&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; or unfavorable impact of a rising or falling equity market on the liability&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, and include the charges discussed above&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;L&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;osses or gains have been recorded in other revenues as a result of the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMDB equity &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;hedg&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;program to reduce equity market exposures.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The majority of the Company's exposure arises under annuities that guarantee that the benefit received at death will be no less than the highest historical account value of the related mutual fund investments on a contractholder's anniversary date.  Under this type of death benefit, the Company is liable to the extent the highest historical anniversary account value exceeds the fair value of the related mutual fund investments at the time of a contractholder's death.  Other annuity designs that the Company reinsured guarantee that the benefit received at death will be:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the contractholder&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;'&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s account value as of the last anniversary date (anniversary reset); or&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:18px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;no less than net deposits paid into the contract accumulated at a specified rate or net deposits paid into the contract.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The table below presents the account value, net amount at risk and average attained ag&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of underlying contractholders for guarantees in the event of death, by type of benefit as of December 31.  The net amount at risk is the death benefit coverage in force or the amount that the Company would have to pay if all contractholders died as of the specified date, and represents the excess of the guaranteed benefit amount over the fair value of the underlying mutual fund investments.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(Dollars in millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Highest anniversary annuity value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Account value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 13,336&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 13,890&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Net amount at risk&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4,372&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,953&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Average attained age of contractholders (weighted by exposure)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 70&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 69&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Anniversary value reset&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Account value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,396&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,403&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Net amount at risk&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 52&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 113&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Average attained age of contractholders (weighted by exposure)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 63&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 61&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Account value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,864&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,918&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Net amount at risk&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 755&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 914&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Average attained age of contractholders (weighted by exposure)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 69&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 68&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Account value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,596&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 17,211&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Net amount at risk&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,179&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,980&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Average attained age of contractholders (weighted by exposure)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 70&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 69&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Number of contractholders (approx.)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 530,000&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 590,000&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company has also written reinsurance contracts with issuers of variable annuity contracts that provide annuitants with certain guarantees related to minimum income benefits. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;All reinsured GMIB policies also have a GMDB benefit reinsured by the Company.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; See Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;11&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for further information.&lt;/font&gt;&lt;/p&gt;</ci:GuaranteedMinimumDeathBenefitsDisclosureTextBlock>
  <ci:GuaranteedMinimumDeathBenefitsTextBlock id="ID_15726" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1,  &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,285&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,609&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 848&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add:  Unpaid Claims&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 36&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 34&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 21&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 83&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,268&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,560&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 850&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Incurred benefits&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (20)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (122)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 822&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Paid benefits&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 124&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 170&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 112&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending balance, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,124&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,268&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,560&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  Unpaid Claims&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 37&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 36&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 34&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 446px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 51&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 83&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:446px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at December 31,&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,138&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,285&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,609&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:GuaranteedMinimumDeathBenefitsTextBlock>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits id="ID_16404_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2007_TO_Dec31_2007" unitRef="USD">848000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits id="ID_16407_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2007_TO_Dec31_2007" unitRef="USD">21000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits>
  <ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables id="ID_16410_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2007_TO_Dec31_2007" unitRef="USD">19000000</ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefitNet id="ID_16412_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2007_TO_Dec31_2007" unitRef="USD">850000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefitNet>
  <ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits id="ID_16413_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">-20000000</ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits>
  <ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits id="ID_16414_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">-122000000</ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits>
  <ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits id="ID_16415_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008" unitRef="USD">822000000</ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit id="ID_16416_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">124000000</ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit>
  <ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit id="ID_16417_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009" unitRef="USD">170000000</ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit>
  <ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit id="ID_16418_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2008" unitRef="USD">112000000</ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefitNet id="ID_16419_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1124000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefitNet>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefitNet id="ID_16420_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1268000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefitNet>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefitNet id="ID_16421_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1560000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefitNet>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits id="ID_16422_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">37000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits id="ID_16423_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">36000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits id="ID_16424_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">34000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits>
  <ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables id="ID_16425_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">51000000</ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables>
  <ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables id="ID_16426_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">53000000</ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables>
  <ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables id="ID_16427_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">83000000</ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits id="ID_16428_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1138000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits id="ID_16429_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1285000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits id="ID_16430_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1609000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits>
  <ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeTableTextBlock id="ID_15727" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(Dollars in millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Highest anniversary annuity value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Account value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 13,336&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 13,890&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Net amount at risk&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4,372&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,953&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Average attained age of contractholders (weighted by exposure)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 70&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 69&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Anniversary value reset&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Account value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,396&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,403&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Net amount at risk&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 52&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 113&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Average attained age of contractholders (weighted by exposure)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 63&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 61&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Account value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,864&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,918&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Net amount at risk&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 755&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 914&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Average attained age of contractholders (weighted by exposure)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 69&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 68&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Account value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,596&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 17,211&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Net amount at risk&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,179&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 6,980&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Average attained age of contractholders (weighted by exposure)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 70&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 69&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 530px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Number of contractholders (approx.)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 530,000&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 590,000&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeTableTextBlock>
  <ci:GuaranteedMinimumDeathBenefitsAccountValue id="ID_16431_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_HighestAnniversaryAnnuityValueMemberMember" unitRef="USD">13890000000</ci:GuaranteedMinimumDeathBenefitsAccountValue>
  <ci:GuaranteedMinimumDeathBenefitsAccountValue id="ID_16432_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_AnniversaryValueResetMember" unitRef="USD">1403000000</ci:GuaranteedMinimumDeathBenefitsAccountValue>
  <ci:GuaranteedMinimumDeathBenefitsAccountValue id="ID_16433_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_OtherMember" unitRef="USD">1918000000</ci:GuaranteedMinimumDeathBenefitsAccountValue>
  <us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath id="ID_16434_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_HighestAnniversaryAnnuityValueMemberMember" unitRef="USD">5953000000</us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath>
  <us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath id="ID_16435_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_AnniversaryValueResetMember" unitRef="USD">113000000</us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath>
  <us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath id="ID_16436_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_OtherMember" unitRef="USD">914000000</us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath>
  <ci:GuaranteedMinimumDeathBenefitsTotalContractholders id="ID_16437_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="Number">530000</ci:GuaranteedMinimumDeathBenefitsTotalContractholders>
  <ci:AverageAttainedAgeOfContractholder id="ID_16438_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_HighestAnniversaryAnnuityValueMemberMember" unitRef="Number">69</ci:AverageAttainedAgeOfContractholder>
  <ci:AverageAttainedAgeOfContractholder id="ID_16439_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_AnniversaryValueResetMember" unitRef="Number">61</ci:AverageAttainedAgeOfContractholder>
  <ci:AverageAttainedAgeOfContractholder id="ID_16440_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_OtherMember" unitRef="Number">68</ci:AverageAttainedAgeOfContractholder>
  <ci:GuaranteedMinimumDeathBenefitsAccountValue id="ID_16441_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_TotalMember" unitRef="USD">17211000000</ci:GuaranteedMinimumDeathBenefitsAccountValue>
  <us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath id="ID_16442_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_TotalMember" unitRef="USD">6980000000</us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath>
  <ci:AverageAttainedAgeOfContractholder id="ID_16443_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2009_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_TotalMember" unitRef="Number">69</ci:AverageAttainedAgeOfContractholder>
  <ci:GuaranteedMinimumDeathBenefitsTotalContractholders id="ID_16444_Number_AsShownDecimals" decimals="0" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="Number">590000</ci:GuaranteedMinimumDeathBenefitsTotalContractholders>
  <ci:GuaranteedMinimumDeathBenefitsAccountValue id="ID_16445_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_HighestAnniversaryAnnuityValueMemberMember" unitRef="USD">13336000000</ci:GuaranteedMinimumDeathBenefitsAccountValue>
  <us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath id="ID_16446_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_HighestAnniversaryAnnuityValueMemberMember" unitRef="USD">4372000000</us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath>
  <ci:AverageAttainedAgeOfContractholder id="ID_16447_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_HighestAnniversaryAnnuityValueMemberMember" unitRef="Number">70</ci:AverageAttainedAgeOfContractholder>
  <ci:GuaranteedMinimumDeathBenefitsAccountValue id="ID_16448_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_AnniversaryValueResetMember" unitRef="USD">1396000000</ci:GuaranteedMinimumDeathBenefitsAccountValue>
  <us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath id="ID_16449_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_AnniversaryValueResetMember" unitRef="USD">52000000</us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath>
  <ci:AverageAttainedAgeOfContractholder id="ID_16450_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_AnniversaryValueResetMember" unitRef="Number">63</ci:AverageAttainedAgeOfContractholder>
  <ci:GuaranteedMinimumDeathBenefitsAccountValue id="ID_16451_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_OtherMember" unitRef="USD">1864000000</ci:GuaranteedMinimumDeathBenefitsAccountValue>
  <us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath id="ID_16452_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_OtherMember" unitRef="USD">755000000</us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath>
  <ci:AverageAttainedAgeOfContractholder id="ID_16453_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_OtherMember" unitRef="Number">69</ci:AverageAttainedAgeOfContractholder>
  <ci:GuaranteedMinimumDeathBenefitsAccountValue id="ID_16454_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_TotalMember" unitRef="USD">16596000000</ci:GuaranteedMinimumDeathBenefitsAccountValue>
  <us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath id="ID_16455_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_TotalMember" unitRef="USD">5179000000</us-gaap:NetAmountAtRiskByProductAndGuaranteeNetAmountAtRiskInEventOfDeath>
  <ci:AverageAttainedAgeOfContractholder id="ID_16456_Number_AsShownDecimals" decimals="0" contextRef="AS_OF_Dec31_2010_ci_GuaranteedMinimumDeathBenefitsAccountValueRiskAndAverageAgeAxis_TotalMember" unitRef="Number">70</ci:AverageAttainedAgeOfContractholder>
  <us-gaap:ReinsuranceTextBlock id="ID_8224" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;N&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ote&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;8&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;&amp;#8213;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; R&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;einsurance&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company's insurance subsidiaries enter into agreements with other insurance companies to assume&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and cede reinsurance.&amp;#160;&amp;#160;Reinsurance is ceded primarily to limit losses from large exposures and to permit recovery of a portion of direct losses.&amp;#160;Reinsurance is also used in acquisition and disposition transactions where the underwriting company is not being acquired. Reinsurance does not relieve the originating insurer of liability.&amp;#160;&amp;#160;The Company regularly evaluates the financial condition of its reinsurers and monitors its concentrations of credit risk.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Retirement benefits business&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#160;&amp;#160;The Company had &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;reinsurance recoverable&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1.7&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; billion as of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2009&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; from Prudential Retirement Insurance and Annuity Company resulting from the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; 2004&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; sale of the retirement benefits business, which was primarily in the form of a reinsurance arrangement.&amp;#160;&amp;#160;The reinsurance recoverable, which is reduced as the Company's reinsured liabilities are paid or directly assumed by the reinsurer, is secured primarily by fixed maturities equal to or greater than 100% of the reinsured liabilities&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; These fixed maturities are&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;held &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;in a trust established for the benefit of the Company.&amp;#160;As of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; fair value of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; trust &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;assets exceed&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ed&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; the reinsurance recoverable&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Individual life and annuity reinsurance&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. The Company had reinsurance recoverables totaling $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;4.3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; billion as of December 31, 2010 and $4.4 billion as of December 31, 2009 from The Lincoln National Life Insurance Company and Lincoln Life &amp;amp; Annuity of  New York resulting from the 1998 sale of the Company's individual life insurance and annuity business through indemnity reinsurance arrangements.&amp;#160;&amp;#160;At December 31, 2010, the $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;3.9&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; billion reinsurance recoverable from The Lincoln National Life Insurance Company was secured by assets held in a trust established for the benefit of the Company, and was less than the market value of the trust assets.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The remaining recoverable from Lincoln Life &amp;amp; Annuity of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;New York&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;402&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million is currently unsecured, however if this reinsurer does not maintain a specified minimum credit or claims paying rating, it is required to fully secure the outstanding balance.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:12pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; As of December 31, 2010 both companies had ratings sufficient to avoid triggering a contractual obligation.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Other Ceded and Assumed Reinsurance&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Ceded Reinsurance: Ongoing operations.&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;T&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he Company's insurance subsidiaries have reinsurance recoverables&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; from &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;various reinsurance arrangement&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s in the ordinary course of business for its Health Care, Disability and Life, and International segments as well as &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;corporate-owned life insurance business.  Reinsurance recoverables&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;282&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;million as of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;are expected t&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;o be collected from more than &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;70&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; reinsurers&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company reviews its reinsurance arrangements and establishes reserves against the recoverables in the event that recovery is not considered probable.  As of December 31, 2010, the Company's recoverables related to these segments were net of a reserve of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;9&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;million.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Assumed and Ceded reinsurance: Run-off Reinsurance segment. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company's Run-off Reinsurance operations assumed risks related to GMDB contracts, GMIB contracts, workers' compensation, an&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;d personal accident business.&amp;#160; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company's Run-off Reinsurance operations also purchased retrocessional coverage to reduce the risk of loss on these contracts.&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;In December 2010, the Company entered into reinsurance arrangements to transfer the remaining liabilities and administration of the workers' compensation and personal accident business&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;es&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;a subsidiary of Enstar Group Limited&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. Under this arrangement&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;new reinsurer also assumes the future &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;risk of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;collection &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;from&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; prior reinsurer&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; See &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for further details regarding this arrangement&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Liabilities related to GMDB, workers' compensation and personal accident are included in future policy benefits and unpaid claims.  Because the GMIB contracts are treated as derivatives under GAAP, the asset related to GMIB is recorded in the Other assets, including other intangibles caption and the liability related to GMIB is recorded in Accounts payable, accrued expenses, and other liabilities on the Company's Consolidated Balance Sheets (see Notes 11 and 24 for additional discussion of the GMIB assets and liabilities).&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The reinsurance recoverables for GMDB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; workers' compensation,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and personal accident &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;total &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$261&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; as of December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. Of this amount, approximately &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;77&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% are secured by assets in trust or letters of credit.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company reviews its reinsurance arrangements and establishes reserves against the recoverables in the event that&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;recovery is not &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;considered &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;probable.  As of December 31, 2010, the Company's recoverables related to this segment were net of a reserve of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;million.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company's payment obligations for underlying reinsurance exposures assumed by the Company under these contracts are based on&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ceding companies' claim payments. For GMDB, claim payments vary because of changes in equity markets and interest rates, a&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s well as mortality and contract&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;holder behavior. A&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ny&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of these claim payments can extend many years into the future, and the amount of the ceding companies' ultimate claims, and therefore the amount of&amp;#160;the Company's ultimate payment obligations and corresponding ultimate collection from retrocessionaires, may not be known with certainty for some time.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Summary.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company's reserves for underlying reinsurance exposures assumed by the Company, as well as for amounts recoverable from reinsurers/retrocessionaires for both ongoing operations and the run-off reinsurance operation, are considered appropriate as of December 31, 2010, based on current information.&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;However, it is possible that future developments could have a material adverse effect on the Company's consolidated results of operations and, in certain situations&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; such as if actual experience differs from the assumptions used in estimating reserves for GMDB, could have a material adverse effect on the Company's financial condition.&amp;#160;The Company bears the risk of loss if its retrocessionaires do not meet or are unable to meet their reinsurance obligations to the Company.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In the Company's Consolidated Income Statements, P&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;remiums and fees &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;were&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; presented&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; ne&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;t&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of ceded premiums, and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Total b&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;enefits and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;e&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;xpenses &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;were&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; presented &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net of reinsurance recoveries, in the following amounts:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Premiums and Fees&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Short-duration contracts:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Direct&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,611&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 13,886&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 13,969&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Assumed&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 496&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,076&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,221&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Ceded&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (187)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (192)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (242)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,920&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 14,770&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 14,948&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Long-duration contracts:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Direct&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,687&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,499&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,521&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Assumed&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 36&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 33&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ceded:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Individual life insurance and annuity business sold&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (195)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (209)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (220)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Other&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (55)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (52)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (49)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,473&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,271&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,305&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 18,393&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,041&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,253&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Reinsurance recoveries&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Individual life insurance and annuity business sold&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 321&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#00FFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 322&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#00FFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 368&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 156&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#00FFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 178&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#00FFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 282&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 477&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 500&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 650&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The decrease in assumed premiums in 2010 primarily reflects the effect of the Company's exit from two large, non-strategic assumed government life insurance programs&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; as well as the transfer of policies assumed in the acquisition of Great-West Healthcare directly to one of the Company's insurance subsidiaries in 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The effects of reinsurance on written premiums and fees for short-duration contracts were not materially different from the recognized premium and fee amounts shown in the above table.&lt;/font&gt;&lt;/p&gt;</us-gaap:ReinsuranceTextBlock>
  <ci:EffectsOfReinsuranceTextBlock id="ID_15728" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Premiums and Fees&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Short-duration contracts:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Direct&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,611&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 13,886&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 13,969&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Assumed&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 496&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,076&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,221&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Ceded&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (187)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (192)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (242)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,920&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 14,770&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 14,948&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Long-duration contracts:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Direct&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,687&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,499&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,521&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Assumed&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 36&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 33&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ceded:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Individual life insurance and annuity business sold&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (195)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (209)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (220)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Other&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (55)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (52)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (49)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,473&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,271&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,305&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 18,393&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,041&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,253&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Reinsurance recoveries&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Individual life insurance and annuity business sold&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 321&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#00FFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 322&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#00FFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 368&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 421px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 156&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#00FFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 178&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#00FFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 282&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 421px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:421px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 477&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 500&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 650&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:EffectsOfReinsuranceTextBlock>
  <ci:PremiumsAndFeesDirectShortDuration id="ID_16457_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">16611000000</ci:PremiumsAndFeesDirectShortDuration>
  <ci:PremiumsAndFeesDirectShortDuration id="ID_16458_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">13886000000</ci:PremiumsAndFeesDirectShortDuration>
  <ci:PremiumsAndFeesDirectShortDuration id="ID_16459_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">13969000000</ci:PremiumsAndFeesDirectShortDuration>
  <ci:PremiumsAndFeesAssumedShortDuration id="ID_16460_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">496000000</ci:PremiumsAndFeesAssumedShortDuration>
  <ci:PremiumsAndFeesAssumedShortDuration id="ID_16461_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1076000000</ci:PremiumsAndFeesAssumedShortDuration>
  <ci:PremiumsAndFeesAssumedShortDuration id="ID_16462_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1221000000</ci:PremiumsAndFeesAssumedShortDuration>
  <ci:PremiumsAndFeesCededShortDuration id="ID_16463_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-187000000</ci:PremiumsAndFeesCededShortDuration>
  <ci:ReinsuranceRecoveriesSoldBusiness id="ID_16464_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">321000000</ci:ReinsuranceRecoveriesSoldBusiness>
  <ci:ReinsuranceRecoveriesSoldBusiness id="ID_16465_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">368000000</ci:ReinsuranceRecoveriesSoldBusiness>
  <ci:ReinsuranceRecoveriesSoldBusiness id="ID_16466_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">322000000</ci:ReinsuranceRecoveriesSoldBusiness>
  <ci:ReinsuranceRecoveriesTotal id="ID_16467_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">477000000</ci:ReinsuranceRecoveriesTotal>
  <ci:ReinsuranceRecoveriesOther id="ID_16468_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">156000000</ci:ReinsuranceRecoveriesOther>
  <ci:ReinsuranceRecoveriesOther id="ID_16469_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">178000000</ci:ReinsuranceRecoveriesOther>
  <ci:ReinsuranceRecoveriesOther id="ID_16470_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">282000000</ci:ReinsuranceRecoveriesOther>
  <ci:ReinsuranceRecoveriesTotal id="ID_16471_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">500000000</ci:ReinsuranceRecoveriesTotal>
  <ci:PremiumsAndFeesCededShortDuration id="ID_16472_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-192000000</ci:PremiumsAndFeesCededShortDuration>
  <ci:PremiumsAndFeesCededShortDuration id="ID_16473_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-242000000</ci:PremiumsAndFeesCededShortDuration>
  <ci:ReinsuranceRecoveriesTotal id="ID_16474_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">650000000</ci:ReinsuranceRecoveriesTotal>
  <ci:PremiumsAndFeesDirectLongDuration id="ID_17319_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1687000000</ci:PremiumsAndFeesDirectLongDuration>
  <ci:PremiumsAndFeesAssumedLongDuration id="ID_17320_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">36000000</ci:PremiumsAndFeesAssumedLongDuration>
  <ci:PremiumsAndFeesCededIndividualLifeInsuranceAndAnnuityBusinessSoldLongDuration id="ID_17321_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-195000000</ci:PremiumsAndFeesCededIndividualLifeInsuranceAndAnnuityBusinessSoldLongDuration>
  <ci:PremiumsAndFeesCededOtherLongDuration id="ID_17322_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">-55000000</ci:PremiumsAndFeesCededOtherLongDuration>
  <ci:PremiumsAndFeesDirectLongDuration id="ID_17324_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">1499000000</ci:PremiumsAndFeesDirectLongDuration>
  <ci:PremiumsAndFeesAssumedLongDuration id="ID_17327_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">33000000</ci:PremiumsAndFeesAssumedLongDuration>
  <ci:PremiumsAndFeesCededIndividualLifeInsuranceAndAnnuityBusinessSoldLongDuration id="ID_17330_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-209000000</ci:PremiumsAndFeesCededIndividualLifeInsuranceAndAnnuityBusinessSoldLongDuration>
  <ci:PremiumsAndFeesCededOtherLongDuration id="ID_17353_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2009_TO_Dec31_2009" unitRef="USD">-52000000</ci:PremiumsAndFeesCededOtherLongDuration>
  <ci:PremiumsAndFeesDirectLongDuration id="ID_17355_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">1521000000</ci:PremiumsAndFeesDirectLongDuration>
  <ci:PremiumsAndFeesAssumedLongDuration id="ID_17357_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">53000000</ci:PremiumsAndFeesAssumedLongDuration>
  <ci:PremiumsAndFeesCededIndividualLifeInsuranceAndAnnuityBusinessSoldLongDuration id="ID_17360_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-220000000</ci:PremiumsAndFeesCededIndividualLifeInsuranceAndAnnuityBusinessSoldLongDuration>
  <ci:PremiumsAndFeesCededOtherLongDuration id="ID_17362_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2008_TO_Dec31_2008" unitRef="USD">-49000000</ci:PremiumsAndFeesCededOtherLongDuration>
  <ci:GoodwillAndIntangibleAssetsPropertyPlantAndEquipmentDisclosureTextBlock id="ID_8078" contextRef="FROM_Jan01_2010_TO_Dec31_2010">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Note 9 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;&amp;#8213;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; Goodwill&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;O&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ther Intangibles&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;, and Property and Equipment&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;G&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;oodwill &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;primarily &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;relat&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;es to the Health Care segment &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;9&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; billion) &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, to a lesser extent, the International segment ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;24&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;increased by &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;approximately &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;m&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;illion during 20&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;a&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s a result of the acquisition of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Vanbreda International&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and foreign currency translation after the acquisition&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The fair value of the Company's reporting units is substantially in excess of their carrying value therefore the risk&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for future impairment is unlikely&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Other i&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ntangible assets were comprised of the following at December 31:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 3px"&gt;&lt;td   style="width: 327px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 87px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:87px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 87px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:87px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Weighted Average&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; text-align:left;border-color:#000000;min-width:327px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Accumulated&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Net Carrying&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 87px; text-align:center;border-color:#000000;min-width:87px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Amortization&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(Dollars in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Cost&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Amortization&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 87px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:87px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Period (Years)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 3px"&gt;&lt;td   style="width: 327px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 87px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:87px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2010&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 87px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:87px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Customer relationships &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 587&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 277&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 310&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 87px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:87px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 70&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 22&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 48&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 87px; text-align:center;border-color:#000000;min-width:87px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;14&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total reported in other assets, including other intangibles&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 657&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 299&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 358&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 87px; text-align:center;border-color:#000000;min-width:87px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Internal-use software reported in property and equipment  &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,379&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 875&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 504&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 87px; text-align:center;border-color:#000000;min-width:87px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 327px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total other intangible assets &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,036&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,174&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 862&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 87px; text-align:center;border-color:#000000;min-width:87px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 87px; text-align:center;border-color:#000000;min-width:87px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 327px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:327px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2009&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 87px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:87px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;t